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Summary  
BACKGROUND: The analgesic effects of manual acupuncture (MA) and 
electro-acupuncture (EA) have been studied in healthy humans and patients with pain. 
The advantage of studying pain in healthy humans is that the intensity of stimulation can 
be accurately controlled and thereby the analgesic effect can be quantitatively assessed. 
However, an important difference between experimentally induced pain and clinical pain 
is central sensitisation, that is, an enhanced activity of the central nervous system (CNS). 
Temporal summation (TS) of pain refers to pain induced by repeated stimulations at 
sub-threshold level. It is a central phenomenon that reflects the sensitivity of CNS. The 
electrical TS pain model has been validated and applied to quantitatively determine the 
levels of analgesia and the central inhibition effects of analgesic medications. 
 
OBJECTIVES: The present study aimed to: 1. systematically review available 
randomised, controlled trials (RCTs) of acupuncture on experimentally induced pain in 
healthy humans; 2. conduct a RCT to assess the effect of MA and EA on TS of pain and 
the spatial characteristics of this effect (i.e. the same and different dermatome segments to 
the acupuncture point), and the temporal factors (i.e. immediately after and 24-hours after 
intervention).  
 
METHODS: The systematic review was carried out in accordance with the 
requirements of a Cochrane Systematic Review. The methodological quality and quality 
of the acupuncture techniques of the included RCTs were assessed. The Review 
Management software (RevMan version 4.2, The Cochrane Library) was used for data 
extraction and data analysis.  
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For the present experiment, 27 healthy volunteers were recruited and randomly assigned 
to either EA, MA or sham-acupuncture (SA) group, with nine volunteers in each group. 
The acupuncture sites were ST36 and ST40 on the dominant leg. Both the volunteers and 
the assessor were blinded to the treatment allocation. A second researcher, who was 
blinded to the outcome assessment processes, delivered all the interventions. Each 
treatment lasted for 25 minutes. To test pain thresholds, transcutaneous electrical 
stimulation was delivered to three sites: 1. the tibia anterior muscle along the sural nerve 
path of the treatment leg and parallel to the mid-point between ST36 and ST40; 2. the 
same area on the other leg; and 3. the dorsum of the non-dominant forearm along the 
median nerve path and 3 to 4 cm above the wrist crease. Pain thresholds to single 
electrical stimulation (SPT) and to TS stimulation (TST) were assessed before, 
30-minutes after and 24-hours after the intervention. Ratings to supra-threshold 
stimulation at intensities of 1.2 and 1.4 times the TST were assessed with a visual 
analogue scale. The level of anxiety was assessed before and after acupuncture. 
 
Data on pain thresholds and anxiety scores were analysed with one-way analysis of 
variance (ANOVA) using Statistical Package for the Social Sciences (SPSS, Version 
13.0) to detect between treatment group differences. Significance for each of the 
ANOVAs was assessed at α = 0.05 / 3 = 0.0167 (Bonferroni Correction). When a 
significant ANOVA was obtained, Bonferroni corrected post-hoc analyses were applied 
for multiple-comparisons. Equivalence of the groups on demographic variables was 
assessed by ANOVA and chi-square tests. Power analysis and sample size calculations 
were performed using MINITAB (Version 15.0). 
 
RESULTS: The literature search identified 605 papers, however, only nine papers met 
the inclusion criteria and thus included in this review. The methodological quality and 
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quality of the acupuncture procedures were satisfactory. In these studies, the pain models 
and interventions varied substantially, therefore, meta-analysis was not practicable. Four 
studies employed both invasive and non-invasive controls with three of them reported 
that the invasive controls induced significantly stronger analgesia than the non-invasive 
controls. One study reported that there was no difference between EA and MA tested 
using a heat pain model.  
 
In the present RCT, baseline values were comparable among the three groups with 
respect of SPT and TST. Overall, the baseline values of TST were lower than those of 
SPT. Within group comparison, the level of anxiety did not change significantly after the 
inventions. Between group comparisons, when sufficient statistical power was 
demonstrated, indicated that EA significantly increased SPT and TST on the treatment 
leg 24-hour after the treatment when compared with SA. In addition, the EA effect was 
not found on the non-treatment leg or the forearm. For the delivery of the supra-threshold 
stimulation, 1.2 and 1.4 times of the TST of each time point, instead of baseline TST, was 
mistakenly applied. Data from this component of the study were not analysed, however 
presented in the thesis for information.  
 
As the first study in this field, the current findings provide the base for sample size 
calculation. For example, the sample sizes for EA and MA comparisons with 80% 
statistical power at a significance level of 0.05 will be 21 subjects in each group to detect 
the immediate effect of acupuncture on TST, ; and 11 to detect the effect of acupuncture 
after 24-hour. 
 
CONCLUSIONS: The systematic review showed that there has been only a small 
number of experimental RCTs. Comparing acupuncture with non-invasive control, 
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significant acupuncture analgesia was reported. These studies also demonstrated that 
invasive controls produced analgesia. Thus, future studies should consider using 
non-invasive intervention as control. No conclusion could be drawn regarding the relative 
analgesic effect of EA versus MA.  
 
Consistent with previous studies, TS of pain can be successfully elicited in healthy 
humans with electrical stimulation. This study on TS demonstrated that the effect of EA 
was stronger than SA. The fact that such an effect increased within 24 hours after 
acupuncture might indicate the potential role of neurohumoral mechanisms in 
acupuncture analgesia. The spatial effect of acupuncture tended to be localised at the 
needling site. It is important to note that acupuncture increased both SPT and TST, which 
may suggest that both peripheral and central nervous systems mechanisms are involved in 
acupuncture analgesia. 
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Chapter 1: Introduction 
1.1 Studying acupuncture analgesia in healthy humans 
Acupuncture is a stimulation-dependent intervention which has been widely used in 
clinical practice to handle a wide range of pain syndromes (1). For example, patients with 
low back pain (2; 3; 4); arthritis (5); headache (6); fibromyalgia (7), and other painful 
disorders (8; 9; 10). 
 
Clinical pain is difficult to study and to compare between patients as many factors may 
affect the reporting of pain, such as the psychological state of patients and the degree of 
peripheral or central nervous system changes associated with diseases. In a clinical 
setting, these psychological and physiological changes are almost impossible to quantify 
(11; 12). Evoking and testing pain in healthy humans eliminates these factors, and has 
been proved to be a useful way to investigate the nociceptive functions of humans. 
Studying pain in healthy humans also has the advantages of precise control of 
experimental stimulations, the delivery of interventions and the utilisation of multiple 
outcome measurement tools. It allows researchers to control and quantify the intensity of 
stimulation, correlate the strength of stimuli with the rating of pain and directly compare 
pain within and among subjects or before and after an intervention (13). Studying pain in 
healthy humans has improved our understanding of pain, such as age and gender 
differences in the response to and the reporting of pain (12; 14).  
 
When studying pain in healthy humans, the methods used include testing of pain 
threshold (PT), pain tolerance threshold (PTT) and rating to supra-threshold (ST) 
stimulation. The International Association of the Study of Pain’s (IASP) definition of 
pain threshold is that “the least experience of pain which a subject can recognize; and 
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pain tolerance threshold is the greatest level of pain which a subject is prepared to 
tolerate” (15). The descriptions to these pain thresholds are clarified as follows. During 
experimental pain studies, when a stimulus is delivered to the skin of a human, one first 
feels some sensation, and the intensity at this level is called sensory threshold. With 
increasing intensity, one starts to feel slight pain, and the intensity at this level is called 
‘pain threshold’. As intensity continue to increase, one will feel pain getting stronger and 
to a degree, one does not want to tolerate the pain any more, this level of stimulation is 
called ‘pain tolerance threshold’. The pain ratings in response to the stimulations between 
the PT and PTT levels are called the ‘ratings to supra-threshold stimulations’ (13). In the 
thesis, the term ‘pain perception study’ refers to studies testing any of these pain 
thresholds. 
 
Observation of changes in pain thresholds provides direct evidence of acupuncture 
analgesia in humans (16). Such studies have been conducted since the 1970s to better our 
understanding of acupuncture analgesia. The literature review in chapter 3 summarises 
the observations of these studies. By comparing human pain thresholds before and after 
interventions, i.e. manual acupuncture (MA) or electro-acupuncture (EA), many studies 
have shown that EA and MA both have greater analgesic effect than sham-acupuncture 
(SA). Furthermore, some of these studies also provided evidence of the spatial 
distribution of the analgesic effect (17; 18), the involvement of naloxone (19), and the 
analgesic mechanisms involved in EA (20; 21; 22).  
 
However, there are three limitations of previous pain perception studies. Firstly, most of 
the previous studies tested pain thresholds to single stimulus which may not mimic 
clinical pain; these pain perception studies are different from clinical pain conditions in 
neurophysiologic aspects (23). One of the significant differences between pain threshold 
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studies and clinical pain is central sensitisation (12). Central sensitisation means the 
central nervous system is amplifying the activity-dependent afferent signals (24). 
Studying the central sensitisation is important because it underlies clinical pain, such as 
pain on light touch, pain on pressure or pain on movement (12). Secondly, in most cases, 
only the effect immediately after acupuncture was investigated. However, in clinical 
practice the acupuncture analgesic effect is thought to last for 24 to 72 hours (25; 26). 
Thirdly, the spatial distribution of the acupuncture analgesic effect is rarely studied to 
explain the general effect of acupuncture. In a recent study, the comparison between 
neural Segmental Inhibition Theory and traditional Meridian Theory was studied by 
measuring the change in pressure pain threshold at various sites of the body (17). MA on 
LI4, one classic analgesic acupoint, led to significant increases in the pain threshold at all 
measured sites; the result partially supports both Segmental Inhibition Theory and 
Meridian Theory. Therefore, further study is required to determine how the actions of 
acupuncture differentially affect different parts of the body i.e. the spatial distributing 
action of acupuncture. 
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1.2 Temporal summation of pain 
Temporal summation (TS) of pain describes a central phenomenon in neurophysiology. 
A non-painful stimulus when repeated at a certain frequency can induce a painful 
sensation. It is understood that repeated afferent signals cause gradually enhanced 
activities of the wide dynamic range (WDR) neurons leading to painful sensation; and its 
underlying mechanism is associated with the activation of N-methyl-D-aspartic (NMDA) 
receptors (27; 28; 29; 30; 31). TS of pain can be induced with thermal (28), mechanical 
(32) or electrical  stimulation (33). The commonly used 2-hertz electrical TS pain model 
was developed by Arendt-Nielsen and his colleagues in 1994 (33). Its reproducibility and 
reliability have also been tested (31; 34; 35; 36; 37). This model has been used in a 
number of studies to quantitatively assess the effectiveness and the central inhibitory 
effects of analgesics in healthy pain-free humans (see Chapter 2 for detail of these 
studies). For example, ketamine (38), codeine (34; 39), and venlafaxine (36; 40). 
 
Employing this electrical TS pain test model to study acupuncture analgesia can help to 
address the limitations mentioned above (section 1.1). Using this valid pain model to 
study acupuncture analgesia allows researchers to quantitatively evaluate the analgesic 
effects of different acupuncture techniques and identify their central inhibitory properties 
associated with central sensitisation. Thereby, this approach may contribute to the overall 
understanding of the mechanisms of acupuncture analgesia. 
 
There are different models that can be used to mimic clinical pains in healthy humans 
other than TS model, such as hyperalgesia model. Hyperalgesia is an increased response 
to a stimulus which is normally painful (15). The stimulation used for the hyperalgesia 
test is usually induced by prolonged, noxious heat, mechanical or electrical stimulation. 
The hyperalgesia model is different from the TS model as the stimulations are noxious, 
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i.e. at supra-threshold level. TS and hyperalgesia pain models can be used to evaluate the 
different levels of sensitivity of the central nervous system. TS model has a few 
advantages than a hyperalgesia model. First, the stimulations of TS are usually not painful 
and can be easily accepted by the participants. Second, the frequency of the repeated 
stimulation can be readily controlled so as to indicate the levels of central sensitisation 
(33). Third, the methods of TS pain model are well validated (see paragraph 1 in this 
section). 
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1.3 Selection of stimulations for the study 
There are a few types of stimulations that can be used to test TS. They are electrical, 
mechanical and thermal stimulations. Electrical stimulation has obvious advantages of 
easy control and recording. However, electrical stimulation method has three major 
shortcomings. Firstly, it is unnatural and non-physiological. Secondly, it does not 
selectively activate certain afferent fibres. Thirdly, the information during the 
transduction processes is lost because electrical stimulations directly activate the sensory 
nerve endings (41). The mechanical and thermal stimulations are categorized as natural 
stimulations, i.e., physiologic stimulations (41; 42). Modern instruments can provide 
precise control for the delivery of mechanical and thermal stimuli. These stimulation 
methods have potential for TS tests. However, we can only choose the electrical 
stimulation method for this experiment due to two reasons. First, the methods using 
electrical stimulation to induce TS had been systematically evaluated by other 
researchers. It has been used in many studies and has been shown to be reliable and 
sensitive to analgesics (34; 36; 38; 39; 40).  Second, we do not have any instrument that 
can deliver heat stimuli reliably. Ideally both electrical and heat stimulations should be 
used. 
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1.4 Systematic reviews and randomised controlled trials 
Large amounts of uncategorized information are published in healthcare areas, including 
updated information and information that is out of date, all of which can influence the 
medical decisions of patients, practitioners and researchers. Systematic reviews using 
explicit methods can refine the reliable evidence and hence benefit healthcare 
management and medical decisions; especially when each systematic review can focus on 
one specific aspect of healthcare (43; 44). The conduct of a systematic review is one of 
the approaches of contemporary evidence-base medicine (EBM), and the other approach 
of EBM is the randomised controlled trials (RCT) using valid methods of randomisation 
and double-blinding (45; 46). The RCT using valid method of randomisation and 
double-blinding can enhance the quality of acupuncture studies (47; 48; 49). The proper 
randomisation methods and double-blinding procedures for acupuncture studies have 
been clarified in the Cochrane Reviewer’s Handbook for Systematic Reviews of 
Interventions (44). The use of computer generated sequence numbers and sealed envelops 
are considered the proper procedures for the method of randomisation. Blinding the 
subjects and evaluator to the group assignment and blinding the acupuncturist to the 
performance of the subjects are considered proper double-blind methods. 
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1.5 Aims of the present project  
The present study utilises two commonly accepted EBM approaches, systematic review 
and RCT, to assess the current data from acupuncture analgesia studies in healthy humans 
and to investigate the effects of acupuncture on TS of pain. An experimental RCT using 
double-blinding method aims to evaluate the effectiveness of acupuncture analgesia in 
healthy pain-free human subjects is conducted. The major comparisons are the effects of 
MA, EA (2/100 hertz) and non-invasive SA on electrical stimulation induced SPT, TST 
and pain ratings to ST levels of TS stimulation. These TS pain tests also take into 
consideration the central-peripheral expression on different limbs (i.e. the same 
dermatome of lumbar-5 segment on treatment leg and non-treatment leg and a second 
dermatome of Cervical-7 segment on the forearm), and the temporal factors (i.e. 
immediately after intervention and 24-hours after intervention).  
 
The aims are: 
1) to systematically review acupuncture studies in health humans to understand whether 
real acupuncture is better than SA and EA is better than MA in terms of improving pain 
thresholds as indicated by various stimulations, such as mechanical, thermal or electrical; 
2) to compare the analgesic effect among EA, MA and SA by assessing the pain 
thresholds to single electrical stimulus (i.e. SPT) and repeated electrical stimulations (i.e. 
TST); 
3) to evaluate the temporal effects of acupuncture analgesia by conducting pain 
assessments at before, 30 minutes after and 24 hours after interventions; and  
4) to assess the spatial distribution of acupuncture analgesia by conducting pain 
assessments on the treatment leg, non-treatment leg and forearm. 
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1.6 About the thesis 
In the thesis, the content is arranged as follows: 
 
• Chapter 1 introduces the background and aims of the present study; 
• Chapter 2 discusses the TS of pain and presents a literature review examining the 
existing studies using the electrical TS pain model; 
• Chapter 3 introduces the acupuncture interventions used in present study and 
examines the literature explaining the mechanisms of these techniques of 
acupuncture; 
• Chapter 4 focuses on systematically reviewing RCTs published in the English 
literature of acupuncture analgesia in healthy humans; 
• Chapter 5 describes the methods of the RCT in the present study; 
• Chapter 6 provides the results of the present study; and 
• Chapter 7 encompasses the discussion and conclusion of the present study.  
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Chapter 2: Temporal summation of pain - 
experimental models and neural mechanisms 
 
2.1 Definition of temporal summation of pain  
In neurobiological and neurophysiological pain research, ‘temporal summation’ (TS) is a 
phenomenon which entails an successive increase of pain perception and / or pain 
response upon repeated nociceptive stimuli being delivered to the skin surface (31; 33; 
50), or to muscle tissues (51; 52; 53). The TS pain threshold (i.e. TST) refers to the 
intensity of repetitive stimulation which is minimumly sufficient to cause a sensation 
identified as pain. This intensity is lower than the pain threshold (PT) which is tested with 
the same type of stimulation but delivered as a single episode, i.e. the single-stimulus pain 
threshold (SPT). Repeating a non-painful stimulus a few times can cause a painful 
sensation due to the process of central amplification (29; 31; 33).  
 
TS of pain can be reliably elicited in healthy human with repeated mechanical, heat or 
electrical stimuli (31). TS of pain is frequency-dependent. A few human and animals 
studies indicate that TS of pain can only occur when electrical stimuli are delivered 
repeatedly at or above 0.5-hertz, thermal stimuli are delivered repeatedly at or above 
0.3-hertz (28; 31), and mechanical stimuli are delivered repeatedly at or above 0.3-hertz 
(32). 
 
Arendt-Nielsen and colleagues studied the parameters required for an electrical TS pain 
model in 1994. In a quantitative study, the pain ratings and the electromyogram (EMG) of 
withdrawal reflexes of healthy humans were recorded when trains of electrical stimuli 
(ES) were delivered at various frequencies (0.1-, 1-, 2-, 3-, 4- and 5- hertz) and at five or 
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ten numbers of stimuli to the skin surface on the retro-malleolar pathway of the sural 
nerve. Each train of ES consisted of five individual 1-ms pulses delivered at 200-hertz. 
This study found that the peak EMG reading was at the fourth and fifth train and ES with 
a frequency of 2-hertz and 3-hertz reliably elicited TS of pain (33). 
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2.2 Mechanisms of temporal summation 
2.2.1 Neural responses to repeated stimulations 
The repeated TS stimulations specifically activate C-fibres’ responses in peripheral 
nerves and then trigger the excitability of the wide dynamic range (WDR) neurons 
located in the dorsal horn of the spine (28; 54; 55; 56). WDR neurons respond to 
information from a variety of afferents, including those of low and high intensity. These 
are different from the smaller neurons called nociceptive specific cells, which selectively 
respond to high intensity afferent signals (55; 57). As the stimuli to the afferent fibres is 
repeated, the excitability of the WDR neurons gradually increases; this phenomenon of 
the central neurons is called windup (55), and is a form of  neuronal plasticity (58; 59). 
Windup has been observed and evaluated in a large numbers of animal and human studies 
over 40 years. Consistent results have been demonstrated which indicate that windup is 
the pathway of the central amplification effect in response to the repeated TS-mode 
stimulations (31; 59; 60). This central amplification effect is called central sensitisation 
(24). The courses between TS stimulations and central nerves responses are summarised 
in the Figure 2.1 as followed. 
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Figure 2.1 Neural mechanism of temporal summation of pain 
 
Repeated stimulations (TS stimulations) deliver to skin or muscle tissues. 
Peripheral C-fibres are activated. 
WDR neurons in spinal dorsal horn are excited. 
This enhanced excitability of WDR neurons in spinal cord in response 
to repeated stimulations is called windup. 
 
The central nervous system amplifies the afferent signals (windup and central 
sensitisation). 
The actions of nociceptive reflexes and / or higher levels of pain response occur if 
the TS stimulations are repeated a few times and at higher than or equal to certain 
frequency. 
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2.2.2 Neural mechanism: temporal summation of pain and NMDA 
receptors 
The activations of N-methyl-D-aspartic (NMDA) receptors in TS of pain has been 
reported in many studies (31; 38; 61). Upon a tissue injury, C and A-delta afferents are 
activated, causing prolonged discharge of the central neurons, such as nociceptive 
specific neurons. These discharges in turn activate the NMDA type of amino acid 
receptors, open up the ion channels (mainly the calcium flux) of the NMDA receptors on 
the WDR neurons (62), and the hyperexcitability of these neurons in the dorsal horn is 
therefore enhanced (63; 64). A similar mechanism is observed in TS of pain. Repeated 
stimulations activate the WDR neurons via opening up the ion channels (mainly the 
calcium flux) of the NMDA receptors (62). The NMDA receptor mechanism of TS pain 
was validated using ketamine studies. Ketamine, an NMDA receptor antagonist 
medication, which specifically blocks the ion channel on the NMDA receptors and 
thereby inhibit the hyperexcitability of the dorsal horn neurons (38; 64). The central 
mechanism of NMDA antagonist medications (i.e. ketamine, nitrous oxide and 
dextromethorphan) have been tested in studies using TS stimuli. An animal study 
demonstrated that the NMDA antagonist medications can decrease the dorsal horn 
neurons’ firing in response to a train of stimuli in rats (56). In two human studies, both 
ketamine and dextromethorphan successfully suppressed the evocation of TS pain (TST) 
but had no effect on single-stimulus induced PT (SPT) (38; 61); a further study used 
ketamine tested fibromyalgia patients and also confirmed this observation (52). These 
results indicate that the central mechanism of TS pain is due to the activation of NMDA 
receptors (31; 38; 52; 61). 
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Inferred from the neural mechanisms of TS pain, if an intervention inhibits TST but has 
no effect on SPT, the intervention is likely to have central inhibitory effect, and 
potentially block the activation of NMDA receptors. If an intervention is effective on 
both SPT and TST, it may suggest that the analgesic effect is via not only inhibiting the 
activation of NMDA receptors but also other receptors, and this analgesic effect possibly 
involves both central and peripheral mechanisms. Studies examining the effects of 
various analgesics on TS of pain are summarised in Section 2.4.2. 
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2.3 Temporal summation and clinical pain 
It is believed that TS closely relates to the central sensitisation underlying clinical pain 
symptoms for two reasons. First, both central sensitisation and temporal summation of 
pain show central amplification effects in response to nociceptive impulses (31). Second, 
the TS of pain has been shown to be enhanced in various clinical pain conditions (31; 52; 
65). Two studies showed fibromyalgia patients had significantly higher pain responses to 
repeated heat stimuli than the pain-free humans control (65; 66). Another study found that 
fibromyalgia patients had significantly higher pain responses to repetitive mechanical 
stimuli when compared with normal subjects (67). A recent study showed 62% of 42 
Caucasian adolescents with complex regional pain syndromes had enhanced TS of pain to 
repeated mechanical stimuli when compared to the normal pain-free controls (68). 
Central sensitisation is understood to be the main neural mechanism underlying the 
symptoms evaluated in the above studies. Enhanced TS of pain in these pain symptoms 
suggests a central contribution to the TS. In a clinical trial using the 2-hertz electrical TS 
pain model, ketamine reduced the pain and increased the TST in fibromyalgia patients 
(52). This study provides further evidence that the reproducible and reliable 2-hertz 
electrical TS model can be used as a good indicator to evaluate the effectiveness of 
analgesic interventions.  
 
There is one type of clinical pain, hyperpathia, which is similar to TS. Hyperpathia is 
commonly seen in neuropathic pain. Patients with such pain experience sensory deficit 
however when a stimulus is delivered repeatedly, an exacerbation of pain is presented, 
due to deafferentation-related central sensitisation (69). TS is not hyperpathia, although 
both present pain upon repeated stimulation. The former can happen in normal humans 
and neuropathic pain patients, whereas hyperpathia only occurs in neuropathic pain 
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patients with sensory deficit. The underlying mechanisms of the two are also likely to be 
different (68; 70). 
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2.4 Analysing clinical trials using electrical temporal 
summation pain model 
A literature search was conducted to examine the use of electrical TS pain model and the 
impacts of analgesics on it. The term ‘temporal summation’ was searched in four major 
electronic databases, Pubmed, Embase, CINAHL and Cochrane, in order to locate the 
clinical trials using the electrical TS pain model. In total 12 papers were found and 
selected (34; 35; 36; 37; 38; 39; 40; 52; 71; 72; 73; 74). Information of their methods and 
results is extracted into Table 2.1 and Table 2.2.  
 
2.4.1 Characteristics of temporal summation electrical 
stimulation model  
The variety of methods used in these studies is listed in Table 2.1. All of the authors 
claimed their TS models were reproducible, and could be used to identify the central 
effect of medications underlying specific NMDA receptor inhibition mechanisms.  
 
2.4.1.1 Sites of assessment and analgesic effects of medications  
Nearly all studies had the assessment site on the skin along the sural nerve path. Ten 
studies had at least one of their assessment sites on the sural nerve along its retromalleolar 
path, one study had one assessment site at the tibia anterior muscle along the sural nerve 
path (52), and the remaining one study conducted the TS pain assessment on the painful 
area which was reported by the individual chronic pain patient (40).  
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Nearly all studies had one assessed site, except for two studies which tested TS on 
multiple sites. One study assessed TST at one of each patient’s neuropathic pain affected 
skin surfaces, according to the individual’s report. This study reported a significant effect 
of venlafaxine, an antidepressant (serotonin-norepinephrine reuptake inhibitor), on 
suppressing the TST when compared with placebo (40). The other study had two 
assessment sites at the right Sacrum-1 (S1) on the foot (distal to the lateral malleolus 
along the sural nerve), and at Lumbar-4 (L4), in the middle of patella. This study 
compared three medications delivered via epidural injection and reported the increased 
TST were significantly higher at L4 than at the S1 areas. The author hypothesised that this 
result might be due to the larger nerve root size in S1 than in L4, affecting the strength of 
injection (35). This study offered evidence of variation in TS pain responses in different 
segmental areas. So far, few studies have addressed the segmental effects of an 
intervention on TS of pain. 
 
2.4.1.2 Stimulation methods 
All of the studies delivered a train of five stimuli at either 2-hertz or 3-hertz, except for 
one study, which delivered a train of four stimuli at 3-hertz (34). Three commonly used 
methods for TS of pain assessment were TST test, the electromyogram (EMG) recording 
of withdrawal reflexes and the pain response to supra-threshold (ST) level of TS 
stimulations reported by the subjects. Nine studies assessed the TST. Their definition of 
TST was whenever the subject experienced increased intensity and felt pain at the fourth 
or fifth train (34; 35; 36; 39; 40; 52; 72; 73; 74). All these nine studies tested the TST 
alone, except for one which also tested the pain tolerance threshold (PTT) of TS of pain 
(39). Three studies recorded both EMG and the subjects’ pain responses to ST or PTT 
level of TS stimulations (37; 38; 71). 
 - 24 - 
Table 2.1 Methods of 2-hertz electrical temporal summation pain model 
(No.) Study Assessed site TS stimuli TS pain assessment 
(1) Curatolo 
M., 1997b 
Sural nerve, behind the lateral 
malleolus 
Single stimulus 
was repeated 5 
times at 2Hz 
TST; experienced 
increased intensity and 
the 4th or 5th stimuli as 
painful 
(2) Curatolo 
M., 1998 
Segmental areas: 
(1) Right S1 (foot, just distal to 
the lateral malleolus). 
(2) Right L4 (middle of the 
patella). 
2Hz (as above) As above 
(3) Curatolo 
M., 1997a 
Sural nerve, just distal to the 
right lateral malleolus. 
(EMG reflex recording: over the 
rectus femoris and the biceps 
femoris) 
2Hz (as above) 
TST; experienced 
increased intensity and 
the 4th or 5th stimuli as 
painful and the EMG 
amplitudes increase in 
the 4th or 5th reflexes. 
(4) 
Peterson-feli
x S., 1995 
Sural nerve was stimulated 
behind the right lateral 
malleolus. (EMG reflex 
recording: over the rectus 
femoris and the biceps femoris). 
2Hz (as above) As above 
(5) 
Arendt-Niels
en L., 1995 
Over sural nerve along its 
retromalleolar path 
(EMG reflex recording: over the 
rectus femoris and the biceps 
femoris). 
2Hz (as above) 
*Reflex threshold: 
defined from the EMG 
amplitudes increase to 
the 5th stimulus. 
(6) 
Graven-Nielse
n T., 2000 
Tibia anterior muscle along the 
sural nerve path 2Hz (as above) 
TST, experienced 
increased intensity and 
the 4th or 5th stimuli as 
painful 
(7) 
Arendt-Niels
en L., 2000 
Sural nerve along its 
retromalleolar path 
Single stimulus 
was repeated 4 
times at 3Hz. 
As above 
(8) Enggaard 
T.P., 2001a 
Sural nerve along its 
retromalleolar path 
Single stimulus 
was repeated 5 
times at 3Hz. 
TS pain tolerance 
threshold, the increase in 
perception of intensity at 
the 4th or 5th stimulation 
that the subject can 
tolerate. 
(9) Enggaard 
T.P., 2001b 
Sural nerve along its 
retromalleolar path 3Hz (as above) 
TST, experienced the 
4th or 5th stimuli as 
painful 
(10) Yucel 
A., 2005 
Within the neuropathic pain 
affected skin 
Single stimulus 
was repeated 5 
times at 2Hz 
As above 
(11) 
Enggaard 
T.P., 2006a 
Sural nerve along its 
retromalleolar path 
Single stimulus 
was repeated 5 
times in 3Hz 
As above 
(12) 
Enggaard 
T.P. 2006b 
Sural nerve along its 
retromalleolar path As above 
TST, experienced the 
4th or 5th stimuli as 
painful 
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2.4.2 Effects of analgesics on temporal summation and single 
stimulus induced pain tests  
In Table 2.2, seven out of 12 studies assessed both electrical SPT induced by a single 
stimulus and electrical TST induced by repeated stimuli, and recorded TST values that 
were lower than the SPT values (34; 36; 37; 40; 52; 71; 72). This indicates that a train of 
five electrical stimuli delivered at 2-hertz or 3-hertz (i.e. stimulations to test TST), using 
an intensity at sub-threshold can cause a painful sensation (33). 
 
The TS of pain was more difficult to block than pinprick and cold sensitivity tests or 
single stimulus induced pain after epidural injection of bupivacaine, lidocain, 
epinephrine, and Clonidine (35; 71; 72), and inhalation of isoflurane (37). For example, in 
a study which tested the effect of isoflurane from 0.25% to 1.5%, the pain responses to 
electrical SPT pain test, pinprick and cold sensitivity tests were attenuated by 
administration of 0.75% isoflurane, but only 1.25% and 1.5% of isoflurane could 
suppress the pain response to TST pain test (37). Hence, these authors argued the pinprick 
and brief stimulation tests were not sufficient to test anaesthesia medications used in 
surgical environments (35; 37; 71; 72). 
 
In eight analgesic medication studies that were not for anaesthesia, six medications were 
tested using TS of pain in human subjects (studies 5 to 12 in Table 2.2), and the reported 
actions of the medications can be divided into four types. Type one includes the effects 
of, ketamine, imipramine and venlafaxine, which reduced the TST and strong (ST and 
PTT) electrical or mechanical single stimulus thresholds but had less effect on SPT or 
pinprick and cold sensitivity tests (36; 38; 39). Their specific effects on TST and strong 
pain other than SPT suggest that they inhibit NMDA receptors and central nervous 
system responses. Type two refers to the effects of levetiracetam and tramadol, which 
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increased the SPT significantly but had no effect on the TST (73; 74). Tramadol is an 
opioid analgesic, when levetiracetam is a non-opioid medication. Type three was the 
effect of codeine, which was significantly more effective than the placebo in all the pain 
assessments of electrical and mechanical single stimulus induced SPT and PTT tests, as 
well as the TST tests and cold sensitivity tests (39). Codeine exerts the analgesic effect 
via endo-morphine (endogenous morphine) mechanism, thus it suggests that analgesic 
medications involving endo-morphine mechanism may be effective on both SPT and TST 
tests. Type four was the effect of UP 26-91, which had no better effect on either the TST 
or SPT (34). The author argues that the analgesic mechanism of UP 26-91 is related to an 
inhibitory action on 5-HT absorption which is similar to the mechanism of tramadol. It is 
notable that the analgesic medications have dose-dependent characteristics. For example, 
a study observed no analgesic effect of 100 mg codeine on electrical stimulation induced 
SPT and TST (34), whereas another study observed a strong analgesic effect of codeine 
125mg on all of the SPT and TST pain tests (39). Hence, the type four analgesic effect of 
UP 26-91 may need to be further evaluated using a higher dosage to reach a firm 
conclusion. 
 
2.4.3 Testing temporal summation in healthy humans and 
clinical pain patients 
There are no human pain models that can perfectly mimic all features of clinical pains 
(13). As a result, the effect of any analgesics on pain-free humans can not be readily 
translated into its clinical efficacy. However, TS as a pain model seems to indicate the 
sensitivity of the central nervous system in both health humans and patients. In Table 2.2, 
in the studies number 5 and 6, the analgesic effect of ketamine was tested on TS pain 
model using healthy human subjects and clinical pain patients respectively (38; 52). The 
studies showed that ketamine significantly suppressed TST in healthy humans (study 
 - 27 - 
number 5) and clinical pain patients (study number 6). Another example is the studies 
number 9 and 10 in Table 2.2. The authors tested the analgesic effect of velafaxine on TS 
pain model using healthy human subjects and clinical pain patients respectively (36; 40). 
They showed that velafaxine significantly suppressed TST in healthy humans (study 
number 9) and clinical pain patients (study number 10). These examples suggest that TS 
pain model can be used in health humans to assess the potential central inhibition 
functions of analgesics on clinical pain. 
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2.5 Summary of the electrical temporal summation pain 
model 
In summary, previous studies confirmed that the electrical TS of pain stimulation and the 
assessment methods (i.e. electrical TS pain model) developed in 1994 by Arendt-Nielsen 
and his colleagues (33) was a reliable and reproducible model. This TS pain model can be 
used as a good indicator for testing the central effect of analgesic interventions. So far, no 
acupuncture study has employed this electrical TS pain model to evaluate acupuncture 
analgesia in either healthy humans or patients with pain. 
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Chapter 3: Acupuncture techniques and their 
neural mechanisms 
3.1 Definitions and descriptions of acupuncture 
The definition of acupuncture described in a publication of the World Health 
Organisation (WHO) in 1995 was that acupuncture “Involves the act of needle insertion, 
although there are many other non-invasive techniques for acupuncture point 
stimulation. Points may be selected according to: traditional medical system, symptoms, 
point selection based on the scientific relationships of point function, and point 
prescription” (75). Whereas, the definition of acupuncture given by National Institutes of 
Health (NIH) in 1997 was “Stimulation, primarily by the use of solid needles, of 
traditionally and clinically defined points on and beneath the skin, in an organised 
fashion for therapeutic and / or preventive purpose” (76). Both these two official 
definitions address the importance of stimulating the acupoint (s) and recognise that 
acupuncture is a traditional medical technique.  
 
The most popular acupuncture techniques are the invasive techniques of manual 
acupuncture (MA) and electro-acupuncture (EA). The other non-invasive acupuncture 
techniques which stimulate the acupoints in collaboration with the rationale of MA and 
EA are: laser acupuncture (using light stimulation), acupressure (using mechanical 
stimulation), transcutaneous electrical acupoint stimulation (TEAS) (using electrical 
stimulation), etc. This thesis mainly addresses the invasive acupuncture techniques of 
MA and EA.  
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Needling manually is the most traditional technique of acupuncture practice. The 
techniques of MA are detailed in textbooks on acupuncture and involve the correct depth 
of needle insertion; the techniques of manipulation and the selection of acupoints for 
various syndromes (77).  
 
EA was first introduced to Western countries as an anaesthesia technique by the Peking 
Acupuncture Anaesthesia Co-ordinating group of China in 1973 (78). The techniques of 
EA were developed on the basis of MA, hence they have the same procedures of acupoint 
selection and needle insertion. MA requires that needles are manipulated manually; 
whereas during EA, needles are stimulated with an electrical stimulator. The intensity and 
frequency of the electrical pulses can be adjusted at the preference of the acupuncturists; 
the intensity is usually increased to a strong but tolerable or strong but comfortable level. 
The frequencies of EA vary between 1- to 1,000- hertz depending on the function of the 
stimulator and the needs of the acupuncturist.  The most popular EA frequencies used for 
clinical trials vary between 2- to 100- hertz in a continuous mode or a dense-disperse 
mode (D-D). EA of certain frequency, such as alternating 2/100 hertz EA in D-D mode, is 
believed to exert the best effect of EA because this combination maximize the release of 
various types of endogenous opioid peptides (79). Details are discussed in the followed 
sections. 
 
When a needle is inserted into certain depth in an acupoint, the subject can feel some 
sensations which are different from painful sensation, such as numbness, distension, 
heaviness and soreness (80; 81; 82; 83). These sensations can be elicited and amplified if 
the needle is manipulated, and are recognised as de qi, or “the arrival of Qi” in Chinese 
(77). De qi is considered to be essential in acupuncture practice and the indicator of the 
treatment being effective. 
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3.2 The involvement of endogenous opioid peptides in 
EA  
3.2.1 Endogenous opioid peptides and 2-hertz and 100-hertz 
EA  
Opioids have morphine-like actions in the human body. Endogenous opioid peptides 
(EOPs) bind to their corresponding receptors (84). Met-enkephalin and Leu-enkephalin 
bind to delta receptors, beta-endorphin to mu and delta receptors (85; 86), dynorphins to 
kappa receptors (87), and endo-morphins (endogenous morphins) to mu receptors (88).  
 
A few lines of evidence have indicated that different areas of the central nervous system 
respond to 2-hertz and 100-hertz EA stimulations. Firstly, a Functional Magnetic 
Resonance Imaging (fMRI) study showed different brain regions were activated when 
acupoints were stimulated with 2-hertz or 100-hertz TEAS; 2-hertz TEAS activated 
primary and supplementary motor areas and hippocampus areas in the brain and 
100-hertz TEAS activated the brodmann area, pons, nucleus accumbens and amygdala 
regions in the brain (89). Secondly, the types of EOPs released in cerebrospinal fluid 
depend on the frequency of EA. In a human study, 2-hertz and 100-hertz of TEAS were 
applied to two randomly allocated groups before and after interventions; 2-hertz TEAS 
significantly increased immunoreactive Met-enkephalin-Arg-Phe (MEAP) but not 
immunoreactive dynorphin-A, whereas the 100-hertz TEAS significantly increased 
immunoreactive dynorphin-A but not immunoreactive MEAP (90). Thirdly, a study 
confirmed that 2-hertz EA facilitated the release of enkephalin, beta-endorphin and 
endo-morphin, but 100-hertz EA specifically increased the release of dynorphin (91). 
Fourthly, a radioimmunoassay gene study confirmed the differences between 2-hertz and 
100-hertz of EA stimulations. The study used cRNA probes to assess the activities of 
mRNA encoding prepro-enkephalin (PPE), prepro-dynorphin (PPD) and 
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proopiomelanocortin in rats’ brains; EA of both frequencies increased PPE mRNA in 
rostromedial reticular formation cells, 2-hertz EA increased PPE mRNA expression in 
supraoptic nucleus, suprachiasmatic nucleus, arcuate nucleus, paraventricular 
hypothalamic nucleus, ventromedial nucleus and the nucleus of the lateral lemniscus, 
whereas 100-hertz EA significantly increased PPD mRNA levels in the supraoptic 
nucleus, paraventricular hypothalamic nucleus, ventromedial nucleus and parabrachial 
nucleus (92). In summary, the differences between 2-hertz and 100-hertz EA lie in the 
types of EOPs released. 2-hertz EA enhances the release of the opioid peptides of 
enkephalin, beta-endorphin and endomorphins, whereas 100-hertz EA increases the 
release of dynorphins. 
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3.2.2 The effect of 2/100 hertz EA 
A previous study compared the effects of alternating 2/15 hertz mode EA and continuous 
mode EA of 2-hertz and 100-hertz on pain tolerance in rats, and found the alternating 
mode EA exerted the best analgesic effect (93). A further study used alternating 2/100 
hertz mode EA and confirmed this observation (91). Therefore, 2/100 hertz D-D mode 
EA might maximize the release of all three types of EOPs and provide a strong analgesic 
effect (79). 
 
In addition, the effects of mu, kappa and delta receptor agonists are antagonised by 
naloxone dose-dependently. Naloxone, in a small dose has a strong blockage effect on mu 
receptor agonists but little effect on delta and kappa receptor agonists (84). It is 
hypothesized that naloxone would be more effective to antagonise the analgesic effect 
produced with continuous mode of low frequency (2-hertz) EA than that of high 
frequency (100-hertz) EA. This hypothesis has been confirmed by human studies. 
Naloxone at 1.2 milligram failed to reverse high frequency EA analgesia (94); and the 
same dosage of naloxone reversed the analgesic effect of low frequency electrical 
stimulations successfully (95). Animal studies also supported the notion that naloxone 
dose-dependently blocks EA analgesia induced by different frequencies (96; 97; 98; 99). 
 
The corresponding relationships between 2-hertz, 100-hertz and 2/100 hertz EA and the 
effective receptors are summarised in Table 3.1 as followed. 
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Table 3.1 Summary of the correlation between EA frequencies, corresponding 
opioid peptides and receptors 
 
EA 
frequency Opioid peptides Opioid receptors Naloxone antagonism 
2-hertz 
Enkephalin, 
beta-endorphin and 
endomorphins 
Delta and mu receptors 
100-hertz Dynorphins Kappa receptor 
2/100 
hertz 
Enkephalin, 
beta-endorphin, 
endomorphins and 
dynorphins 
Delta, mu and kappa 
receptors 
The analgesic effect acts via 
the delta, kappa and mu 
receptors and can be 
antagonised by naloxone 
dose-dependent; The analgesic 
effect acting via mu receptors 
is more sensitively to blockage 
by naloxone than the effect 
acting via other receptors. 
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3.3 Neural mechanisms of acupuncture 
3.3.1 Mechanism of needle insertion 
Both EA and MA insert needles into the acupoints. Needle insertion activates the 
polymodal nociceptors in the skin and muscles (100), which respond to mechanical 
stimulations indicative of potential tissue damage (101). This notion is the only 
explanation found in the literature which addresses the mechanism of needle insertion. 
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3.3.2 Gate Control Theory 
Gate Control Theory contends that the gates located at the spinal level controls the 
transmission of pain signals from the peripheral to the central nervous system. The gate 
can be opened or closed in response to different types of somatic signal (102). The 
activation of small myelinated A-delta afferents and unmyelinated C-fibres opens the 
gate; whereas the activation of large myelinated A-beta afferents closes the gate so as to 
suppress pain (57; 103). Based on this theory, Melzack hypothesised the mechanisms of 
TEAS and EA (104). Unfortunately, we have not found a human experiment that can 
prove specifically that acupuncture analgesia is via A-beta fibre activation. In addition, 
the gate is closed during the time when A-beta afferents are concurrently activated while 
pain signals are transmitted, and the analgesic effect from this action does not last beyond 
the termination of A-beta activation. This theory alone can not explain acupuncture 
analgesia, which often lasts up to a few days (25).  
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3.3.3 Segmental Inhibition Theory and Meridian Theory 
Segmental Inhibition Theory argues that acupuncture inhibits the spinal neurons at the 
segment of the needling site, and this affects the transmission of pain signals from the 
dermatome, myotome, sclerotome or viscerotome that are innervated by the same spinal 
nerves (57; 79; 105; 106). This theory potentially explains the action of acupuncture 
using anatomical knowledge instead of classical Meridian Theory. Meridian Theory 
argues that the spatial distribution of the acupuncture effect follows the classical defined 
meridian paths. Results from a recent RCT in healthy humans indicates that neither 
Segmental Inhibition Theory nor Meridian Theory could fully explain the distributions of 
the acupuncture analgesic effect (17). The study found that stimulating LI4 increased 
mechanical pain thresholds at 10 body sites located on various meridians and on the same 
or different segments to the site of simulation. The results indicate that the effect of 
acupuncture is general and diffusely distributed in the body. 
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3.3.4 Diffuse Noxious Inhibitory Control Theory 
Diffuse Noxious Inhibitory Control (DNIC) Theory argues that any noxious stimulation 
can inhibit wide dynamic range neurons in the central nervous system and induce 
analgesia in a distant body area (107). This theory is supported by studies which showed a 
widespread analgesia after electrical or ice stimulations (108; 109). Many acupuncture 
studies also supported the involvement of DNICs in acupuncture analgesia (17; 110). 
However, since neural activities only last for a few seconds to a few minutes, DNIC 
theory is not able to explain the long-lasting effect of acupuncture (110). 
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3.3.5 Acupuncture effect on central limbic system 
The limbic system, including hypothalamus and amygdala, controls humans’ emotional 
and motivational activities, and has been recognised as the centre controlling the feeling 
of pleasure (111). A human fMRI study used TEAS on ST36 and found 100-hertz but not 
2-hertz electrical stimulation enhanced activities of nucleus accumbens in hypothalamus 
(89). Another fMRI study evaluated the effect of 4-hertz EA at GB34 and observed that 
EA significantly de-activated activities at the limbic system areas (112). A recent fMRI 
study found that MA and 2-hertz EA suppressed the activities of amygdala areas but 
enhanced the activities of hypothalamus areas in chronic pain patients and confirmed that 
acupuncture inhibit the limbic system in both healthy and chronic pain patients (113). 
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3.3.6 Neurohumoral mechanisms of acupuncture 
Various EOPs are released after acupuncture (sections 3.2.1 and 3.2.2), the analgesic 
effect of acupuncture can be antagonisted by naloxone (section 3.2.2), and  the effects of 
EA can last for 72 hours (25); this evidence suggests a neurohumoral mechanism which 
involves the enhanced production of the precursor of EOPs (79). This neurohumoral 
mechanism explains that acupuncture can release EOPs, and the EOPs exert their effects 
as the agonists of opioid receptors throughout the whole nervous system (central and 
peripheral nervous systems) (79; 114).  
 
Since EOPs exert their analgesic effects by agonising opioid receptors (84), if the number 
of opioid receptors is insufficient to uptake the available EOPs, the analgesic effect would 
be lower than when there is a sufficient number of opioid receptors. So far, a map 
indicating the amount of opioid receptors in different regions of the human body under 
normal conditions (i.e. quiet and without stimulation) has not been discovered.  
 
With regard to the neurohumoral mechanisms of acupuncture a number of questions arise. 
Firstly, are there any spatial characteristics in the activation of opioid receptors after 
acupuncture? Secondly, does acupuncture stimulation also activate other non-opioid 
receptor like the action of TS stimulation? As discussed in a previous section (see section 
2.2.2), TS stimulation can activate NMDA receptor in the body and thereby increases the 
number of NMDA receptors in the stimulated area (62). These questions need to be 
answered by further human experiments. 
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Chapter 4: A systematic review of acupuncture 
analgesia assessed in healthy humans 
4.1 Introduction 
Although acupuncture analgesia has been studied in healthy humans extensively, to date, 
there has only been one ‘systematic review’ in this area (16). The review argues the analgesic 
effect of electro-acupuncture (EA) is better than manual acupuncture (MA). However, this 
review has some limitations. Firstly, the authors did not distinguish invasive control from 
non-invasive control but accepted both of them as SA control. The use of an invasive or 
non-invasive control for SA has been debated, and some studies argue that the invasive 
control can produce analgesia (1; 115; 116). Secondly, the review included both randomised 
and non-randomised studies, and the authors did not assess the reporting quality of the 
included studies. Consequently, the conclusion was made without considering the validity 
and reliability of the studies. Thirdly, the data analysis was not sufficiently detailed. 
Percentages of PT change were summarised without considering the various forms of 
acupuncture stimulation used in these studies. Different acupuncture stimulations might 
cause different analgesic effect. This issue has been discussed in Chapter 3. Hence, it is 
necessary to conduct a systematic review on reliable and valid data to assess acupuncture 
analgesia in healthy pain-free human subjects which takes the various acupuncture 
techniques into consideration. 
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4.2 Aims 
The present review aimed: 
 
1) To examine the effect of MA or EA on experimentally induced pain, when compared with 
non-invasive sham acupuncture and invasive sham acupuncture. 
 
2) To compare the effect of MA on experimentally induced pain when compared with EA. 
 
3) To summarise the acupuncture techniques and pain models (i.e. pain stimulation and 
assessment methods) used in these studies. 
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4.3 Methods of the systematic review 
The methods adopted in this review, including a literature search and selection, 
methodological quality assessments, extensive data extraction and effectiveness 
estimation analysis. They followed the recommendations from the Cochrane Reviewer’s 
Handbook for Systematic Reviews of Interventions (44). 
 
4.3.1 Search methods for identification of studies  
Literature was electronically searched in four major databases (Pubmed, Cochrane Library, 
CINAHL and EMBASE) from their respective inceptions to 01 January 2006. The key words 
were ‘acupuncture’, ‘analgesia’, ‘randomised controlled trial’ and ‘healthy humans’. The 
strategies and results of the literature search are presented in Table 4.1.  
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Table 4.1 Literature search strategies 
      Strategy 
 
Database 
Steps Result 
Pubmed #1 search acupuncture 
#2 search human OR healthy subject OR healthy human OR humans OR 
healthy humans OR healthy subjects 
#3 search #1 AND #2  
#4 search analgesia OR analgesic  
#5 search #4 AND #3  
#6 search #4 AND #3 Field: All Fields, Limits: Animals  
#7 search #4 AND #3 Field: All Fields, Limits: Humans  
#8 search #6 NOT #7  
#9 search #5 NOT #8  
#10 search #5 NOT #8 Field: All Fields, Limits: Randomized Controlled Trial 
222 
Cochrane 
library 
 
#1 search acupuncture 
#2 search control OR control! 
#3 search analgesi! 
#4 search healthy subject! AND human* 
#5 search #1 AND #2 
#6 search #3 AND #5 
#7 search #4 AND #6 
66 
ScienceDirect 
(Embase) 
 
#1 search acupuncture 
#2 search control OR control! 
#3 search analgesi! 
#4 search healthy subject! AND human* 
#5 search #1 AND #2 
#6 search #3 AND #5 
#7 search #4 AND #6 
141 
CINAHL 
 
#1 search (acupuncture) and (analgesi*) and (control*) 
#2 search (human*) or (healthy subject*) or (healthy human*) 
#3 search #1 AND #2 
189 
Total result 618 papers were collected, with 13 duplicated papers.  605 
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4.3.2 Inclusion and exclusion criteria for considering studies 
for this review 
The protocol for literature selection is provided in Figure 4.1. Information on excluded 
studies is listed in Appendix 11. 
 
Studies were included if they met all of the following criteria: 
1. Randomised controlled trials including quasi-randomised controlled trials;  
2. including a placebo or SA control; 
3. the study interventions were MA or EA or both (excluding auricular or scalp 
acupuncture);  
4. healthy pain-free humans were used as study subjects; and 
5. pain perceptions (including PT, PTT or pain ratings to ST stimulations) were reported.  
 
Studies were excluded if they met one of the following criteria: 
1. Description of the acupuncture technique was absent; 
2. acupuncture intervention did not involve needle insertion (i.e. laser acupuncture); 
3. acupuncture points used were not standard points described in acupuncture textbooks; 
and 
4. the study was not published in the English language. None of the authors could read 
literature other than those in English and Chinese, and the Chinese literature was not 
included due to time limitations.  
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Figure 4.1 Protocols of literature selection 
 
 
Potentially relevant RCTs were identified and screened for retrieval (n=49) 
Studies were excluded because acupuncture was 
not on the trunk of the body or the four extremities 
or MA or EA was not used (n=26) 
Potentially appropriate RCTs to be included (n=23) 
RCTs were excluded because the description of 
acupuncture was absent, the acupoint used was not 
standard, or there was no non-invasive control 
group (n=14) 
Studies were excluded because subjects were not 
pain-free or healthy humans (n=556) 
Nine RCTs were included (n=9) 
RCTs were found (n=605) 
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4.3.3 Assessment of methodological quality  
The methodological quality was assessed with the Jadad Scale (117) and the Internal 
Validity Scale (IVS) (118). These scales have been validated and used previously in other 
acupuncture systematic reviews by other researchers (6; 119; 120). 
 
 4.3.3.1 Jadad scale 
The items of the Jadad Scale include: 
 Random allocation (1 point if allocation was described as random + 1 point if an 
adequate method to generate the random sequence was described) 
 Double-blind (1 point if there was a statement that patients and evaluators were blinded 
+ 1 point when the procedure was described and adequate) 
 Reporting of dropouts/exclusions (1 point if dropouts or withdrawals, as well as the 
reasons, were listed independently for each treatment group) 
The maximum score is five; studies scoring three or more points were considered high 
quality. The use of valid randomisation methods, for example computer generated sequence 
of numbers with a central random method or with sealed envelops, were considered adequate 
randomisation methods. Studies were considered to have inadequately reported the method 
of randomisation if they mentioned the use of a randomisation method but failed to provide a 
description of how the random numbers were generated. Studies with blinded participants 
and evaluator and / or data collector were considered as adequate as double-blind studies. 
The points achieved for each of the above three items are listed in order for each study in 
Table 4.2 ‘Methodological quality of included studies’. For a trial receiving full points on all 
aspects, the score is displayed as 2-2-1.  
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4.3.3.2 Internal validity scale 
The six items of the scale are described as: 
 Method of allocation to groups; 
 concealment of allocation; 
 baseline comparability; 
 blinding of patients; 
 blinding of evaluator; and 
 likelihood of selection bias after allocation to groups by dropouts, etc. 
Each item is scored as 0 (criterion not met or insufficient information provided), 0.5 
(criterion partially met), or 1 (criterion met). The points achieved for each of the six items are 
listed for each trial in Table 4.2 ‘Methodological quality of included studies’. For a trial 
receiving full points on all items, the scores are displayed as 1-1-1-1-1-1.  
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4.3.4 Acupuncture adequacy assessment 
A scale was developed for this review. The assessed items were selected from the checklist of 
‘Standards for Reporting Interventions in Controlled Trials of Acupuncture’ (STRICTA) 
which has been validated for acupuncture systematic reviews (121). It takes into 
consideration the important features of acupuncture techniques as described in textbooks (77; 
122). 
 
All five items on this scale are associated with the nature and accuracy of the acupuncture 
stimulation and are described as:  
 
(a) Use of standardised acupuncture point (s) in accordance with an acupuncture textbook. 
(b) Proper depth of needle insertion.  
(c) De qi sensations were reported.  
d) Duration of acupuncture treatment was no less than 15 minutes.        
(e) The needle was manipulated at least three times during MA or EA stimulation was use. 
- (77; 121; 122) 
 
Each item is scored as 0 (criterion not met), 0.5 (insufficient information provided) or 1 
(criterion met). The points achieved for each of the five items are listed in order for each 
trial in Table 4.3 ‘Acupuncture adequacy assessment’. For a trial receiving full points on 
all items, the scores are displayed as 1-1-1-1-1. A study that rated ‘4’ or more points was 
considered as using adequate acupuncture. 
 
Using standard points is a part of acupuncture practice. The special locations of acupoints 
have been clearly documented and used for a long period. Acupuncture textbooks were used 
to identify the proper depth of stimulation for each acupoint (77; 122), and the information is 
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listed in Table 4.3. If the depth of any acupoint used in the studies is shallower than the 
recommended depth of this point, it would be considered shallow needle insertion. An 
acupuncture treatment should not be shorter than 15 minutes, and three times of manipulation 
during 15 minutes (at five minute intervals) should be a minimum requirement for MA 
treatment. EA stimulation should not be shorter than 15 minutes. 
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4.3.5 Data extraction 
All accessible data including information on participants, sample size, intervention 
techniques, control techniques, noxious painful stimulations, outcome measurements and 
reported results were extracted by the author and checked by a second researcher. 
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4.3.6 Data analysis 
4.3.6.1 The factors preventing overall meta-analysis 
After data extraction, the design of the included studies was found to be too diverse to 
perform meta-analysis. Factors preventing meta-analysis are listed as follows: 
 
 Different interventions and controls: EA or MA with various techniques and frequencies 
of stimulation were applied and compared with non-invasive control, invasive control 
with or without manual manipulation, or invasive control with different electrical 
frequencies of electrical stimulations. 
 Different temporal effects of acupuncture were assessed, such as: instant effects (during 
acupuncture) and immediate effects (within 60 minutes after acupuncture). 
 Different types of noxious stimulation were used in each study to induce pain, such as: 
electrical stimulation induced dental pain, transcutaneous electrical stimulation induced 
pain, transcutaneous thermal stimulation induced pain, and transcutaneous mechanical 
pressure pain.  
 Different pain perceptions were assessed: PT, ST and PTT. 
 
As a result, the standardised mean difference (SMD) of each study was calculated and 
presented. The explanation to ‘standardised mean difference (SMD)’ is provided in the 
following section. 
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4.3.6.2 Comparisons of acupuncture analgesic effect  
The data analysis package, Review Manager (also named ‘RevMan’, version 4.2 for 
Windows, The Cochrane Library), was used to compare the effects between the 
interventions in a same study via calculation of estimated SMD if mean and standard 
deviation values or numbers of responders were presented. Sub-category comparisons 
were also conducted to determine the temporal characteristics of acupuncture analgesia, 
including instant effects (during the intervention) and immediate effects (within 60 
minutes after intervention) or examine the effect of acupuncture on different pain 
perceptions (i.e. PT, ST and PTT). Studies that did not report SD values were not 
included in the calculation of SMD estimates. Instructions for the use of RevMan and the 
explanations of its calculations are provided in Cochrane Reviewer’s Handbook for 
Systematic Reviews of Interventions. The term ‘standardised mean difference’ (SMD) is 
used in this chapter and the appendices because the Cochrane Reviewer’s Handbook for 
Systematic Reviews of Interventions recommends using the term “standardised mean 
difference” instead of the term ‘effect size’ to avoid confusion (44). The SMD is 
calculated using Hedges’ g. Hedges’ g examines the sample sizes of the respective 
standard deviations and also adjusts the overall effect size based on the sample sizes 
(123). 
 - 56 - 
4.4 Results 
 
4.4.1 Description of selected studies 
The literature search provided 605 papers (Table 4.1 in above section 4.3.1), and in total 
nine papers (17; 18; 19; 20; 21; 22; 83; 124; 125) were included after applying the 
inclusion and exclusion criteria. All of the included studies had a non-invasive control 
group, and five of them also had an invasive control group (17; 18; 20; 21; 22). In 
addition, the study by Mayer et al. contained two trials (19);  the first trial assessed the 
change of PT during MA treatment and the authors selected the subjects who had greater 
than 20% PT increase in response to acupuncture for the second trial. The second trial, 
which was during MA treatment, assessed the change of PT after administering either 
naloxone or saline injections to evaluate the involvement of endogenous opioid peptides 
during acupuncture. The present review only included the data of the first trial for 
analysis.  
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4.4.2 Methodological quality 
Table 4.2 shows that the scores of the IVS and Jadad scale were consistent; none of the 
studies with a low Jadad score (Jadad score < 3) had an IVS score higher than 3.5. The 
overall median value of the Jadad score was 3 and the IVS score was 4.5, suggesting an 
overall high methodological quality for these studies. However, only two high quality 
studies had both an adequate randomisation method and a double-blind design; they were 
published in 1974 and 2003 respectively (study number 1 and 7 in Table 4.2) (17; 18). 
The other four high quality studies were deficient in either randomisation method or 
double-blind design (study number 2, 3, 4 and 8 in Table 4.2) (19; 20; 22; 124). None of 
the three low methodological quality studies used an adequate randomisation method or 
double-blind design (study number 5, 6 and 9 in Table 4.2) (21; 83; 125).  
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Table 4.2 Methodological quality assessments 
Study Jadad* IVS* 
1) Anderson, et al., 1974 2-2-1 =5 1-1-1-1-1-1  =6 
2) Berlin et al., 1975 1-2-1 =4 0.5-0-1-1-1-1 =4.5 
3) Chapmen et al., 1976 1-2-1 =4 0.5-0-1-1-1-1 =4.5 
4) Mayer et al., 1977 0-2-1 =3 0-0-1-1-1-1  = 4 
5) Stewart et al., 1977 1-0-1 =2 0.5-0-0-1-0-1 =2.5 
6) Johnson et al., 1996 1-0-1 =2 0.5-0-0-1-0-1 =2.5 
7) Zaslawski et al., 2003 2-2-1 =5 1-1-1-1-1-1  =6 
8) Downs et al., 2005 2-0-1 =3 1-0.5-1-1-0-1 = 4.5 
9) Kong et al., 2005 1-0-1 =2 0.5-0-1-1-0-1 = 3.5 
Median value:  3 4.5 
Mean ± SD value:  3.33±1.23 4.22±1.28 
 
*Jadad items: Randomisation - Blinding - Dropouts. 
*IVS items: Randomisation - Concealment of allocation - Baseline comparability - Blinding of 
patients - Blinding of evaluator - Dropouts. 
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4.4.3 Acupuncture techniques 
The information on acupuncture techniques is summarised in Table 4.3, and described in 
the following paragraphs. 
 
4.4.3.1 The types of acupuncture intervention 
Four studies employed only MA (study number 1 - 4 in Table 4.3) (17; 19; 124; 125). 
Another four studies used continuous mode EA with different frequencies; two studies 
used 2- and 2.5- hertz low frequencies of EA respectively (study number 7 and 8 in Table 
4.3) (20; 21), one study used 120-hertz high frequency EA (study number 6 in Table 4.3) 
(22), and one study did not report the EA frequency (study number 5 in Table 4.3) (18). 
The remaining one study compared the effects of 2/15 hertz EA and MA (study number 9 
in Table 4.3) (83). 
 
4.4.3.2 Acupuncture adequacy assessment 
The median value of acupuncture treatment duration was 24.56 (SD 7.2) minutes. All 
studies used recognised classical acupoints. Four studies used a proper depth of needle 
insertion (study number 3, 6, 7 and 8 in Table 4.3) (17; 20; 21; 22), and two studies used 
shallow insertion (study number 2 and 9 in Table 4.3) (83; 125). The depth of needle 
insertion in another three studies was indeterminable because of the absence of 
information (study number 1, 4 and 5 in Table 4.3) (18; 19; 124). The overall median 
score of acupuncture adequacy was four. Two studies used MA and had acupuncture 
adequacy scores lower than four points. In these two studies, one study had absent 
information on two assessed items and the de qi sensations were not achieved in four of 
the subjects (study number 4 in Table 4.3) (124), another study used a shallow depth for 
needle insertion and had few subjects were achieved de qi sensations (study number 2 in 
Table 4.3) (125). 
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4.4.3.3 Adverse events in response to acupuncture 
Only one study reported two out of 31 participants experiencing dizziness after 
acupuncture (study number 9 in Table 4.3) (83). None of the remaining studies reported 
any adverse event or side effects from the acupuncture treatments. 
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4.4.4 Procedures to enhance the precision of pain assessments  
Table 4.4 lists information relating to the experimental procedures used to enhance the 
precision of pain assessments in these studies. The procedures were pre-testing training, 
temperature control in the testing environment, and the interval between two treatment 
sections if a subject is assigned to more than one intervention groups (this factor relates to 
the wash-out period for the analgesic effect after the first acupuncture treatment). 
 
4.4.4.1 Pre-testing training 
Four studies employed a training session before the start of the pain perception tests 
(study number 3,7,8 and 9 in Table 4.4) (17; 20; 83; 124). This was not reported in the 
other five studies (study number 1, 2, 4, 5 and 6 in Table 4.4) (18; 19; 21; 22; 125). 
 
4.4.4.2 Control of the room temperature 
Only one study reported that the room temperature was controlled during the pain tests. 
The study reported the room temperature during the experiment, which was 21 degrees 
Celsius (study number 6 in Table 4.4) (125). 
 
4.4.4.3 Intervals between interventions 
Each of the participants in five of the studies was assigned to receive one type of 
intervention (study number 1, 2, 3, 4 and 6 in Table 4.4) (18; 19; 20; 22; 125). In the other 
four studies, each participant experienced more than one intervention, the interval 
between the interventions was at least two days in two studies (study number 5 and 7 in 
Table 4.4) (17; 21), and at least one week in the other two studies (study number 8 and 9 
in Table 4.4) (83; 124). 
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Table 4.4 Procedures for precise pain tests 
Participant assignment for interventions Room 
temperature 
 Pre-test 
training 
Numbers of 
interventions 
received by a 
single subject 
Length of intervals between 
acupuncture sections  
 
1) Anderson, 
et al., 1974 
/ 1 / / 
2) Berlin et 
al., 1975 
/ 1 / / 
3) Chapman et 
al., 1976 
Yes 1 / / 
4) Mayer et 
al., 1977 
/ 1 / / 
5) Stewart et 
al., 1977 
/ 2 At least 2 days / 
6) Johnson et 
al., 1996 
/ 1 / 21 degrees 
Celsius 
7) Zaslawski 
et al., 2003 
Yes 3 At least 2 days / 
8) Downs et 
al., 2005 
Yes 3 At least 1 week / 
9) Kong et al., 
2005 
Yes 3 At least 1 week / 
 
 / : No information available. 
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4.4.5 Pain models 
Table 4.5 provides information on the types of stimulation, the methods of pain assessment 
and the values reported in the studies. Seven types of stimulation were used to evoke pain and 
each study employed only one type of these stimulations. In the studies using the same pain 
stimulation method, the pain assessment in each study varied for except two studies (study 
number 06 and 07 in Table 4.5) (21; 22). However, these two studies had employed different 
frequencies of EA stimulation (study number 06 and 07 in Table 4.6). The variations in the 
pain models and acupuncture techniques are summarised in Table 4.6. 
 
4.4.5.1 Electrical stimulation induced pain and assessment 
Two types of single electrical stimulus models were used in three studies. Single electrical 
stimulus induced dental pain was used in two studies, but their pain assessments varied. One 
study assessed pain ratings to three levels of ST intensity immediately after EA (study 
number 1 in Table 4.5) (20), and the other study assessed PT during MA (study number 2 in 
Table 4.5) (19). Another pain stimulation method was the transcutaneous single electrical 
stimulus induced pain. One study employed this stimulation method and assessed PT and 
PTT immediately after MA (study number 3 in Table 4.5) (125). 
 
4.4.5.2 Thermal stimulation induced pain and assessment 
The thermal pain stimulation methods were transcutaneous ice-water cold pain stimulation, 
transcutaneous cold-heat prolonged stimulation and transcutaneous prolonged heat 
stimulation. One study employed ice-water pain stimulation. Subjects were asked to immerse 
their forearms in zero degree Celsius ice-water and give pain ratings every 10 seconds within 
one minute (study number 4 in Table 4.5) (18). The transcutaneous prolonged cold-heat pain 
stimulation was used in another study (study number 5 in Table 4.5) (124). The name 
‘cold-heat prolonged stimulation’ was used because the intensity (temperature) of the stimuli 
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was continuously changed; the study firstly assessed the cold stimulation induced PT and 
then increased the temperature until the heat stimulation induced PT was reached. The 
transcutaneous prolonged heat stimulation method was employed in three studies. Their 
assessment methods and interventions are described as follows. One study used consistent 
heat stimulation to assess the time it took to reach PTT before and immediately after 
120-hertz EA (study number 6 in Table 4.5) (22); another study assessed the time it took to 
reach PT and PTT immediately after 2.5-hertz EA (study number 7 in Table 4.5) (21); the 
remaining one study assessed the pain ratings in response to low, medium and high levels of 
ST stimulations (12 seconds of each stimulation) immediately after 2/15 hertz EA and MA 
(study number 8 in Table 4.5) (83). 
 
4.4.5.3 Mechanical stimulation induced pain and assessment 
One study used continuously increasing pressure (1 kg/s) as the mechanical stimulation to 
assess PT immediately after MA (study number 9 in Table 4.5) (17). 
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Table 4.5 Pain models and outcome assessments of the included studies 
 
Pain 
stimulation Types of measurement 
Assessed 
Unit  Presented values  
(1) 
Chapmen 
et al. 1976 
Single electrical 
stimulus 
induced dental 
pain 
Pain ratings to pre-defined low, 
medium and high levels of ST 
stimulus - Immediate effect. 
(Baseline PT defined as low 
level, medium level = low+2µA, 
high level = low+4µA) 
VAS rating 
(0-7) 
Pain rating to the 
stimulus (Mean and 
SD values) 
(2) Mayer 
et al. 1977 
Single electrical 
stimulus 
induced dental 
pain 
PT (The intensity of electrical 
stimulus). - Instant effect. 
Electrical 
potential 
(Volts) 
(1) Percentage 
changes of intensity 
(mean and confidence 
interval values); (2) 
the number of 
responders whose PT 
was increased more 
than 20%. 
(3) 
Johnson et 
al. 1996 
Transcutaneous 
single electrical 
stimulus 
PT and PTT (electrical current) – 
Instant and immediate effects 
Electrical 
current (µA) 
Electrical current 
intensity (mean and 
SD values); 
(4) 
Anderson, 
et al. 1974 
Cold pressor  
(immersing the 
forearm in 0℃ 
ice-water)  
Pain rating every 10 seconds 
within 1 minute (6 ratings). – 
Immediate effect 
VAS (0-10) 
Rating (Mean values 
presented in a chart. 
No SD values or any 
value that can be 
converted into SD 
value.) 
(5) Downs 
et al. 2005 
Transcutaneous 
cold-heat 
prolonged 
stimuli 
Cold PT and heat PT– 
Immediate effect 
Temperatu
re (℃) 
Temperature (Mean 
and SD values) 
(6) Berlin 
et al. 1975 
Transcutaneous 
prolonged heat 
stimuli 
PTT (Duration from the onset of 
the  continuous heat stimulation 
to when pain was reported) – 
immediate effect  
Time (sec)  
Changes of PTT 
(mean and SD values 
were provided in 
chart)  
(7) 
Stewart et 
al. 1977 
Transcutaneous 
prolonged heat 
stimuli 
PT and PTT (Duration from the 
onset of the continuous heat 
stimulation, PT was recorded and 
the stimulation was not stopped 
until PTT was reached) – 
Immediate effect   
Time (sec) 
Changes of PT and 
PTT (Mean and SEM 
values) 
(8) Kong 
et al. 2005 
Transcutaneous 
prolonged heat 
stimulation (12 
seconds 
duration each)  
Pain ratings to pre-defined low, 
medium, and high levels of ST 
heat stimulus of 12 seconds 
duration. – Immediate effect. 
(Baseline low, medium and high 
levels were defined as 
magnitude 7-10, 11-14, 15-18 of 
VAS ratings respectively) 
VAS 
(0-20) 
(1) Pain rating (Mean 
and SEM values); (2) 
The numbers of 
individual responder 
whose pain was 
significantly reduced 
after acupuncture.  
(9) 
Zaslawski 
et al. 2003 
Transcutaneous 
mechanical 
stimulation 
PT (pressure was increased at a 
speed of 1 kg/s until PT was 
reported). – immediate effect 
Pressure  
(Kg/ cm2) 
Pressure (Mean and 
confidence interval 
values) 
 
Note: PT = pain threshold, ST = supra-threshold, PTT = pain tolerance threshold.  
Immediate effect = the effect assessed at within 30 minutes after acupuncture. Instant effect = the 
effect assessed at during acupuncture. 
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Table 4.6 Description of interventions and pain models 
 Acupunct
ure 
Control Pain model (stimulation, 
assessed pain perception) 
Assessed 
temporal 
effect 
Single electrical stimulus   
(1) 
Chapmen et 
al. 1976 
2Hz EA (1) Non-invasive 
control. (2) Invasive 
control e+. 
Electrical single stimulus 
induced dental pain, assessed 
pain responses to ST 
stimulations. 
Immediately 
after 
interventions 
(2) Mayer et 
al. 1977 
MA Non-invasive 
control. 
Electrical single stimulus 
induced dental pain, assessed 
the intensity achieving PT 
Instantaneously 
during 
interventions 
(3) Johnson 
et al. 1996 
MA Non-invasive 
control. 
Transcutaneous electrical 
single stimulus, assessed the 
intensity achieving PT and 
PTT 
Instantaneously 
during and 
immediately 
after 
interventions 
Prolonged thermal or mechanical stimuli   
(4) 
Anderson, et 
al. 1974 
EA 
(unknown 
frequency) 
(1) Non-invasive 
control. (2) Invasive 
control e+. 
Ice-water cold stimuli, assessed 
pain response ratings. 
Immediately 
after 
interventions 
(5) Downs 
et al. 2005 
MA Non-invasive 
control. 
Transcutaneous cold-heat 
stimuli, assessed the intensities 
achieving cold and heat PT 
Immediately 
after 
interventions 
(6) Berlin et 
al. 1975 
120Hz EA (1) Non-invasive 
control. (2) Invasive 
control e+. 
Transcutaneous heat stimuli, 
assessed the duration 
achieving PTT  
Immediately 
after 
interventions 
(7) Stewart 
et al. 1977 
2.5Hz EA (1) Non-invasive 
control. (2) Invasive 
control e+. 
Transcutaneous heat stimuli, 
assessed the duration 
achieving PT and PTT 
Immediately 
after 
interventions 
(8) Kong et 
al. 2005 
(1) 2/15 Hz 
EA; (2) 
MA. 
Non-invasive 
control. 
Transcutaneous heat stimuli, 
assessed pain responses to ST 
stimulations 
Immediately 
after 
interventions 
(9) 
Zaslawski et 
al. 2003 
(1) MA 
m+; (2) 
MA m-. 
(1) Non-invasive 
control; (2) Invasive 
control m+; (3) 
Invasive control m-. 
Transcutaneous mechanical 
stimulations, assessed the 
intensity to achieve PT  
Immediately 
after 
interventions 
 
Note: e+ = with EA-like electrical stimulation; m+ = manipulation was present; m- = manipulation 
was absent. Immediately after intervention = the effect assessed at within 30mins after the 
intervention. Instantaneously during intervention = the effect assessed at during the intervention. 
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4.4.6 Between interventions comparisons of effectiveness 
Instructions for how to read the RevMan output figure is provided in Appendix 12; the 
RevMan output figures for the results of comparisons and original data are provided in 
Appendices 13 to 20. The following paragraphs describe these results according to the 
interventions. The results of effectiveness comparisons between interventions in each 
study are summarised in the Tables following each section. 
 
4.4.6.1 MA versus non-invasive control 
Five studies compared MA versus non-invasive control (Table 4.7) (17; 19; 83; 124; 
125). 
 
Instant effect: In these five studies using MA as intervention, two studies evaluated the 
analgesic effect during MA. One study reported the effect during MA was significantly 
higher than that of non-invasive SA by assessing PT to a single electrical stimulus 
induced dental pain model (study 01 in Table 4.7) (19). Another study used six subjects in 
each group and reported the analgesic effect of MA was not better than non-invasive SA 
by assessing PT and PTT using transcutaneous single electrical stimulus induced pain 
model (study 02 in Table 4.7) (125).  
 
Immediate effect: In the five studies using MA as intervention, four studies evaluated 
the analgesic effect immediately after intervention (study 02, 03, 04 and 05 in Table 4.7); 
Three of the four studies reported the MA effect was not significantly higher than 
non-invasive control using the transcutaneous single electrical stimulus induced pain 
model (six subjects in each group), the transcutaneous prolonged cold-heat stimulation 
induced pain model (18 subjects in each group) and the transcutaneous prolonged heat 
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stimulation pain model (11 subjects in each group), respectively (study 02, 03, 04 in 
Table 4.7) (83; 124; 125). Whereas the remaining one study reported that MA 
significantly increased PT more than the non-invasive control when assessed using the 
transcutaneous mechanical stimulation pain model (13 subjects in each group) (study 05 
in Table 4.7) (17).  
 
In summary, MA significantly induced analgesia to electrical stimulus induced dental 
pain during intervention (19), and to transcutaneous mechanical pressure pain 
immediately after the interventions (17). However, MA did not produce analgesia better 
than non-invasive SA to transcutaneous electrical pain at, during, or immediately after 
intervention (125), and the analgesic effect of MA was not statistically higher than that of 
non-invasive SA to transcutaneous thermal heat-cold pain immediately after 
interventions (124). 
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Table 4.7 MA versus non-invasive control 
Sub-category.  Result (P value*) 
Study 01: Mayer et al. 1977 (single electrical stimulus induced dental pain assessed by 
percentage change of intensity) - (Figure in Appendix 13) 
Comparison: Instant effect of MA vs. non-invasive control 
01. The percentage change of PT (MA, n = 
35; non-invasive control n=40) 
Favours MA, p= 0.0003 
Study 02: Johnson et al. 1996 (transcutaneous single electrical stimulus induced pain 
assessed by the intensity of electrical current) - (Figures in Appendix 15) 
Comparison: Instant effect of MA vs. non-invasive control  
01. PT (n=6) Favours control. P= 0.23 
02. PTT (n=6) Favours control. P= 0.38 
Comparison: Immediate effect of MA vs. non-invasive control 
01. PT (n=6) Favours control. P= 0.25 
02. PTT (n=6) Favours control. P= 0.35 
Study 03: Downs et al. 2005 (transcutaneous prolonged cold-heat stimuli induced pain 
assessed by the intensity of temperature) - (Figure in Appendix 16) 
Comparison: Immediate effect of MA vs. non-invasive control  
01. Cold stimulation induced PT (n=18) Favours MA, p= 0.35 
02. Heat stimulation induced PT (n=18) Favours MA, p= 0.13 
Study 04: Kong et al. 2005 (transcutaneous prolonged heat stimuli induced pain assessed 
by pain response rating to supra-threshold stimulations) - (Figures in Appendix 19) 
Comparison: Immediate effect of MA vs. non-invasive control 
01. Pain rating to low level ST stimulation 
(n=11) 
Favours MA, p= 0.44 
02. Pain rating to medium level ST 
stimulation (n=11) 
Favours MA, p= 0.51 
03. Pain rating to high level ST stimulation 
(n=11) 
Favours MA, p= 0.76 
Study 05: Zaslawski et al. 2003 (transcutaneous prolonged mechanical stimulus induced 
pain assessed by pressure pain threshold) - (Figures in Appendix 20) 
Comparison: Immediate effect of MA vs. non-invasive control 
PT assessed in 10 points. (n=13) All 10 results significantly favour MA. 
 
Note: PT = pain threshold; ST = supra-threshold; PTT = pain tolerance threshold.  
 
* The statistical significance of the above comparisons is at p < 0.05.
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4.4.6.2 Low frequency EA versus non-invasive control 
Two studies compared continuous mode low frequency (2-hertz and 2.5-hertz) EA versus 
non-invasive control (Table 4.8) (20; 21). Both studies evaluated the effect immediately 
after interventions. The study, with 15 subjects in each group, reported the analgesia of 
2-hertz EA was significantly stronger than non-invasive control when assessed with the 
electrical stimulus induced dental pain model (study 01 in Table 4.8) (20). The other 
study, with 12 subjects in each group, reported the 2.5-hertz EA analgesic effect was not 
significantly better than non-invasive control using the transcutaneous heat stimulation 
induced pain model, however, there was a trend favouring EA ( p = 0.07 and  p = 0.08) 
(study 02 in Table 4.8) (21).  
 
In summary, low frequency EA showed pronounced analgesia to electrical dental pain 
model but not to transcutaneous heat pain model. 
 
Table 4.8 Low frequency EA versus non-invasive control 
Sub-category.  Result (P value*) 
Study 01: Chapmen et al. 1976 (single electrical stimulus induced dental pain assessed by 
pain response rating) - ( Figures in Appendix 14) 
Comparison: Immediate effect of 2Hz EA vs. non-invasive control 
01. Pain rating to low level ST stimulation (n=15) Favours EA, p= 0.001  
02. Pain rating to medium level ST stimulation (n=15) Favours EA, p= 0.0001 
03. Pain rating to high level ST stimulation (n=15) Favours EA, p= 0.0008 
Study 02. Stewart et al. 1977 (transcutaneous prolonged heat stimuli induced pain 
assessed by the stimulation duration required to achieve pain threshold and pain 
tolerance threshold) - (Figures in Appendix 18) 
Comparison: Immediate effect of 2.5Hz EA vs. non-invasive control 
01. The duration to reach PT (n=12) Favours 2.5Hz EA, P= 0.08 
02. The duration to reach PTT (n=12) Favours 2.5Hz EA, P= 0.07 
 
Note: PT = pain threshold; ST = supra-threshold; PTT = pain tolerance threshold. 
* The statistical significance of the above comparisons is at p < 0.05. 
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4.4.6.3 High frequency EA versus non-invasive control 
Only one study compared continuous mode 120-hertz EA versus non-invasive control 
(Table 4.9) (22). The effect immediately after EA was significantly higher than that of 
non-invasive control assessed by transcutaneous heat stimulation induced pain (n = 10 in 
each group). 
 
Table 4.9 High frequency EA versus non-invasive control 
 
Sub-category.  Result (P value *) 
Study: Berlin et al. 1975 (transcutaneous prolonged heat stimuli induced pain assessed by 
the stimulation duration required to achieve pain tolerance threshold) - (Figures in 
Appendix 17) 
Comparison: Immediate effect of 120 Hz EA vs. non-invasive control  
01. The duration to reach PTT (n=10) Favours 120Hz EA, P< 0.00001 
 
Note: PTT = pain tolerance threshold. 
* The statistical significance of the above comparisons is at p < 0.05. 
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4.4.6.4 EA (2/15 hertz) versus non-invasive control 
Only one study compared alternating mode 2/15 hertz EA versus non-invasive control 
(Table 4.10) (83). The effect immediately after EA was not significantly higher than that 
of non-invasive control, when assessed with the transcutaneous heat stimulation induced 
pain model (n=11 in each group). 
 
4.4.6.5 EA (2/15 hertz) versus MA 
Only one study compared alternating mode 2/15 hertz EA versus MA (Table 4.10) (83). 
The effect immediately after EA was not significantly higher than that of MA when 
assessed with the transcutaneous heat stimulation induced pain model (n=11 in each 
group). 
 
Table 4.10 EA (2/15 hertz) versus non-invasive control and MA 
Sub-category.  Result (P value*) 
Study: Kong et al. 2005 (transcutaneous prolonged heat stimuli induced pain assessed by 
pain response rating to supra-threshold stimulations) - (Figures in Appendix 19) 
Comparison: Immediate effect of 2/15Hz EA vs. non-invasive control 
01. Pain rating to low level ST stimulation (n=11) Favours 2/15Hz EA, p=0.47 
02. Pain rating to medium level ST stimulation (n=11) Favours 2/15Hz EA, p=0.22 
03. Pain rating to high level ST stimulation (n=11) Favours 2/15Hz EA, p=0.33 
Comparison: Immediate effect of 2/15Hz EA vs. MA  
01. Pain rating to low level ST stimulation (n=11) Favours MA, p=0.92 
02. Pain rating to medium level ST stimulation (n=11) Favours 2/15Hz EA, p=0.43 
03. Pain rating to high level ST stimulation (n=11) Favours 2/15Hz EA, p=0.43 
 
Note: ST = supra-threshold. 
* The statistical significance of the above comparisons is at p < 0.05. 
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4.4.6.6 A comparison of the studies including results of acupuncture versus 
invasive control and acupuncture versus non-invasive control 
Four studies employed both invasive and non-invasive controls (Table 4.11) (17; 20; 21; 
22). All of the invasive controls used in these studies were inserted needles into 
non-acupoints.  
 
One study compared the effects of 2-hertz EA, invasive control with 2-hertz electrical 
stimulation (named ‘2-hertz e+ invasive control’; ‘e+’ represents ‘with electrical 
stimulations’) and non-invasive control using the electrical dental pain model. EA 
significantly reduced the pain ratings to low, medium and high ST levels of electrical 
stimulation compared with non-invasive control, but the effect of EA on high level ST 
stimulation was not statistically higher than that of 2-hertz e+ invasive control (study 01 
in Table 4.11) (20). Another study compared the effects of 2.5-hertz EA, 2.5-hertz e+ 
invasive control and non-invasive control using the transcutaneous heat pain model. The 
PT immediately after EA was not significantly higher than that of either non-invasive 
control or 2.5-hertz e+ invasive control (study 02 in Table 4.11) (21). The above two 
studies showed that e+ invasive controls induced some level of analgesia and at times 
their effect was indistinguishable from that of EA on real acupoints. 
 
Another study observed no difference in results between 120-hertz EA versus 120-hertz 
e+ invasive control and 120-hertz EA versus non-invasive control; this study assessed the 
PTT using the transcutaneous heat pain model (study 03 in Table 4.11) (22). 
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One study compared the effects of MA, invasive control with manipulations (named 
‘invasive control m+’), invasive control without manipulations (named ‘invasive control 
m-’) and non-invasive control (study 04 in Table 4.11) (17). This study found the results 
of MA versus non-invasive control were similar to those of MA versus invasive control 
m-, which was that MA analgesia was significantly higher than that of either of the 
controls assessed at all 10 sites. A comparison of MA with invasive control m+ showed 
that the MA effect was significantly greater at nine out of 10 sites. 
 
In summary, 2-hertz e+ invasive control and invasive control m+ had strong analgesic 
effects. When they were used as SA control, the difference between real acupuncture and 
the control was reduced.  
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Table 4.11 A comparison of the studies including results of acupuncture versus 
invasive control and acupuncture versus non-invasive control 
Sub-category.  Result (P value*) 
Study 01: Chapmen et al. 1976 (single electrical stimulus induced dental pain assessed by 
pain response rating) - ( Figures in Appendix 14) 
Comparison 01. Immediate effect of 2Hz EA vs. non-invasive control 
01. Pain rating to low level ST stimulation 
(n=15) 
Favours EA, p= 0.001  
02. Pain rating to medium level ST stimulation 
(n=15) 
Favours EA, p= 0.0001 
03. Pain rating to high level ST stimulation 
(n=15) 
Favours EA, p= 0.0008 
Comparison 02. Immediate effect of 2Hz EA vs. 2 Hz e+ invasive control  
01. Pain rating to low level ST stimulation 
(n=15) 
Favours EA, p= 0.03 
02. Pain rating to medium level ST stimulation 
(n=15) 
Favours EA, p= 0.008 
03. Pain rating to high level ST stimulation 
(n=15) 
Favours EA, p= 0.1 
Study 02: Stewart et al. 1977 (transcutaneous prolonged heat stimuli induced pain 
assessed by stimulation duration required to achieve pain threshold and pain tolerance 
threshold) - (Figures in Appendix 18) 
Comparison 01. Immediate effect of 2.5Hz EA vs. non-invasive control 
01. The duration to reach PT (n=12) Favours 2.5Hz EA, P= 0.08 
02. The duration to reach PTT (n=12) Favours 2.5Hz EA, P= 0.07 
Comparison 02. Immediate effect of 2.5Hz EA vs. 2.5Hz e+ invasive control 
01. The duration to reach PT (n=12) Favours 2.5Hz EA, p= 0.27 
02. The duration to reach PTT (n=12) Favours 2.5Hz EA, p= 0.5 
Study 03: Berlin et al. 1975 (transcutaneous prolonged heat stimuli induced pain assessed 
by stimulation duration required to achieve pain tolerance threshold) - (Figures in 
Appendix 17) 
Comparison 01. Immediate effect of 120 Hz EA vs. non-invasive control 
01. The duration to reach PTT (n=10) Favours 120Hz EA, P< 0.00001 
Comparison 02. Immediate effect of 120 Hz EA vs. 120 Hz e+ invasive control 
01. The duration to reach PTT (n=10) Favours 120Hz EA, P< 0.00001 
Study 04: Zaslawski et al. 2003 (transcutaneous prolonged mechanical stimulus induced 
pain assessed by pressure pain threshold) - (Figures in Appendix 20) 
Comparison 01. Immediate effect of MA vs. non-invasive control 
Intensity of PT assessed in 10 points. (n=13) All 10 results significantly favour MA. 
Comparison 02. Immediate effect of MA vs. invasive control m+ 
Intensity of PT assessed in 10 points. (MA, 
n=13; Invasive control m+, n=9) 
All 10 results favour MA; with 9 significant 
and 1 insignificant results. 
Comparison 03. Immediate effect of MA vs. invasive control m- 
Intensity of PT assessed in 10 points. (n=13) All 10 results significantly favour MA. 
 
Note: e+ = with EA-like electrical stimulation; m+ = manipulation was present; m- = 
manipulation was absent. PT = pain threshold; ST = supra-threshold; PTT = pain tolerance 
threshold. 
* The statistical significance of the above comparisons is at p < 0.05. 
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4.4.6.7 A direct comparison between invasive control and non-invasive 
control  
A direct comparison of the standardised mean differences of the invasive and non-invasive 
controls in each of the four studies was conducted (Table 4.12) (17; 20; 21; 22). 
 
In one study, 2-hertz e+ invasive control significantly reduced the pain ratings to medium 
and high level ST stimulations compared with non-invasive control in the electrical 
stimulus dental pain model (study 01 in Table 4.12) (20). In another study, 2.5-hertz e+ 
invasive control did not significantly increase PT or PTT more than non-invasive control 
did using the transcutaneous heat pain model (study 02 in Table 4.12) (21). In a third 
study, 120-hertz e+ invasive control significantly increased PTT compared with 
non-invasive control in the transcutaneous heat pain model (study 03 in Table 4.12) (22). 
The last study assessed transcutaneous mechanical stimulation induced pain at ten sites 
and reported the invasive control m+ produced better analgesic effect than non-invasive 
control at all ten sites. The analgesic effect reached statistical significance at seven of ten 
sites in the invasive-control m+ group; whereas the invasive control m- produced 
significantly greater effect than non-invasive control at two of these sites (study 04 in 
Table 4.12) (17). 
 
In summary, three out of four studies showed that invasive controls produced significant 
change in pain perception which was better than that the change produced by 
non-invasive control (17; 20; 22). 
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Table 4.12 A direct comparison between invasive control and non-invasive control 
Sub-category.  Result (P value*) 
Study 01: Chapmen et al. 1976 (single electrical stimulus induced dental pain assessed by 
pain response rating) - ( Figures in Appendix 14) 
Comparison: Immediate effect of 2 Hz e+ invasive control vs. non-invasive control 
01. Pain rating to low level ST stimulation 
(n=15) 
Favours 2Hz e+ invasive control, p= 0.07 
02. Pain rating to medium level ST stimulation 
(n=15) 
Favours 2Hz e+ invasive control, p= 0.04 
03. Pain rating to high level ST stimulation 
(n=15) 
Favours Invasive control e+, p= 0.04 
Study 02. Stewart et al. 1977 (transcutaneous prolonged heat stimuli induced pain 
assessed by stimulation duration required to achieve pain threshold and pain tolerance 
threshold) - (Figures in Appendix 18) 
Comparison: Immediate effect of 2.5Hz e+ invasive control vs. non-invasive control 
01. The duration to reach PT (n=12) Favours 2.5Hz e+ invasive control, p= 0.34 
02. The duration to reach PTT (n=12) Favours 2.5Hz e+ invasive control, p= 0.29 
Study 03. Berlin et al. 1975 (transcutaneous prolonged heat stimuli induced pain assessed 
by stimulation duration required to achieve pain tolerance threshold) - (Figures in 
Appendix 17) 
Comparison: Immediate effect of 120 Hz e+ invasive control vs. non-invasive control 
01. The duration to reach PTT (n=10) Favours 120Hz e+ invasive control,  
P< 0.00001 
Study 04. Zaslawski et al. 2003 (transcutaneous prolonged mechanical stimulus induced 
pain assessed by pressure pain threshold) - (Figures in Appendix 20) 
Comparison: Immediate effect of invasive control m+ vs. non-invasive control 
Intensity of PT assessed in 10 points. (Invasive 
control m+, n=9; non-invasive control, n=13) 
All 10 results favour invasive control m+; 
with 7 significant and 3 insignificant results. 
 Comparison: Immediate effect of invasive control m- vs. non-invasive control  
Intensity of PT assessed in 10 points (n=13) 2 results significantly favour invasive 
control m-. 8 results insignificantly favour 
non-invasive control (no effect). 
 
Note: e+ = with EA-like electrical stimulation; m+ = manipulation was present; m- = 
manipulation was absent. PT = pain threshold; ST = supra-threshold; PTT = pain tolerance 
threshold.  
* The statistical significance of the above comparisons is at p < 0.05.
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4.4.7 Description of the study with no SD value for 
effectiveness estimation  
In Table 4.8, information from a study with no SD value for standardised mean difference 
estimation is extracted (18). This study employed zero degree Celsius cold water pain 
stimuli, and the pain ratings were recorded every 10 seconds within one minute (6 
ratings). This study only provided the mean values in a chart without the SD values. It 
was reported the EA (the information of EA frequency was absent) significantly reduced the 
pain ratings compared with either e+ invasive control or non-invasive control on the 
treatment side of the forearm but no significant result was detected on the non-treatment 
side of the forearm. 
 
Table 4.13 The study with absent value for standardised mean difference estimation  
 
Study Intervention Acupuncture 
techniques 
Measurement Results 
Anderso
n, et al. 
1974 
(1)EA (no 
frequency was 
provided).  
(2) 
Non-acupoint 
invasive 
control with 
EA-like 
electrical 
stimulation.  
(3) Group with 
no treatment. 
Unilateral, 
right forearm 
(1) LI11-LI5, 
(2) SI5-SI8. 
The treatment 
duration was 
15 minutes. 
Ice-water pain: immerse 
the forearm into zero 
Celsius degree 
ice-water, subjects rated 
the pain response in a 
VAS (0-10) every 10 
seconds in a 60 seconds 
period. Pain assessments 
were conducted before 
and immediately after 
intervention. Firstly, test 
the treatment side of 
forearm (right). 
Secondly, test the 
non-treatment side 
forearm (left). Finally, 
test the treatment side 
forearm (right) once 
again.  
Mean values were 
calculated and 
presented in a chart. 
No SD value was 
published. EA 
significantly 
reduced the pain 
response to 
ice-water pain 
compared with 
either the invasive 
control with 
electrical 
stimulation or 
non-invasive 
control on the 
treatment limb but 
not on the other 
non-treatment limb. 
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4.5 Discussion 
4.5.1 Summary of results 
In summary, the median values of the methodological quality score and the acupuncture 
adequacy assessment score were high. In these studies, due to the diverse treatment 
methods, pain models used and control intervention employed, a meta-analysis was not 
conducted. The analgesic effect during MA and immediately after low frequency EA 
were significantly greater than non-invasive control, in an electrical stimulus induced 
dental pain model. The analgesic effect immediately after MA was significantly better 
than non-invasive control in a transcutaneous mechanical stimulation induced pain model. 
The effect immediately after continuous mode high frequency EA was significantly 
higher than non-invasive control in a transcutaneous heat stimulation pain model. There 
was no difference in the analgesic effects of 2/15 hertz EA, MA and non-invasive control 
in a study using transcutaneous heat pain model. Three out of four studies reported that 
the invasive controls induced significantly stronger analgesia than non-invasive controls. 
Furthermore, the findings have to be interpreted with caution because in most cases there 
is only one study in each sub-group comparison.  
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4.5.2 Strengths and limitations 
The literature search found two previous reviews which addressed  acupuncture analgesia 
studies on healthy humans (16; 23). One of these reviews did not publish the methods and 
data analysis in the article (23). The other review compared the effectiveness of EA and MA 
respectively with SA, but there were some deficiencies in the methods which were discussed 
in a previous section (section 4.1) (16). Neither of the two reviews drew conclusions 
concerning the invasive and non-invasive controls, and neither made their conclusions 
distinguishing between RCTs and non-RCTs. Hence, the current review may be the first 
review of pain perception studies evaluating acupuncture analgesia which makes 
comparisons between EA, MA, non-invasive control and invasive control. Furthermore, the 
included studies of this review were RCTs with relatively high methodological quality and 
were published in English speaking countries. This afforded the review further reliability 
since a previous review concerning certain countries indicated bias in result reporting (126). 
In addition, it has been advocated that the acupuncture qualifications of experimenters and 
reviewers need to be considered (127). The present reviewers have sufficient qualifications 
and clinical background in acupuncture practice. 
 
This review is different from the Cochrane Systematic Review in some aspects and these 
differences may be criticised. A Cochrane Systematic Review requires at least three 
reviewers in different locations to review literature covering all major languages, and 
must include the literature of RCT and non-RCT, as well as published and unpublished 
literature. In the present review, due to the limited human resources and time constraints, 
only the published RCT papers in English were reviewed, but the methods, results and 
interpretations of this review were examined and discussed within the RMIT Chinese 
Medicine research group. These review procedures ensured the interpretations made in 
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this study properly reflect the relevant published English language experimental RCT 
literature.  
 
Another limitation of this review was the diversity in study designs, procedures and 
outcome measures precluded the possibility of meta-analysis. So that an overall 
standardised mean difference could not be obtained (see section 4.3.6). In the present 
review, the comparisons in the analyses were valid because there was no overlap of 
different pain assessments within the studies. This limitation would be resolved if more 
studies in this area are conducted in the future. Moreover, a similar situation occurred in a 
previous Cochrane Systematic Review. This review had a limited number of included 
studies and meta-analysis was not possible, but this did not affect the interpretation when 
the results of the included studies were analysed (2). 
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4.5.3 Acupuncture analgesia and pain models 
This review showed that each of the acupuncture techniques of MA, continuous mode 
low frequency EA and continuous mode high frequency EA were reported to produce 
significantly greater analgesia than non-invasive control according to assessments using 
different pain models; and the effect of MA was similar to that of low frequency of EA 
when assessed with the same pain model. The strong analgesic effect of acupuncture has 
been advocated in a number of reviews of clinical trials of patients (1; 10; 128; 129; 130). 
However, a recent review written by Staud and Price examining both clinical trials and 
experimental studies concluded that acupuncture analgesia showed strong evidence in 
experimental pain studies but there was less convincing evidence for chronic pain 
conditions in clinical trials. Unfortunately, this article did not publish the details of the 
data-analysis (23). The present review showed each form of acupuncture technique was 
effective in some pain models but not in all of these pain models. Therefore, it is possible 
that different acupuncture techniques might suit different types of clinical pain conditions. 
It is still too early to draw conclusions on the overall effects of acupuncture analgesia for 
clinical pain. 
 
In the comparison between 2/15 hertz EA, MA and non-invasive control in a study using 
a thermal pain model immediately after intervention, it is surprising that the analgesic 
effect of alternating mode 2/15 hertz EA was not better than non-invasive control. Three 
factors, the heat pain model, the acupuncture technique used and the experimental 
method should be considered. Regarding the heat pain model, other included studies in 
this review show MA has less effect on heat pain, and the 2/15 hertz EA may be not 
effective on heat pain as well. This hypothesis needs to be confirmed with further 
experiments. Regarding the second factor, the acupuncture technique used in this study 
had a deficiency, which was the shallow needle insertion. This aspect of acupuncture 
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technique has been widely accepted as an important factor and a standard for acupuncture 
practice (121). Besides this, the study has a methodological deficiency in the concealment 
of allocation and the blinding of the evaluator. 
 
In the present review no studies using a TS pain model, which delivers standardised 
repetitive stimulations at high frequencies, were located. 
 - 85 - 
4.5.4 The use of controls in acupuncture studies 
The present review shows that the analgesia effect induced by invasive controls with 
acupuncture-like stimulation was stronger than that of non-invasive controls. The 
consideration here is certain analgesic effects are activated during the needle insertion. In 
relation to this consideration, one of the included studies has addressed this issue of type 
of control. Zaslawski and his colleagues compared the effects of MA, invasive control 
m+, invasive control m- and non-invasive control; this study showed the importance of 
needle manipulations in producing MA analgesia, and also identified that the use of 
invasive control without manipulations can produce a certain degree of analgesia which is 
better than non-invasive control but was less likely to induce the reporting of MA 
analgesia (17). Future publications should distinguish invasive control and non-invasive 
control in instead of calling both of them ‘sham-acupuncture’. 
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4.5.5 The necessity of long term acupuncture effect evaluation  
Pain perception studies investigating the analgesic effect 24-hours after an acupuncture 
treatment can help to answer the questions “How long can the effect of acupuncture last?” 
and “What is the change in pain perceptions over night after acupuncture?”. Studying 
these issues can also help identify the wash-out period (the time it takes for the treatment 
to no longer have any effect on the participant) of an acupuncture treatment in order to 
avoid any carry-over influence if the study uses the same participant for more than one 
intervention. For example, the interval between different interventions was at least two 
days in two of the included studies (17; 21). This incites the critical question of whether 
this wash out period is enough. In this review, no experimental study was found which 
evaluated the analgesic effect hours after an acupuncture treatment. A review regarding 
clinical trials on patients found that only one clinical trial had evaluated the effects after a 
single acupuncture treatment at longer than 24 hours after the treatment (26). Hence the 
long lasting analgesic effect after a single acupuncture treatment needs to be further 
explored in human studies. 
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4.5.6 Safety and side effects of acupuncture 
Only a minimum number of adverse events with mild symptoms were reported in 
association with acupuncture. The result of this review is in accordance with previous 
reviews which found that acupuncture is a relatively safe treatment when using clean 
needles and trained practitioners (128; 129; 131; 132). In addition, one of the studies 
excluded from this review reported that the application of morphine was associated with 
significant adverse events and ketamine (5 mg/kg) was associated with greatest severity 
of adverse events whereas there were no adverse eventts in association with acupuncture 
in the pain-free healthy participants (133). 
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4.5.7 Recommendations for future research  
4.5.7.1 The selection of acupuncture techniques for research 
A variety of acupuncture techniques have been used in clinical trials, such as shallow or 
deep needle insertions, various durations and techniques of manipulation used in MA, 
various modes of electrical stimulation used in EA and there has been a wide selection of 
acupoints used (8; 116; 134). When the results of these diverse trials are interpreted 
together, a complexity of factors is introduced. This could lessen the likelihood of a valid 
evaluation of the acupuncture effect with the result that the effectiveness of acupuncture 
would remain controversial. Therefore, improved strategies that consider these various 
factors are required when conducting acupuncture experiments. Consequently, it is 
recommended that studies should investigate each of the various acupuncture techniques 
in a systematic series of experiments using validated assessment methods with high 
quality design. This approach may enable conclusions to be drawn regarding the 
effectiveness of acupuncture. 
 
4.5.7.2 Evaluate acupuncture analgesia using a temporal summation pain 
model 
The TS of pain model has relatively clear mechanisms and well defined methods of 
stimulation and assessment which were introduced in Chapter 2. Therefore, an 
experimental RCT which quantitatively compares acupuncture with non-invasive control 
could be used to assess acupuncture analgesia on TST in healthy pain-free subjects. Such 
studies might provide data that could be applied to explain the effects of acupunture in 
clinical pain conditions. In addition, future studies could conduct pain assessments at 
different segmental areas and at time periods longer than 24 hours after interventions 
using this pain model. 
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4.6 Conclusion 
In acupuncture, in the area of RCT studies in healthy pain-free humans in the English 
language, the published acupuncture analgesia pain perception studies with non-invasive 
control have been systematically evaluated. Within these studies, the invasive control 
produced greater analgesia than non-invasive control. When comparing acupuncture with 
non-invasive control, significant acupuncture effects were reported in the studies which used 
both valid pain assessment methods and high quality of acupuncture techniques. The 
observation, which suggests the analgesic effect of EA is better than MA, can not been firmly 
concluded. The long term effects of acupuncture analgesia and the comparison between EA 
and MA needs to be further evaluated. Acupuncture is a relatively safe treatment. The model 
of temporal summation of pain has not been employed in acupuncture RCT quantitative 
studies using non-invasive control. 
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Chapter 5: Methods 
 
The current project is a randomised, double-blinded, sham-acupuncture controlled 
experimental study. This project was reviewed and approved by the Human Research 
Ethics Committee of RMIT University (Reference No. 24/05) (Appendix 01), of which the 
principles were in accordance with the ‘National Statement on Ethical Conduct in 
Research Involving Humans 1999’ issued by National Health and Medical Research 
Council. All the tests were conducted at the Clinical Research Lab of RMIT Chinese 
Medicine Research Group, Bundoora West Campus. The laboratory room was a quiet, 
temperature-controlled room. The room temperature was adjusted to 22 - 25 degrees 
Celsius. 
 
In the thesis, ‘Investigator A’ refers to the evaluator, ‘Investigator B’ refers to the 
acupuncturist and ‘Investigator C’ refers to the person in responsible for randomisation 
and data analysis.  
 
5.1 Volunteer recruitment 
The volunteers were recruited via advertisements placed on the RMIT University website 
and posted at the University’s Bundoora and City campuses (Appendix 02). RMIT staff 
and students or members of the public who answered the advertisements were recruited as 
long as they met the selection criteria. They were volunteers with no payment or any other 
benefit for their participation. 
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5.1.1 Inclusion and exclusion criteria 
The selection of volunteers was based on the information provided by the volunteers 
(Appendix 03), and according to the inclusion and exclusion criteria detailed below. 
 
Volunteers were included if they    
(a) were aged between 18 and 40 years old and healthy at the time of recruitment;  
(b) agreed to fully participate in the study; 
(c) provided a written consent form for participation; and   
(d) never had acupuncture prior to this study. 
 
Volunteers were excluded from the study if they   
(a) did not comprehend English; 
(b) were currently pregnant at the time of recruitment; 
(c) had severe heart disease, wore a pacemaker, or had a high risk of cardiovascular 
diseases as assessed using the Cardiovascular Risk Questionnaire (Appendix 04);  
(d) had a brain tumour or epilepsy 
(e) had the tendency to bleed, such as being haemophilia;  
(f) had drug addiction; 
(g) had taken any analgesics in the previous two weeks;  
(h) suffered from chronic pain or recurrent pain; or 
(i) had skin problems at the proposed acupuncture sites. Investigator A checked if 
there was any ulcer or dermatitis at the proposed stimulation sites.  
 
Volunteers were given written information (i.e. Plain Language Statement, Appendix 05) 
and a verbal explanation concerning the study. Full explanation to any questions raised 
was given by Investigator A. Signed Informed Consent (Appendix 06 and 07) was then 
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obtained from each volunteer. Every volunteer was also notified that he/she was free to 
withdraw from the study at any time. 
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5.2 Method of randomisation and double-blinding  
Randomisation and double-blinding were employed. Each volunteer was randomly 
assigned to one of three groups, i.e. manual acupuncture (MA), electro-acupuncture (EA) 
and sham acupuncture (SA), by drawing a sealed envelop which contained a random 
number that indicated the group allocation. Investigator C created these random numbers 
by using Microsoft Excel software (Microsoft Office 2002, Windows version) (Appendix 
08). Investigator C was not involved in any of the testing procedures. He passed the 
random numbers only to the acupuncturist, i.e., Investigator B. The acupuncturist 
(Investigator B) delivered the interventions of MA, EA and SA, and was blinded to the 
pain assessments. The evaluator, i.e., Investigator A, who conducted pain assessments, 
was blinded to treatment allocation. During the treatment period, the volunteers lay on a 
treatment bed in a supine position and their vision to the sites of acupuncture was blocked 
by an object placed at their waist level. At the conclusion of the whole experiment, 
Investigator C collected the data from Investigator A and used the random numbers to 
identify the group assignment and conduct the data analysis. 
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5.3 Interventions  
There are two active intervention groups, EA and MA, and a sham control intervention 
group. Acupuncture needles were two 0.25 x 40mm sterile single-use needles with guide 
tube (Hwato, Suzhou Medical Appliance Company, China). Table 5.1 shows the 
comparisons between the techniques of these three interventions. 
 
5.3.1 Selection of acupoints 
Acupoints Zusanli (ST 36) and Fenglong (ST 40) were selected for the intervention as 
they are often used for pain reduction. Methods of locating these acupoints are described 
as follows: 
 
ST36: “The point is located in the fossa one finger breadth lateral to the anterior margin of 
the tibia, and 3 inches inferior to ST35. The location of ST35 is, with the knee flexed at 90o, 
at the inferior margin of the patella in the fossa lateral to the tendon of the patella.” - Page 
63 and 68, (122). 
 
ST40: “At the midpoint between the inferior margin of the patella and the skin crease of 
the ankle joint, 1.5 inches lateral to the anterior margin of the tibia, and between the tibia 
and fibula.” - Page 73, (122). 
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5.3.2 Manual acupuncture  
Needles were inserted into acupoints to a depth of 20-25 mm. The manipulation 
technique involved needle rotation between the fingers at a medium rate of stimulation 
with 180 to 360 degrees in a bidirectional manner, first clockwise then anticlockwise. 
This action was repeated nine times, and lasted approximately 10 seconds. De qi 
sensations, described as soreness, numbness, or distension at the needling site, were 
produced. This manipulation was repeated every five minutes over a period of 25 minutes; 
so in total six episodes of manipulation were performed in 25 minutes. Similar MA 
techniques were used in a recent acupuncture study (17). 
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5.3.3 Electro-acupuncture  
After needles were inserted into the correct depth, needles were manipulated to achieve 
the de qi sensations. A modified acupuncture electrical stimulator (Myer 501, Australia) 
was then connected to the two needles via two electrodes. The mode of EA used was 
dense-disperse (D-D) mode with alternating frequency between 2- and 100- hertz every 
six seconds. The stimulus intensity was adjusted to a strong but tolerable level with 
visible muscle contraction. When the intensity of electrical stimulation had been adjusted, 
no further change of the intensity was made during the rest of the EA period. The duration 
of EA treatment was 25 minutes. The same machine and the mode of EA were used in a 
previous clinical trial (79). 
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5.3.4 Sham acupuncture 
In the SA group, a non-invasive method was used (81). An empty plastic guide tube was 
tapped at ST36 and ST40 on the dominant leg to produce some discernible sensation, and 
then two bent needles, each with a piece of adhesive bandage (see Figure 5.1) were then 
taped to the dermal surface of the two acupoints respectively for 25 minutes. 
Manipulations were made by pressing the bent needles to produce a pressing sensation on 
the skin surface of the acupoints every five minutes. A non-functioning electrical 
acupuncture stimulator was connected to the end of the two needles via wires, and was 
placed on a table within the volunteers’ eyesight, showing a continuously flashing light. 
De qi sensations were not intended and were avoided.   
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Figure 5.1 Sham-acupuncture design 
The top panel shows the reverse side of the sham needle. The needle is bent and the tip is 
hidden under the bandage. The lower panel shows the top side of the sham needle.   
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Table 5.1 Summary of interventions 
 Manual 
acupuncture 
Electro-acupuncture Sham acupuncture 
Posture of the 
subjects 
Supine Supine Supine 
Locations ST 36 and ST 40 on 
the dominant leg 
ST 36 and ST40 on the 
dominant leg 
1-2 cm next to ST36 
and ST40 on the 
dominant leg 
Insertion 20-25 mm 20-25 mm Non-invasive mock 
insertion 
De qi Yes Yes No 
Duration 25 min 25 min 25 min 
Schedule of 
needle 
manipulations 
Every 5 minutes. Once (at the beginning). Every 5 minutes. 
 
Conduction of 
manipulations  
Needles were twirled 
at a moderate speed 
with 180 to 360 
degrees of rotation in 
a bidirectional 
manner, first 
clockwise then 
anticlockwise. This 
action was repeated 
nine times in each 
episode of 
manipulation, and 
lasted about 10 
seconds. 
After needle insertion 
and de qi sensations, a 
modified EA stimulator 
was connected to the two 
needles via two 
electrodes.  
Frequency: Dense- 
Disperse mode with  
alternating frequencies 
at 2- and 100- Hz,every 6 
seconds. 
 
Intensity: a strong but 
tolerable intensity with 
visible muscle 
contraction. The 
intensity of electrical 
stimulation was kept 
consistent during the 
treatment period. 
Manipulations were 
made by pressing the 
bended needles to 
produce a pricking 
sensation.  A mock 
electrical acupuncture 
stimulator was 
connected to the end of 
the two needles via 
wires, and was placed 
on a table within 
volunteers’ eyesight, 
showing a 
continuously flashing 
light.    
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5.4 Primary outcome measures – pain assessment 
Primary outcome measures were: 1. pain threshold to single electrical stimulation (i.e. 
SPT); 2. pain threshold to repeated electrical stimulation (i.e. TST); and 3. pain ratings to 
supra-threshold stimulation at 1.2 X TST and 1.4 X TST intensity, using the methods 
developed by Arendt-Nielsen et al., 1994 (33). SPT and TST were assessed at three body 
sites during baseline, immediately after the intervention and 24-hours after the 
intervention. 
 
5.4.1 Sites of assessment 
The following three sites were selected for assessment (Figures 5.2 – 5.4). 
 
Treatment leg site: At the skin surface of the tibia anterior muscle along the sural nerve 
path of the dominant leg and parallel to the mid point between the acupoints ST36 and 
ST40 (dermatome Lumbar-5 segment). 
 
Non-treatment leg site: At the skin surface of the tibia anterior muscle along the sural 
nerve path of the non-dominant leg and parallel to the mid point between the acupoints 
ST36 and ST40 (dermatome Lumbar-5 segment). 
 
Forearm (non-dominant side): At the dorsal skin surface of the non-dominant forearm 
along the median nerve path and 3-4 cm above the wrist crease (dermatome Cervical-7 
segment). 
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The following pictures illustrate the locations of assessment sites and the locations of 
acupuncture points; no picture was taken of the volunteers during the experimental period 
due to privacy considerations. The pictures are edited uding Adobe Photoshop 8.0 
software (Adobe software company, USA). 
 
 
 
Figure 5.2 Sites of assessment and acupuncture on the treatment leg (dominant leg) 
Two green spots represent the assessment sites, i.e. the location of the two adhesive electrodes. 
Two yellow spots represent the acupuncture sites. The digitally whitened area represents the skin 
area that has been prepared for pain assessment.    
 
 
 
Figure 5.3 Sites of assessment on the non-treatment leg (non-dominant side)  
Two green spots represent the assessment sites, i.e. the location of the two adhesive electrodes. 
The digitally whitened area represents the skin area that has been prepared for pain assessment. 
 
 
 
Figure 5.4 Sites of assessment on the forearm (non-dominant side) 
Two green spots represent the assessment sites, i.e. the location of the two adhesive electrodes. 
The digitally whitened area represents the skin area that has been prepared for pain assessment. 
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5.4.2 Electrical stimulation and instruments  
Electrical stimulations were delivered with an electrical stimulator (Grass S88, USA) that 
was connected to an isolation unit (Grass SIU5, USA) and a constant current unit (Grass 
CCU1, USA). The isolation unit was connected between the stimulator and the constant 
current unit to avoid electricity surge. The constant current unit controlled the magnitude 
of the electrical current and was connected to the assessment sites via electrodes. 
Constant current pulses were delivered to the proposed skin surface via two adhesive 
ECG electrodes (1x1 cm diameter, Dantec Medical, USA), which were filled with 
electrode gel. A standard pulse train, consisting of five individual 1-ms pulses delivered 
at 200-Hz was used as a single stimulus throughout the experiment. This single stimulus 
was repeated five times at 2-hertz to form a train of stimuli, and these repeated stimuli 
were used for TST tests. The frequency of the electrical impulses was calibrated with an 
oscilloscope (HM1007, HAMEG, Germany) before the start of the pain assessments. The 
instruments and their connections are displayed in Figure 5.5 as follows.   
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Figure 5.5 The instruments used to produce electrical stimulations 
Grass CCU1 is the model of the constant current unit. Grass SIU5 is the model of the isolation 
unit. 
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5.4.3 Procedures of pain assessment  
Three steps were involved in assessing the intensities of electrical current induced SPT and 
TST and the pain response ratings to ST levels of TS stimuli (at 1.2 x TST and 1.4 x TST 
intensities). They were performed at each assessed site before (baseline), immediately 
after and 24-hours after the intervention session. Each step is explained as follows. 
 
Step 1:  Testing SPT. The intensity of the current was increased from zero milliampere 
(mA) in steps of 2 mA. If no pain was recorded at 20 mA, the current intensity was 
increased in steps of 5 mA until a pain threshold could be recorded, or a maximum 50 mA 
was reached, whichever was reached first. The lowest current value of a single stimulus to 
elicit a sensation of pain (via verbal report) was recorded. Pain was defined as a definite 
sharp or pin prick sensation, like an injection. Inter-stimulus interval was 30 seconds. The 
SPT test was measured twice. The mean value was accepted for data analysis. 
 
Step 2: Testing TST. TST was tested after SPT. The intensity of the current was increased 
from zero mA in steps of 2 mA, if no TST could  recorded at 20 mA, the current intensity 
was increased in steps of 5 mA until a TST could be recorded, or a maximum 50 mA was 
reached. The lowest current value to elicit a painful sensation in response to the 4th or 5th 
stimulus of a train of five stimuli (via verbal report) was recorded. Inter-stimulus interval 
was 30 seconds. TST was tested twice, and the mean value was accepted for data analysis.  
 
 
 - 105 - 
Step 3: Pain ratings in response to supra-threshold stimulation. According to the protocol, 
after TST was obtained, Investigator A delivered ST stimulation at 1.2 and 1.4 times the 
baseline TST. After each train of stimuli, the volunteers were asked to rate the intensity of 
their responses to the first and the fifth stimulus within a train of five stimuli on a Visual 
Analogue Scale (VAS). Stimulation at each intensity (1.2 x TST, 1.4 x TST) was measured 
twice. The mean values of pain ratings to the fifth stimulus (highest intensity perceived) 
were used for data analysis. The VAS is a standard instrument for measuring the intensity 
of pain. One end of the scale is ‘0’, indicating ‘no pain’ at all; while ‘100’ is at the other 
end of the scale, indicating “worst pain imaginable” (Appendix 09). 
 
 
 
 - 106 - 
5.5 Secondary outcome measures 
The secondary outcome measures include:   
1) Spielberg State and Anxiety Inventory (SSAI), administered before and after the 
intervention by Investigator A (the evaluator); and   
2) a post-treatment questionnaire, administered once after the intervention by 
Investigator A. 
 
The SSAI was used to measure volunteers’ level of anxiety before and after the 
intervention (135). A total of 20 questions with 10 negative and 10 positive questions 
listed in random order were answered by each volunteer. Each question had four possible 
answers: 1. not at all; 2. some what; 3. moderately so; 4. very much so. An answer key 
form provided the true score to each answer of each question and this answer key was kept 
away from the volunteers. The total score was calculated by adding up the true scores. Due 
to copyright reason, a copy of this questionnaire and the answer key form are not 
presented in this thesis. 
 
Immediately after the intervention session, Investigator A asked the volunteer to complete 
the post-treatment questionnaire. This questionnaire had three questions. In the first 
question, the volunteer was asked to describe the sensation he / she perceived during the 
intervention using a standardised verbal pain categorical scale: (1) no pain at all; (2) mild 
pain; (3) moderate pain; (4) severe pain. The other two questions were developed by Lao 
and colleagues in 1999 (80), to evaluate whether the volunteers were blinded successfully 
(Appendix 10).  
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5.6 Description of experimental procedures  
One day prior to the experiment, the volunteer was asked not to miss breakfast or lunch 
and not to drink coffee or take any stimulants on the day of the experiment. On the 
experiment day, after arrival and after obtaining the written consent form, Investigator A 
prepared the skin area for testing and conducted the training session. Investigator A 
gently shaved the body hair at the proposed stimulation sites if necessary, cleaned the 
skin with a moisturised tissue and alcohol swab (Briemar, Australia) to remove any oil on 
the skin and enhance electrical conduction. 
 
The procedure of the experiment is illustrated in Table 5.4. During the 30 minutes training 
session, the volunteer was asked to feel and be familiarised with the sensation and mild 
pain induced by electrical stimulation of various intensities. The volunteer was also trained 
to use VAS.  
 
The volunteer then had a five-minute rest. In the following 45 minutes, the baseline pain 
assessments were conducted, this was followed by the completion of the baseline SSAI 
by the volunteer. Investigator A then left the room and Investigator B entered the room. 
The volunteer was asked to pick one of the sealed envelops which contained a random 
number. Investigator B then conducted the allocated intervention in the following 25 
minutes with the volunteer in a supine position. The volunteer and Investigator B were 
free to communicate as if in a clinical situation. Once Investigator B had finished the 
intervention and left the room, Investigator A came back. Immediately after the 
intervention, Investigator A asked the volunteer to complete the SSAI questionnaire once 
again, followed by the post-treatment questionnaire. These procedures were finished 
within 10 minutes followed by a 20-minute rest in the chair. At 30 minutes after the 
intervention, pain assessments were conducted within 45 minutes using the same 
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methods.  The next day, at 24 hours after the intervention, the volunteer came back to the 
clinical trial room. Investigator A prepared the skin area once again and conducted 
another 45 minutes of pain assessments using the same methods. 
Table 5.2 Experimental procedures 
Step 
No. 
 
Timeline 
(minutes) 
Title of Activity Activity description 
 1. Prior to test   Preparation  Obtain written consent. 
Skin preparation. 
2. 
 
0 - 30 
 
Training session  
 
The volunteer was trained to familiarise 
themselves with the sensation induced by 
electrical stimulation and learn how to use 
VAS.   
3. 30 - 35  A rest period The volunteer was seated and rested for 5 
minutes. 
4. 
 
35 - 80 
 
The baseline pain 
assessments  
 
Firstly, the pain threshold to a single 
electrical stimulus (SPT) was tested, and 
then the pain threshold to repetitive stimuli 
(TST) was tested at each of the three 
assessed sites in a sitting position.  
5. 
 
80 - 90 
 
Baseline SSAI 
questionnaire 
Spielberg state anxiety inventory (SSAI) 
was completed by the volunteer. 
6. 
 
90 - 120 
 
Intervention 
procedures 
 
Volunteer was randomly allocated to one of 
the three groups, and then one of the 
interventions (MA, EA and SA) was 
delivered to the volunteers in a supine 
position. 
7. 
 
120 - 130 
Post-treatment SSAI 
and the post-treatment 
questionnaires 
 
SSAI was completed by the volunteer once 
again. Then they completed the 
post-treatment questionnaires. 
8. 130 - 150 A rest period The volunteer was seated and had a rest for 
20 minutes. 
9. 
 
150 - 195 
Pain assessments 30 
minutes after 
intervention 
 
Pain assessments were conducted 30 
minutes after the end of the intervention 
using the same methods and schedules as the 
baseline measurement. 
10. 24 hours after 
the end of 
intervention 
Pain assessments 
24-hours after 
intervention 
Pain assessments were repeated 24 hours 
after the end of the intervention using the 
same methods and schedules as the baseline 
measurement. 
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5.7 Statistical analysis 
The data of SPT, TST and anxiety assessment (SSAI) were analysed by analysis of 
variance (ANOVA) using the Statistical Package for the Social Sciences (SPSS, 
Windows Version 13.0) to detect between treatment group differences. Significance for 
each of the ANOVA’s was assessed at α = 0.05 / 3 = 0.0167 (Bonferroni Correction). 
Post-hoc tests via multiple-comparisons using a Bonferroni correction were used to detect 
significant differences among the three interventions when a significant ANOVA was 
obtained. Equivalence of the groups on demographic variables, i.e. age, gender, dominant 
hand; and on the answers provided in the post-treatment questionnaires were assessed by 
ANOVA and chi-square tests. Statistical power analysis and sample size calculations 
were done via the MINITAB statistical package (MINITAB, Windows Version 15.0). 
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Chapter 6: Results 
6.1 General information about the volunteers 
The experiment was conducted from May to September in 2006. A total of 27 volunteers 
were recruited according to the inclusion/exclusion criteria. All volunteers signed the 
written consent forms and completed all experimental procedures. No one withdrew from 
the study, and no side effects were reported. The demographic data about the volunteers 
are provided in Table 6.1. All volunteers were University students, including 15 males 
and 12 females. The average age was 24.81 years (SD 5.4), with a range from 18 to 41 
years. Three volunteers had a left-dominant side and 24 volunteers had a right-dominant 
side; the dominant side of leg and forearm were consistent in every person. The three 
groups were comparable for demographic characteristics.  
 
Every step of the experiment was conducted according to the trial protocol except for the 
rating to supra-threshold stimulation. An error was made when conducting this step of the 
experiment and this is described in the Methods. This error did not affect other steps of 
the study. There was no missing data. 
 
In this thesis, the terms “treatment leg”, “non-treatment leg” and “forearm” represent the 
dominant-leg, non-dominant leg and the non-dominant forearm respectively. In addition, 
the term single pain threshold (SPT) represents the pain threshold to single electrical 
stimulus, and the term temporal summation threshold (TST) represents the pain threshold 
to a train of five repeated stimuli delivered at 2-hertz. 
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Table 6.1 Demographic variables at baseline in each group 
 
 SA 
(n = 9) 
MA 
(n = 9) 
EA 
(n = 9) Statistical tests p 
Total 
(n=27) 
Age (years) 
(Mean ± SD) 
24.67 
±5.03 
25.22 
±4.32 
24.56 
±7.11 
F value (2, 24) = 0.036 0.964 * 
24.81 
± 5.4 
Gender  
(Male : Female) 
3 : 6 5 : 4 7 : 2 
χ
2
 (df=2) = 3.6 a 0.165 ▲ 15:12 
Dominant hand 
(Right : Left)       
8 : 1 9 : 0 7 : 2  
χ
2
 (df=2) = 2.25 b 0.325 ▲ 24:3 
 
* The significance level for the ANOVA was set at α = 0.05/3 = 0.0167 (Bonferroni Correction). 
df: degrees of freedom. 
χ
2: chi-square value. 
a
 3 cells (50.0%) have expected count less than 5. The minimum expected count is 4.00. 
b
 3 cells (50.0%) have expected count less than 5. The minimum expected count is 1.00. 
▲ The significance level for the above chi-square calculations was at p < 0.05.  
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6.2 A comparison of the baseline variables among the 
three groups 
There was no statistically significant difference among the three groups in any of the 
baseline pain tests or the anxiety test (Table 6.2). The baseline mean values of TST were 
always lower than those of SPT assessed at each site (Figure 6.1). 
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Table 6.2 A comparison of the baseline values of all pain assessments among the 
three intervention groups – One-way ANOVA 
  Mean ±  SD n df F p* 
SA: 1.98 ± 0.71 9 
MA: 1.78 ± 1.05 9 
SPT baseline - 
Treatment leg  
Between 
Groups 
EA: 2.19 ± 0.88 9 
2, 26 
  
0.475 
  
0.627 
SA: 1.16 ± 0.35 9 
MA: 0.92 ± 0.75 9 
TST baseline - 
Treatment leg  
Between 
Groups 
EA: 1.26 ± 0.55 9 
2, 26  0.796 0.463 
SA: 1.97 ± 0.59 9 
MA: 1.96 ± 0.91 9 
SPT baseline - 
Non-treatment leg  
Between 
Groups 
EA: 1.98 ± 0.83 9 
2, 26 
 
 
0.002 
  
  
0.998 
SA: 1.18 ± 0.32 9 
MA: 1.10 ± 0.66 9 
TST baseline - 
Non-treatment leg 
Between 
Groups 
EA: 1.04 ± 0.50 9 
2, 26 
 
 
0.153 
  
  
0.859 
SA: 2.31 ± 0.80 9 
MA: 1.81 ± 0.96 9 
SPT baseline - 
Forearm 
Between 
Groups 
EA: 2.21 ± 0.82 9 
2, 26 
 
 
0.842 
  
  
0.443 
SA: 1.41 ± 0.62 9 
MA: 0.98 ± 0.66 9 
TST baseline - 
Forearm 
Between 
Groups 
EA: 1.13 ± 0.55 9 
2, 26 
 
 
1.151 
  
  
   
0.333 
SA: 33.33 ± 9.50 9 
  MA: 32.22 ± 11.10 9 SSAI Baseline 
Between 
Groups 
EA: 29.00 ± 5.50 9 
2, 26 0.561 0.578 
 
* The significance level for each of the ANOVAs was set at α = 0.05/3 = 0.0167 (Bonferroni 
Correction). 
SPT – single pain threshold  
TST - temporal summation threshold  
SSAI - Spielberg state anxiety inventory 
df: degrees of freedom  
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Figure 6.1 SPT and TST assessed at each site during the baseline  
Figure 6.1 shows the single pain threshold and temporal summation threshold assessed at 
three sites during the baseline (n = 27).  
SPT – single pain threshold  
TST - temporal summation threshold 
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6.3 Single pain thresholds 
6.3.1 The effect of acupuncture on single pain thresholds tested 
immediately after the interventions 
 
Table 6.3 shows the one-way ANOVA results of the effect immediately after intervention 
on SPT among the three intervention groups. Although SPT in the MA and EA groups 
were higher than those in the SA group at the treatment leg, no statistically significant 
differences were detected.  
 
Table 6.3 A comparison of single pain thresholds assessed immediately after 
interventions among the three groups – One-way ANOVA. 
 Mean ±  SD n df F p* 
SA: 1.92 ± 0.81 9 
MA: 2.41 ± 1.55 9 
SPT immediately after 
the interventions - 
Treatment leg 
Between 
Groups 
EA: 4.27 ± 2.44 9 
2, 26 4.585  0.021  
SA: 1.83 ± 0.64 9 
MA: 2.27 ± 0.87 9 
SPT immediately after 
the interventions - 
Non-treatment leg 
Between 
Groups 
EA: 2.98 ± 1.44 9 
2, 26 2.791 0.081  
SA: 1.99 ± 0.67 9 
MA: 2.08 ± 1.11 9 
SPT immediately after 
the interventions - 
Forearm 
Between 
Groups 
EA: 3.22 ± 1.71 9 
2, 26 2.777 0.082 
 
* The significance level for each of the ANOVAs was set at α = 0.05/3 = 0.0167 (Bonferroni 
Correction). 
SPT – single pain threshold  
TST - temporal summation threshold 
df: degrees of freedom  
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6.3.2 The effect of acupuncture on single pain thresholds tested 
24-hours after the interventions 
 
Table 6.4 shows the one-way ANOVA results of SPT assessed 24-hours after the 
interventions. There was statistically significant group difference in SPT, assessed on the 
treatment leg (p = 0.01). Bonferroni corrected post-hoc comparisons indicated that EA 
increased the SPT significantly greater than SA on the treatment leg 24-hours after 
intervention (Table 6.5) (EA versus SA, p = 0.012), and there was no statistically 
significant difference between MA and SA or EA and MA. Although EA also increased 
the SPT on the non-treatment leg and forearm, they failed to reach a statistical 
significance level. 
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Table 6.4 A comparison of single pain threshold assessed 24-hours after the 
interventions among the three groups – One-way ANOVA 
  Mean ±  SD n df F p* 
SA: 1.98 ± 0.76 9 
MA: 2.82 ± 1.70 9 
SPT 24-hours after 
the interventions - 
Treatment leg 
Between 
Groups 
EA: 5.82 ± 4.03 9 
2, 26 
 
 
5.601 
 
 
0.010 # 
SA: 1.88 ± 0.61 9 
MA: 2.37 ± 1.08 9 
SPT 24-hours after 
the interventions - 
Non-treatment leg 
Between 
Groups 
EA: 3.42 ± 1.45 9 
2, 26 4.623 0.020 
SA: 2.01 ± 0.68 9 
MA: 2.29 ± 1.13 9 
SPT 24-hours after 
the interventions - 
Forearm 
Between 
Groups 
EA: 3.26 ± 1.62 9 
2, 26 2.644 0.092 
 
* The significance level for each of the ANOVAs was set at α = 0.05/3 = 0.0167 
(Bonferroni Correction). 
#
 indicates statistically significant.   
SPT - single pain threshold  
TST - temporal summation threshold 
df: degrees of freedom  
 
Table 6.5 Between-group comparisons of single pain threshold assessed on the 
treatment leg 24-hours after the interventions between groups - Bonferroni 
corrected post-hoc tests 
Bonferroni corrected post-hoc tests (n = 9 in each group) 
95% Confidence 
Interval Dependent 
Variable Comparison 
Mean 
Difference Std. Error p* Lower 
Bound 
Upper 
Bound 
SA vs. MA -0.84 1.21 1.000 -3.95 2.26 
MA vs. EA -3.00 1.21 0.061 -6.11 0.11 
SPT 24-hours 
after the 
interventions - 
Treatment leg SA vs. EA -3.84 1.21 0.012 # -0.74 -6.95 
 
* The significance level for each of the ANOVAs was set at α = 0.05/3 = 0.0167 
(Bonferroni Correction). 
#
 indicates statistically significant.   
 - 118 - 
6.3.3 The time effect of acupuncture on the single pain 
thresholds within 24-hours  
Figure 6.2 shows the change of SPT values assessed at baseline, immediately after and 
24-hours after the interventions at the three sites, i.e. the treatment leg, the non-treatment 
leg and the forearm. 
 
On the treatment leg, the SPT in the SA group did not change over time, whereas those in 
the EA and MA groups increased, and the increase in the EA was much higher than that in 
MA. Only the result of EA versus SA at 24-hours after the interventions showed 
statistically significant differences (see sections 6.3.1 and 6.3.2). 
 
On the non-treatment leg, after the interventions, the SPT in the SA group did not change 
over time, whereas those in the EA and MA groups were increased. However, no 
statistical significance between the three groups in the SPT assessed on the non-treatment 
leg was detected (see sections 6.3.1 and 6.3.2). 
 
On the forearm, after the interventions, the SPT in SA and MA groups did not change 
much over time, when those in the EA group were increased immediately after the 
intervention and maintained that level at 24-hours after. No statistical significance 
between the three groups in the SPT assessed on the forearm was detected (see sections 
6.3.1 and 6.3.2). 
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Figure 6.2 Single pain thresholds of the three intervention groups tested at the three 
sites at baseline, immediately after the interventions and 24-hours after (n = 9 in 
each group) 
SA = sham-acupuncture, MA = manual acupuncture, EA = electro-acupuncture.  
Immediate effect = immediately after interventions; After 24hours = 24 hours after interventions. 
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6.4 Temporal summation pain threshold  
6.4.1 The effect of acupuncture on temporal summation 
thresholds tested immediately after the interventions 
Table 6.6 shows the one-way ANOVA results of the effect immediately after intervention 
on TST among the three intervention groups. Although TST in the MA and EA groups 
were much higher than those in the SA group at the treatment leg, no statistically 
significant difference was detected. 
 
Table 6.6 A comparison of temporal summation thresholds assessed immediately 
after interventions among the three groups – One-way ANOVA. 
  Mean ±  SD n df F p* 
SA: 1.03 ± 0.43 9 
MA: 1.28 ± 0.92 9 
TST immediately 
after the 
interventions - 
Treatment leg 
Between 
Groups 
EA: 2.32 ± 1.38 9 
2, 26 4.309 0.025 
SA: 1.07 ± 0.41 9 
MA: 1.37 ± 0.78 9 
TST immediately 
after the 
interventions - 
Non-treatment leg 
Between 
Groups 
EA: 1.43 ± 0.69 9 
2, 26 0.826 0.450 
SA: 1.27 ± 0.55 9 
MA: 1.31 ± 0.81 9 
TST immediately 
after the 
interventions - 
Forearm 
Between 
Groups 
EA: 1.57 ± 0.73 9 
2, 26 0.475 0.627 
 
* The significance level for each of the ANOVAs was set at α = 0.05/3 = 0.0167 (Bonferroni 
Correction). 
SPT - single pain threshold  
TST - temporal summation threshold 
df: degrees of freedom  
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6.4.2 The effect of acupuncture on temporal summation 
thresholds tested at 24-hours after the interventions 
Table 6.7 shows the one-way ANOVA results on TST assessed 24-hours after 
interventions. There was a statistically significant group difference in TST, assessed on 
the treatment leg (p = 0.013). Bonferroni corrected post-hoc comparisons indicated that 
EA increased the TST significantly greater than SA on the treatment leg 24-hours after 
interventions (Table 6.8) (EA versus SA, p = 0.011), and there was no statistically 
significant difference between MA and SA or EA and MA. Although EA also increased 
the TST on the non-treatment leg and forearm, they failed to reach a statistical 
significance level. 
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Table 6.7 A comparison of temporal summation threshold assessed 24-hours after 
the interventions among the three groups – One-way ANOVA 
  Mean ±  SD n df F p* 
SA: 1.06 ± 0.40 9 
MA: 1.66 ± 0.96 9 
TST 24-hours 
after the 
interventions - 
Treatment leg 
Between 
Groups 
EA: 2.4 ± 1.12 9 
2, 26 5.233 0.013 # 
SA: 1.07 ± 0.43 9 
MA: 1.40 ± 0.86 9 
TST 24-hours 
after the 
interventions - 
Non-treatment leg 
Between 
Groups 
EA: 2.01 ± 0.66 9 
2, 26 4.551 0.021 
SA: 1.24 ± 0.59 9 
MA: 1.32 ± 0.82 9 
TST 24-hours 
after the 
interventions - 
Forearm 
Between 
Groups 
EA: 1.91 ± 0.66 9 
2, 26 2.452 0.107 
 
* The significance level for each of the ANOVAs was set at α = 0.05/3 = 0.0167 
(Bonferroni Correction). 
# indicates statistically significant.   
SPT – single pain threshold  
TST - temporal summation threshold 
df: degrees of freedom.  
 
Table 6.8 Comparisons of temporal summation threshold assessed on the treatment 
leg 24-hours after interventions within groups - Bonferroni post hoc tests 
Bonferroni corrected post-hoc tests (n = 9 in each group) 
95% Confidence 
Interval Dependent 
Variable Comparisons 
Mean 
Difference Std. Error p* Lower 
Bound 
Upper 
Bound 
SA vs. MA -0.60 0.42 0.488 -1.67 0.47 
MA vs. EA -0.74 0.42 0.259 -1.82 0.33 
TST 24-hours 
after the 
interventions - 
Treatment leg EA vs. SA 1.34 0.42 0.011 # 0.27 2.42 
 
* The significance level for each of the ANOVAs was set at α = 0.05/3 = 0.0167 
(Bonferroni Correction). 
#
 indicates statistically significant. 
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6.4.3 The time effect of acupuncture on the temporal 
summation thresholds within 24-hours 
Figure 6.3 shows the change of TST values assessed at baseline, immediately after and 
24-hours after the interventions at the three sites, i.e., the treatment leg, the non-treatment 
leg and the forearm. 
 
On the treatment leg, the TST in the SA group did not change over time, whereas those in 
the EA and MA groups increased, and the increase in the EA was much higher than that in 
MA. Only the result of EA versus SA at 24-hours after the interventions showed 
statistically significant differences (see sections 6.4.1 and 6.4.2). 
 
On the non-treatment leg, after the interventions, the TST in the SA group did not change 
over time, whereas those in the EA and MA groups were increased. However, no 
statistical significance between the three groups in the TST assessed on the non-treatment 
leg was detected (see sections 6.4.1 and 6.4.2). 
 
On the forearm, after the interventions, the TST in the SA and MA groups did not change 
much over time, whereas those in the EA increased immediately after the intervention 
and maintained that level 24-hours after. No group differences in the TST assessed on the 
forearm were detected (see sections 6.4.1 and 6.4.2). 
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Figure 6.3 Temporal summation thresholds of the three intervention groups tested at the 
three sites at baseline, immediately after the interventions and 24-hours after (n = 9 in each 
group) 
SA = sham-acupuncture, MA = manual acupuncture, EA = electro-acupuncture.  
Immediate effect = immediately after interventions; After 24hours = 24 hours after interventions. 
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6.5 The number of responders in the three groups 
In a previous acupuncture study in healthy humans, the volunteers who had a greater than 
20% increase in pain thresholds from the baseline were classified as a responder (19). The 
same method was used in the current study, and the result is summarised in Table 6.9. No 
subject in the SA group was classified as responders. Overall, more subjects in the EA 
group than in the MA groups were responders.   
  
Table 6.9 The number of responders in each group  
 Numbers of responders in 
each intervention group 
 SA (n) MA (n) EA (n) 
Treatment Leg 0 6 7 
Forearm 0 2 3 
Immediately after 
interventions 
Non-treatment Leg 0 2 7 
Treatment Leg 0 8 9 
Forearm 0 5 4 
 
SPT 
24-hours after 
interventions 
Non-treatment Leg 0 5 7 
Treatment Leg 0 7 9 
Forearm 0 4 8 
Immediately after 
interventions 
Non-treatment Leg 0 4 6 
Treatment Leg 0 9 8 
Forearm 0 6 7 
 
TST 
24-hours after 
interventions 
Non-treatment Leg 0 5 8 
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6.6 Post-hoc power analyses and sample size 
calculations 
In Tables 6.10, 6.11 and 6.12, the effective power of the statistical tests with the existing 
sample size and the required number for 80% power for the comparisons of EA versus 
MA, EA versus SA and MA versus SA in SPT and TST tests are presented.  
 
6.6.1 EA versus MA 
For the comparison between EA and MA (Table 6.10), none of the statistical power 
values of the pain assessments was above 49%. The least number of subjects in both 
groups required to achieve an effective power of 80% would be: 21 subjects for SPT test 
immediately after interventions, 18 subjects for SPT test 24-hours after interventions, 21 
subjects for TST test immediately after interventions and 26 subjects for TST test 
24-hours after interventions.  
 
Table 6.10 Post-hoc power analyses and required sample sizes for EA versus MA 
comparisons 
EA versus MA 
  EA MA Effective 
power 
*n required for 80% 
power in each group 
  n n   
Treatment leg 9 9 44% 21 
Non-treatment leg 9 9 22% 45 
SPT 
immediately 
after  
 
Forearm 9 9 35% 26 
Treatment leg 9 9 49% 18 
Non-treatment leg 9 9 38% 25 
SPT 
24-hours 
after Forearm 9 9 28% 34 
Treatment leg 9 9 43% 21 
Non-treatment leg 9 9 5% 1943 
TST 
immediately 
after  Forearm 9 9 10% 144 
Treatment leg 9 9 30% 32 
Non-treatment leg 9 9 35% 26 
TST 
24-hours 
after Forearm 9 9 35% 27 
 
* The sample size that would be required in each group for 80% power. 
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6.6.2 EA versus SA 
For the comparison between EA and SA (Table 6.11), the effective statistical power of 
the pain assessments were from 15% to 92%. The TST pain assessments after 24-hours at 
the non-treatment leg and treatment leg had effective statistical powers above 80%; these 
were 92% and 89% respectively. The SPT pain assessment after 24-hours at the 
non-treatment leg had 79% effective power with the sample sizes used. The least number 
of subjects in both groups that could have achieved an effective power of 80% would be: 
11 subjects for immediate effect SPT test, 10 subjects for after 24-hours SPT test, 11 
subjects for immediate effect TST test and seven subjects for after 24-hours TST test.  
 
Table 6.11 Post-hoc power analyses and required sample sizes for EA versus SA 
comparisons 
EA versus SA 
  EA SA Effective 
power 
* n for 80% power 
required in each group 
  n n   
Treatment leg 9 9 73% 11 
Non-treatment leg 9 9 54% 16 
SPT 
immediately 
after  
 
Forearm 9 9 47% 19 
Treatment leg 9 9 75% 10 
Non-treatment leg 9 9 79% 10 
SPT 
24-hours 
after Forearm 9 9 52% 17 
Treatment leg 9 9 71% 11 
Non-treatment leg 9 9 25% 39 
TST 
immediately 
after  Forearm 9 9 15% 75 
Treatment leg 9 9 89% 8 
Non-treatment leg 9 9 92% 7 
TST 
24-hours 
after Forearm 9 9 58% 15 
 
* The sample size that would be required in each group for 80% power. 
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6.6.3 MA versus SA 
For the comparison between MA and SA (Table 6.12), none of the statistical power 
values of the pain assessment statistical tests was above 37%. The least number of 
subjects in both groups that could have achieved an effective power value of 80% would 
be: 50 subjects for immediate effect SPT test, 40 subjects for after 24-hours SPT test, 69 
subjects for immediate effect TST test and 25 subjects for after 24-hours TST test. 
 
Table 6.12 Post-hoc power analyses and required sample sizes for MA versus SA 
comparisons 
MA versus SA 
  MA SA Effective 
power 
* n for 80% power 
required in each group 
  n n   
Treatment leg 9 9 12% 101 
Non-treatment leg 9 9 20% 50 
SPT 
immediately 
after  
 Forearm 9 9 5% 1675 
Treatment leg 9 9 25% 40 
Non-treatment leg 9 9 20% 52 
SPT 
24-hours 
after Forearm 9 9 9% 178 
Treatment leg 9 9 10% 138 
Non-treatment leg 9 9 16% 69 
TST 
immediately 
after  Forearm 9 9 5% 3851 
Treatment leg 9 9 37% 25 
Non-treatment leg 9 9 11% 132 
TST 
24-hours 
after Forearm 9 9 6% 1328 
 
* The sample size that would be required in each group for 80% power. 
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6.7 Percentage change in pain threshold after the 
interventions 
6.7.1 Percentage change of single pain threshold 
Table 6.13 provides the percentage change of SPT after each intervention from the 
baseline value of each group. SA showed no effect on SPT, whereas the effects in EA and 
MA showed increases. EA had apparent higher percentage increases than MA on each 
site. The increase rates 24-hours after acupuncture were always higher than the increase 
rates immediately after acupuncture.  
 
 
Table 6.13 Percentage change of single pain threshold from baseline 
  Percentage change of SPT 
immediately after interventions 
(%) 
Percentage change of SPT 
24-hours after interventions 
(%) 
EA + 95.0% + 165.8% 
MA + 35.4% + 58.4% 
Treatment leg  
SA - 3.0% 0% 
EA + 50.5% + 72.7% 
MA + 15.8% + 20.9% 
Non-treatment 
leg 
SA - 7.1% - 4.6% 
EA + 45.7% + 47.5% 
MA + 14.9% + 26.5% 
Forearm 
SA - 13.9% - 13.0% 
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6.7.2 Percentage change of temporal summation threshold 
Table 6.14 provides the percentage change of TST after each intervention from the 
baseline value of each group. SA showed no effect on TST, whereas the effects of EA and 
MA showed increases. The percentage increases of TST were similar to the percentage 
increases of SPT. EA had higher percentage increases than MA on each site. The increase 
rates 24-hours after acupuncture were always higher than the increase rates immediately 
after acupuncture. 
 
Table 6.14 Percentage change of temporal summation threshold from baseline 
  Percentage change of TST 
immediately after interventions 
(%) 
Percentage change of TST 
24-hours after interventions 
(%) 
EA + 84.1% + 90.5% 
MA + 39.1% + 80.4% 
Treatment leg  
SA - 11.2% - 8.6% 
EA + 37.5% + 93.3% 
MA + 24.5% + 27.3% 
Non-treatment 
leg 
SA - 9.3% - 9.3% 
EA + 38.9% + 69.0% 
MA + 33.7% + 34.7% 
Forearm 
SA - 9.9% - 12.0% 
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6.8 Summary of pain assessments 
In comparison to SA, MA and EA consistently increased the SPT and TST within 
24-hours after the intervention. Only the difference between the EA group and the SA 
group was, however, statistically significant on the treatment leg at 24-hours after EA 
treatment. These results were validated by the fact that the power of the statistical tests 
reached values of 75% and 89% respectively for these comparisons (see sections 6.3.2, 
6.4.2 and Table 6.11). A small increase in the sample size would achieve 80% statistical 
power for the comparisons between EA versus SA on SPT and TST measured on the 
non-treatment leg and the forearm immediately after the treatment or 24-hours after (See 
Table 6.11). Comparisons of SPT and TST for the MA versus the SA, and the EA versus 
the MA showed no statistically significant differences at all of the three sites. 
 
In the post-intervention pain assessments, SA showed no effect on either SPT or TST. 
However, EA and MA increased both SPT and TST in each post-intervention pain 
assessement. The percentage increases of SPT and TST after EA were always higher than 
those increases after MA. The increase rates 24-hours after acupuncture were always 
higher than the increase rates immediately after acupuncture (See sections 6.7.1 and 
6.7.2). 
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6.9 Anxiety evaluation 
The baseline values of the Spielberg State Anxiety Inventory (SSAI) were comparable 
among the three groups (p = 0.578) (see Table 6.2 in section 6.2). After interventions, the 
one-way ANOVA comparison among the three groups showed no statistically significant 
difference (p = 0.493) (Table 6.15). 
 
Table 6.15 Post-intervention SSAI scores – One-way ANOVA  
ANOVA 
 
 Mean ± SD n df F p* 
SA: 31.67 ± 6.38 9 
MA: 36.33 ± 13.59 9 
Post-treatment 
Spielberg state anxiety 
inventory (SSAI) test 
Between 
Groups 
EA: 31.56 ± 7.06 9 
2 
0.729 
 
 
0.493 
 
 
 
* The significance level for the ANOVAs was set at α = 0.05/3 = 0.0167 (Bonferroni Correction). 
df: degrees of freedom.  
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6.10 Success of blinding 
Credibility of the blinding process was assessed with a post-treatment questionnaire. All 
27 volunteers completed this one-item questionnaire. No statistically significant 
difference was detected among the three groups. The results indicated that the blinding 
procedure was successful (Table 6.16).  
 
Table 6.16 Volunteers’ perception of treatment in each group 
The three choices 
for the answer 
Volunteers’ perception of treatment in 
each group (number) 
 
Statistical test 
 EA (n) MA (n) SA (n) χ2 (df) p value ▲ 
(1) Real 
Acupuncture 
5 5 6 
(2) Placebo/sham 
acupuncture 
0 0 0 
(3) Don’t know 4 4 3 
0.318* (2) 
 
0.853 
 
 
▲ Significance for the above chi-square calculation is at p < 0.05.  
*3 cells (100%) had an expected count less than 5. The minimum expected count was 3.33. 
df: degrees of freedom.  
χ
2: chi-square value. 
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6.11 Ratings of acupuncture needling and the side 
effects of acupuncture 
The answers in response to the intensity of acupuncture stimulation are provided in Table 
6.17. There were more subjects in the SA group (56%) reporting that acupuncture was not 
painful than those in the EA (22%) and in the MA (11%). 33% of subjects in each group 
reported mild pain in response to acupuncture. About 50% of subjects in the EA or MA 
group considered acupuncture stimulation to be of moderate pain in comparison to only 
one subject in the SA group. None of the subjects reported experiencing severe pain. 
There was no statistically significant difference in the ratings of acupuncture stimulation 
among the three groups.  
 
None of the volunteers reported side effects such as nausea or dizziness during or after the 
experimental period. 
 
Table 6.17 The intensity rating of response to acupuncture stimulation 
 
*The intensity of acupuncture stimulation  
 
No pain; 
n(%)  
Slight/mild 
pain; n(%)    
Moderate 
pain; 
n(%)    
Severe 
pain; 
n(%) 
χ
2
 (df) P ▲ 
EA (n=9, 100%) 2 (22%) 3 (33%) 4 (44%) 0 
MA (n=9, 100%) 1 (11%) 3 (33%) 5 (56%) 0 
SA (n=9, 100%) 5 (56%) 3 (33%) 1 (11%) 0 
5.85* (4) 0.211 
 
▲ Significance for the above chi-square calculation is at p < 0.05.  
* 9 cells (100%) had expected count less than 5. The minimum expected count was 2.67. 
df: degrees of freedom.  
χ
2: chi-square value. 
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6.12 Ratings of supra-threshold painful stimulation 
An error was made when delivering the supra-threshold painful stimulation. The original 
intention was to deliver 1.2x and 1.4x the baseline TST at three time points (baseline, 
immediate after the interventions and 24-hours after). During the tests, stimulation with 
the intensity of 1.2x and 1.4x the TST obtained at each time point was delivered.  
 
This mistake increased the level of stimulation significantly as shown by the two examples 
illustrated in Tables 6.18 and 6.19.  
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Table 6.18 An example using the correct method to assess pain ratings to 
supra-threshold levels of temporal summation stimulations  
 
Baseline pain 
assessments 
Immediately after 
acupuncture 
24hours after 
acupuncture 
If the TST values assessed 
in step 2 was: 
2 mA 4 mA 6 mA 
The intensity used for 1.2 
x TST supra-threshold 
pain test in step 3 should 
be: 
2 x 1.2 = 2.4 mA 2 x 1.2 = 2.4 mA 2 x 1.2 = 2.4 mA 
The intensity used for 1.4 
x TST supra-threshold 
pain test in step 3 should 
be: 
2 x 1.4 = 2.8 mA 2 x 1.4 = 2.8 mA 2 x 1.4 =2.8 mA 
 
Table 6.18 shows an example of the intensity would have been used for the pain ratings to ST 
levels of TST tests. The pain ratings in response to the consistent intensity can be calculated to 
assess whether the pain responses to the same intensity of painful stimuli are changed in response 
to the interventions. 
 
Table 6.19 An example using the incorrect method mistakenly employed in the 
present study to assess the pain response ratings to supra-threshold levels of 
temporal summation stimulations 
 Baseline pain 
assessments 
Immediately after 
acupuncture 
24hours after 
acupuncture 
If the TST values assessed 
in step 2 was: 
2 mA 4 mA 6 mA 
The intensity used for 1.2 
x TST supra-threshold 
pain test in step 3 was: 
2 x 1.2 = 2.4 mA 4 x 1.2 = 4.8 mA 6 x 1.2 = 7.2 mA 
The intensity used for 1.4 
x TST supra-threshold 
pain test in step 3 was: 
2 x 1.4 = 2.8 mA 4 x 1.4 = 5.6 mA 6 x 1.4 = 8.4 mA 
 
Table 6.19 shows an example of the intensity used in present study for the pain ratings to ST 
levels of TST tests. The pain ratings in response to the inconsistent intensities used for these pain 
assessments can not be calculated to detect the true effects of the intervention. 
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Due to this error, only descriptive data are presented in Table 6.20 and no inferential 
statistical analyses were conducted. In these supra-threshold pain tests, each of the 
baseline mean values of the pain ratings to 1.2x the TST level stimulations was lower than 
the corresponding mean value of the pain ratings to 1.4x the TST level stimulations. 
Hence, stimulation with higher intensity induced a stronger pain rating.   
 
At the baseline, the ratings were similar among the three groups. After the interventions, 
it was expected that the ratings to supra-threshold stimulation would reduce as the pain 
thresholds increased. Contradictory to the expectation, the ratings did not either increase 
or decrease greatly in the three groups. This was due to the mistake in the delivered 
intensity of stimulation. For instance, the subjects in the EA group assessed on the 
treatment leg, the mean values of TST assessed at baseline (Table 6.2 in section 6.2), 
immediately after interventions (Table 6.6 in section 6.4.1) and 24-hours after 
interventions (Table 6.7 in section 6.4.2) were 1.26 mA, 2.32 mA and 2.4 mA 
respectively; and the TST increased by 84% immediately after interventions and 90% 
24-hours after. As a result, the intensities of the stimulations of 1.2x the TST also 
increased by 84% and 90%. However, the subjects in the EA group reported ratings to the 
stimulations of 1.2x the TST delivered to the treatment leg and assessed at three time 
points of 2.92, 2.54 and 3.19; which indicated that their pain ratings decreased by 13% 
immediately after EA and increased by 9% 24-hours after EA. The mismatch in the 
percentage changes in ratings and pain thresholds suggests the analgesic effect induced 
by acupuncture.    
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Table 6.20 Descriptive data for supra-threshold pain rating tests 
 
  
(n = 9 in 
each of 
the three 
groups) 
Baseline 
(Mean ± SD) 
Immediately 
after 
interventions 
(Mean ± SD) 
24-hours after 
interventions 
(Mean ± SD) 
SA 2.65 ± 0.42 2.43 ± 0.94 2.8 ± 0.94 
MA 2.85 ± 1.39 2.24 ± 1.28 2.47 ± 1.07 
assessed on the 
treatment leg 
EA 2.92 ± 1.86 2.54 ± 1.61 3.19 ± 1.04 
SA 2.36 ± 0.74 2.60 ± 1.14 2.88 ± 0.89 
MA 3.03 ± 1.49 2.38 ± 1.01 2.6 ± 1.33 
assessed on the 
non-treatment 
leg 
EA 2.79 ± 1.11 2.37 ± 1.12 2.79 ± 1.53 
SA 2.35 ± 1.02 2.23 ± 0.97 2.60 ± 1.14 
MA 2.19 ± 1.17 2.01 ± 0.97 2.13 ± 1.08 
Pain rating 
to the 
stimulation 
of 1.2xTST 
intensity 
assessed on the 
forearm  
EA 2.66 ± 1.49 2.74 ± 1.32 3.07 ± 1.11 
SA 3.33 ±0.89 3.18 ± 1.12 3.23 ± 0.90 
MA 3.46 ± 1.75 2.72 ± 1.55 3.28 ± 1.49 
assessed on the 
treatment leg 
EA 3.55 ± 1.66 3.34 ± 1.60 3.68 ± 1.16 
SA 3.25 ± 1.11 3.18 ± 0.90  3.41 ± 0.99 
MA 4.09 ± 1.89 3.55 ± 1.59 3.48 ± 1.70 
assessed on the 
non-treatment 
leg 
EA 3.51 ± 0.96 3.11 ± 1.16 3.36 ± 1.60 
SA 2.91 ± 1.03 2.94 ± 0.89 3.38 ± 1.19 
MA 2.84 ± 1.26 2.73 ± 1.29 2.94 ± 1.42 
Pain rating 
to the 
stimulation 
of 1.4xTST 
intensity 
assessed on the 
forearm 
EA 3.31 ± 1.23 3.43 ± 1.21 3.87 ± 1.56 
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Chapter 7: Discussion and Conclusion 
 
7.1 A summary of the results 
In the study, the model of temporal summation of pain was successfully elicited. The 
statistical calculations showed that EA significantly increased SPT and TST 24-hours 
after the treatment on the treatment leg when compared with SA. There was a trend to 
show that EA also increased SPT and TST assessed on the treatment leg immediately 
after acupuncture, and on the non-treatment leg 24-hours after when compared with SA. 
There was no significant difference between EA versus MA or MA versus SA in pain 
thresholds measured at any body site. This may have been due to the small sample size.  
 
This is the first study that examines the effect of acupuncture on TS of pain. The results 
indicate that the EA (2/100 hertz) can induce a strong analgesic effect on the central 
nervous system. This effect is expressed ipsilaterally on the same spinal segment as the 
acupuncture sites. This effect grows stronger 24-hours after the intervention. 
 - 140 - 
7.2 Strengths 
The baseline TST was lower than SPT at each assessed site across the three groups, 
suggesting that the model of TS of pain was successfully induced. The acupuncture naïve 
subjects were properly blinded to the treatment allocation, so was the evaluator (the 
author). An acupuncturist who did not know the treatment allocation delivered the 
treatment. This dummy double-blinding design ensures that performance bias on the part 
of the subjects and the researchers was well-controlled.  
 
Other factors that might influence the results were also controlled. In a training session 
prior to the testing, the subjects were trained to be familiar with the electrical stimulation 
and the reporting of pain. The room temperature was controlled at 22 - 25 degrees Celsius 
as temperature can impact on human responses to pain stimulation (136). The 
non-invasive SA was particularly successful. The SA group showed contrary effects on 
SPT or TST to the acupuncture groups. None of the subjects in the SA group had 
increased pain thresholds. Moreover, subjects in the SA group were not aware they were 
experiencing a sham procedure. 
 
Acupuncture is an invasive procedure, and can produce anxiety and stress. Previous 
studies have indicated that anxiety or stress can increase or decrease pain threshold (137; 
138; 139). The level of anxiety in this study was measured with the well-accepted 
Spielberg state anxiety inventory (SSAI) (137; 140). There was no difference in the level 
of anxiety before and after acupuncture, indicating that the increased pain thresholds were 
not due to the stress associated with needling. This result is in accordance with those from 
other studies (1; 12; 16; 75; 79; 80; 83). The current experiment recruited young humans 
and hence no age group can be divided for analysis. 
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7.3 Limitations   
There are two major limitations of the study, the small sample size and the error in 
delivering the supra-threshold stimulations.  
 
As this is the first study evaluating the effect of acupuncture on the TS of pain, it was 
difficult to predict the proper sample sizes. Based on previous studies on SPT (the studies 
examined in Chapter 3), we proposed to recruit 45 subjects with 15 in each groups. We 
were only able to recruit 27 subjects with 9 subjects in each group by the end of 
experimental period. Various factors contributed to the difficulty in recruiting subjects. 
Firstly, the subjects were limited to being acupuncture naïve. Secondly, the subjects had 
to come twice within 24-hours. Thirdly, the experiment involves needle insertion, which 
would have excluded a group of people who are afraid of needles. 
 
The small sample size limited the power of the statistical test analyses. For instance, to 
detect a difference in TST with 80% power on the non-treatment leg and forearm 
24-hours after the treatment for the effect of EA versus SA, seven to fifteen subjects in 
each group would be needed. The interpretation of the results will take into account this 
limitation.  
 
Pain ratings to supra-threshold stimulation at 1.2x and 1.4x the baseline TST were 
included in the design. Due to the error in the delivery of supra-threshold stimulations, the 
intensity of stimulation delivered immediately after the interventions and 24-hours after 
was much higher (over 80% higher) than planned. Consequently, pain ratings to 
supra-threshold stimulations remained the same or slightly increased instead of reduced 
as expected. The resultant data could not be statistically analysed to detect group 
differences. As explained in the ‘Results’ chapter (section 6.12), the increase of the TST 
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and the intensity of stimulation was over 80%, whereas the increase of the pain ratings 
was less than 10%. The results indicate that a strong analgesia was induced not only at the 
pain threshold level but also at the supra-pain threshold level.   
 
This error does not, however affect the value of the pain thresholds and therefore does not 
limit the interpretation of the findings from TST and SPT tests.  
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7.4 Interpretation of the findings 
7.4.1 The effects of acupuncture on SPT and TST 
The EA and MA evaluated in present study increased both TST and SPT. Therefore, the 
acupuncture analgesic effect is unlike that of an NMDA antagonist, such as ketamine, 
imipramine or venlafaxine, which enhance TST but have little effect on SPT (36; 38; 39). 
This finding is in line with two recent animal studies which provide evidence that 
acupuncture analgesia does not inhibit NMDA receptors directly. One study reported 
ketamine (0.5 mg/kg), an NMDA receptor antagonist medication, was not antagonised by 
the analgesia effect of 100-hertz EA, but on the contrary it enhanced the rats’ pain 
tolerance threshold (141). Another study reported that the effects of 3-hertz EA on ST36 
of rats was not affected by the administration of ketamine or nitrous oxide, both of which 
are NMDA receptor antagonist medications (142). These animal studies showed 
acupuncture and NMDA antagonist medications (i.e. ketamine and nitrous oxide) had no 
competitive relationship to agonise NMDA receptors. So far, no study provides evidence 
that acupuncture specifically antagonises NMDA receptors immediately after a 
treatment. 
 
In addition, the acupuncture analgesic effect is unlike the effects of levetiracetam and 
tramadol, which increase the SPT significantly but have no effect on the TST (73; 74). On 
the contrary, the 2/100 hertz EA effects on SPT and TST 24-hours after treatment are 
similar to the effects of codeine, which is significantly more effective than placebo on 
both SPT and TST (39). Codeine exerts its analgesic effect via an endo-morphine 
mechanism (39); thus this suggests the acupuncture analgesic effect involves an 
endo-morphine mechanism as well. This finding confirms the observation of a previous 
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animal study that 2/100 hertz EA enhances the release of endogenous opioid peptides 
(93).  
 
In a previous section (section 2.4.2), the evidence for some medications showing 
dosage-dependent analgesic effects on SPT and TST was discussed. For example, the 
suppression of TST requires a high dose of isoflurane than for SPT (37). This seems also 
to be the case in the present study. At 24-hours after, EA increased SPT by 165.8% and 
TST by 90.5% on the treatment leg. However, this dose-dependent response was not the 
aim of the present study and was not examined. Future studies should investigate the 
effect of acupuncture on TST with various strengths of stimulation. 
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7.4.2 The spatial characteristics of acupuncture analgesia   
The statistical calculations showed that EA significantly increased SPT and TST on the 
treatment leg 24-hours after the treatment when compared with SA, and this EA effect 
was not found on the non-treatment leg or the forearm. The sites of the pain assessments 
were in the same dermatome as the treatment site; thus, the present finding favours the 
Segmental Inhibition Theory. The current result is different from that of a study by 
Zaslawski and his colleagues, who assessed the analgesic effect of MA on right LI4 by 
testing the pressure pain thresholds on 10 sites within the treatment side or on the central 
line of the body. The study showed the analgesic effect of MA was significantly higher 
than non-invasive SA at all 10 sites, and the result does not support either traditional 
Meridian Theory or the Segmental Inhibitory Theory (17). However, another pain 
perception study reported a different observation. A RCT with 10 subjects in each group 
tested the effect of continuous mode EA (information of EA frequency was absent), 
which involved needling four acupoints on the right forearm. Immediately after the 
treatment, EA significantly reduced the pain ratings to pain induced by zero degree 
Celsius ice-water assessed on the treatment side of forearm but had no effect on the other 
side of forearm indicating a segmental effect of EA (18). It is important to note that the 
two studies and the current one employed different pain models and used different modes 
of acupuncture stimulation.  
 
Electrical pain model was used in the current study. Previous studies showed that the 
effect immediately after MA did not increase electrical pain threshold on the skin (125); 
although it increased electrically induced dental pain (19). In the current study, MA 
increased SPT by 58.4% and TST by 80.4% at 24-hours after acupuncture on the 
treatment leg. However, the comparisons of MA versus SA on SPT or TST were not 
statistically significant. It is likely that the small sample size of the current study 
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compromises the potential MA-induced analgesia in the whole body. According to the 
power analysis, in order to demonstrate the effect of MA on SPT in the treatment leg, 
non-treatment leg and forearm, 101, 50 and 1675 subjects are required for the effect 
immediately after MA in each group, when 40, 52 and 178 subjects are required for the 
effect 24-hours after MA in each group. MA perhaps does not have a strong analgesic 
effect on electrically induced cutaneous pain. 
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7.4.3 The temporal characteristics of acupuncture analgesia  
All the acupuncture studies in healthy humans tested its immediate effect. The 
non-significant results found for the immediate effect comparison in this study were, 
however, not able to be interpreted because the inadequate sample sizes limited the power 
of the statistical tests. To demonstrate the analgesic effect immediately after EA, 11 
subjects for each group will be needed.  
 
In the current study, the effects of EA and MA on TST grew stronger with time and their 
effects at 24 hours after the intervention were better than immediately after the 
intervention. Since no previous human RCT addressing the temporal effect of 
acupuncture could be found, it is not possible to place these results within the context of 
previous studies. Nevertheless, it seems that the enhanced central inhibitory effect of the 
EA and MA at 24-hours after may be due to a neurohumoral effect (i.e. activation of 
endogenous opioid peptides and opioid receptors) rather than a purely neural effect as the 
former acts slowly in hours whereas the latter acts within seconds and minutes of 
stimulation (57). 
 
It has been hypothesed that the analgesic effect of a single acupuncture treatment might 
be more beneficial overnight (26). The significant EA effect after 24 hours found in the 
current study provides supporting evidence for the hypothesis. So far, this hypothesis has 
not been tested in a human study previously. In an animal study, preproenkephalin 
mRNA gene transcription in the brain was observed for 72 hours after a single session of 
EA; the preproenkephalin mRNA gradually increased in the brain with the peak 
occurring at 48 hours, and then a 50% decline after 72 hours (25). Such an effect has yet 
to be examined in humans.   
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7.5 Conclusion and implications for future studies     
The D-D mode 2/100 hertz EA has strong inhibitory effects on both SPT and TST at 24 
hours after a single session of treatment, and the effects are likely to be mediated via the 
central nervous system with peripheral contributions, and are more pronounced within 
same dermatome segment of the needling sites. 
 
The mechanism of acupuncture actions need to be examined by using various 
medications, such as NMDA antagonists and opioid receptor antagonists. Future human 
studies should also assess the analgesia of single acupuncture session after 48 hours to 
understand the temporal characteristics of acupuncture.  
 
On the basis of our study results, we calculated the sample size for the comparison 
between EA and MA to achieve 80% power in statistical tests (section 6.6.1). In future 
human studies, in order to compare the effects of EA and MA assessing with the electrical 
pain thresholds, at least 21 subjects and 18 subjects in each group would be required for 
the effects immediately after acupuncture and 24-hours after acupuncture, respectively. 
The result of this study is to be compared with future studies employing thermal and 
mechanical TS pain models. Future studies using this paradigm to test acupuncture 
analgesia in clinical pain patients are essential. 
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Appendix 02 Advertisment for pariticipant recruitment  
 
Division of Chinese Medicine Research Group 
School of Health Science                                            
Does Acupuncture Reduce Pain?                
Do You Want To Contribute to an Acupuncture Study? 
Welcome, Volunteers! 
RMIT Chinese Medicine Research Group is conducting an acupuncture study at the 
RMIT Bundoora West Campus. We urgently need 60 healthy volunteers to 
participate in this study. 
 
Aims of this study 
 
The aims of the study are to investigate whether acupuncture reduces 
experiment-induced pain in health humans, how long the acupuncture analgesic effect 
lasts and how widely this effect is distributed in your body. 
 
Criteria of participants 
 
 Any healthy human aged between 18-40 years old. 
 Never experienced acupuncture. 
 
What will you be asked to do to help us?  
 
We will test your rating to a few sets of painful and non-painful electrical stimuli 
delivered to your skin before and after acupuncture treatment. You will be asked to 
report the level of pain and strength of sensation. The stimulation will range from 
below your pain level to slightly above your pain level. 
 
How long does the study take? 
 
The study consists of a 3-hour test including 30 minutes acupuncture treatment on the 
first day and a 30-minute test on the next day. 
 
Your participation in this study is voluntary. You are free to withdraw from the study 
at any stage of the study. If you are happy to take part in the study please contact: 
 
Sam Feng 
BH: 9925 7176; AH: 0432 214 011 (mobile)   
Email: s3069785@student.rmit.edu.au 
 
This project has been reviewed and approved by the Human Research Ethics 
Committee of RMIT University. 
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Appendix 03 Participants’ self-reporting form 
 
Participant Record 
Project Title: The effect of acupuncture on experimental pain (temporal summation of pain): a randomised, 
double-blind, controlled-study 
Date of Participation: 
Name:                                          Age:                 ethnicity: 
Gender:                                        Occupation: 
Telephone: 
Mobile: 
Email: 
Address: 
 
Medical history: 
 
 
 
 
Are you currently taking any medication?                           Yes       No 
If yes, please specify: 
 
Have you had any acupuncture treatment before this experiment?    Yes       No 
 
Are you pregnancy or malignancy?                                 Yes       No         
 
Do you have any followed conditions? Mark a tick if yes. 
 
• Severe heart disease or wear a pacemaker  
• Brain tumour or epilepsy 
• Tendency to bleed 
• Drug addiction 
• Had any analgesics in the previous weeks 
• Suffer from chronic pain or recurrent pain 
• Skin problems at the proposed acupuncture sites 
 
Note: 
Your personal information and relevant data will be stored in password protected computer. All other 
documents and records will be stored in the cabinet protected by key-lock. Only the investigators can 
access the information. No name will be referred to any reports or publications or discussions. Only 
group data will be reported. The information will be retained as required by RMIT for 15 years. At the 
end of the period, the documents will be destroyed according to the University document disposal 
procedure. 
 
Signature of participant:                                Date: 
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Appendix 04 Cardiovascular Risk Questionnaire 
 
 CARDIOVASCULAR RISK FACTOR QUESTIONNAIRE 
 
In order to be eligible to participate in the experiment you are required to 
complete the following questionnaire, designed to assess the risk of you 
having a cardiovascular event during the course of the trial. 
 
ID:                                                                 
            
Circle the most appropriate responses for the following questions: 
1. Are you overweight?     Yes No Don’t Know 
2. Do you smoke?                                  Yes  No Don’t Know 
3. Do you or your family have a history of premature cardiovascular 
    problems (e.g. heart attack, stroke)?                     Yes No Don’t Know 
4. Do you have high blood cholesterol levels? Yes No  Don’t Know 
5. Do you have high blood pressure?   Yes No  Don’t 
Know 
6. Do you have an arrhythmia?                      Yes No  Don’t Know 
7. Do you have a heart murmur?   Yes  No  Don’t Know 
8. Do you have impaired circulation in the hands or feet when cold?  
                                                                                 
                                                                                  Yes  No  Don’t Know 
9. Are you on any medication    Yes  No 
If so, what is the medication?         
10. Do you think you have any medical complaint or any other reason which 
you know of which you think may prevent you from participating in this 
trial?         Yes    No 
If yes, please elaborate.           
   
I,                                                                       , believe that the answers to these 
questions are true and correct. 
 
Signed:                                                              Date: _________________ 
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Appendix 05 Plain Language Statement  
 
Information about acupuncture and pain study 
 
PROJECT TITLE: The effect of acupuncture on experimental pain (temporal 
summation of pain): a randomised, single-blind, controlled study in humans  
 
 
INVESTIGATOR: Jian Qiang (Sam) Feng, Registered Acupuncturist, Masters Candidate 
 
Dear Volunteer, 
 
My name is Jian Qiang (Sam) Feng, a Masters student at the division of Chinese 
Medicine Research Group, RMIT University. My study is under the supervision of Dr. 
Zhen Zheng, Prof. Charlie Xue and A/Prof Chun Guang Li (RMIT, Chinese Medicine 
Research Group). In this study, I will use electrical stimulation as a means to assess the 
neural mechanism of acupuncture analgesic effect in healthy humans. This is to provide 
you with relevant information about my study. 
 
1. Purpose of the study 
 
The aims of the study are to evaluate whether manual or electro-acupuncture modifies 
your level of pain sensitivity, how long the acupuncture analgesic effect lasts and how 
widely this analgesic effect distributes in your body. 
 
2. What will you be asked to do during the study? 
 
The study includes a 3-hour session on the first day and a 30-minute session on the next day. 
During the first session, you will be asked to report your sensation to a few sets of painful and 
no-painful single or repeated electrical stimulation. You will then receive manual, electrical 
or sham acupuncture for 30 minutes. Finally the electrical stimulation tests will be repeated, 
and you will ask to report your sensation to those stimuli again. On the following day, the 
electrical stimulation tests will be repeated. 
 
On the first day, you will also be asked to complete two questionnaires.  
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3. What kind of pain will you experience?  
 
Electrical stimuli will be delivered to the skin of one of your forearms and both legs via 
surface electrodes (each is 0.5cm in diameter) with a standard electrical stimulator. When 
a single electrical stimulus is delivered to your skin, you will feel different sensations as 
the intensity of the stimulus increases. At first you will feel buzzing, tingling, or vibrating 
sensation. Then you may feel prickling, stinging, sharp, slightly burning or slightly 
discomfort sensation, and you may consider this sensation painful.  
 
When five single non-painful electrical stimuli are delivered one after another within a 
short period of 2.5 seconds, your sensation to the stimulation may increase, and you may 
consider the sensation painful. It is this enhanced pain sensitivity that we are interested in, 
in this study. This enhanced pain sensitivity phenomenon plays an important role in our 
understanding of clinical pain.  
 
Please note, in this study, we only investigate your pain sensitivity and your ratings 
to some painful stimuli. We do not assess how much you can tolerate pain.    
 
4. Safety issues and potential discomfort of electrical pain tests 
 
The electrical stimulator used will be connected to an isolation unit and a constant current 
unit to ensure your safety. The magnitude of current will be monitored and adjusted 
within a safe range.  
 
A number of studies have used the current method with human participants in the last 
decade, and have proved this method to be safe and acceptable to humans.  
 
5. The Real or Placebo Treatment 
 
It is necessary to have an inactive treatment group who will undergo sham acupuncture 
treatment, so that the true effect of acupuncture can be demonstrated. Sham acupuncture 
is a form of placebo treatment with minimal effect on your body. It is used to show 
whether the real treatment has a true effect. Once you have met the inclusion and 
exclusion criteria, you will be allocated randomly into one of the three groups (two real 
acupuncture and one sham acupuncture groups). Please note that you will have a 1/3 
chance of being placed in an inactive treatment group. 
 
6. Safety issue and potential discomfort of acupuncture 
 
Acupuncture procedure is widely used in everyday practice with an excellent safety 
profile. Only disposable needles will be used and they are much thinner than needles used 
for injections. Acupuncture has been reported to be associated, in a very few cases, with 
minor risks, such as fainting, infection, and hematoma. Needles may puncture small 
blood vessels during the procedures. Precautions will be taken to avoid inserting needles 
too deeply or into nerves or arteries. There is no evidence that acupuncture treatment may 
result in psychological damage. 
 
In the current study, two sterilised and single-used needles will be used, and the 
acupuncture site will be on one of your legs. Some people may experience minor pricking 
sensations during the early phase of acupuncture. This sensation normally subsides after a 
few seconds. The sensation of soreness, numbness or distension at the needle site may be 
perceived at the acupuncture sites.  
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The electrical acupuncture stimulation machine to be used in this study has been approval 
by the Therapeutic Goods Administration of Australia. 
 
The investigator who will deliver acupuncture treatment is a registered and experienced 
acupuncturist. And all researchers involved in the study have a level 2 First Aid 
certificate.   
 
7. Discontinuation and termination of your participation 
 
Your participation in this study is voluntary. You are free to withdraw from the study at 
any stage of the study. 
 
8. Confidentiality of information you provide 
 
All information provided by you and data collected through this study will be stored in a 
password protected computer program. Authorised auditors may inspect your records. 
You will have access to your records through the investigator. In any form of publication, 
all the personal information will be removed. Group results will be provided on request at 
the end of the study.  
 
9. Benefit of your participation 
 
Your participation will benefit human pain studies and enhance our understanding of 
acupuncture analgesic mechanisms underlying clinic pain. There is no direct benefit to 
you. 
 
10.  Your participation in other research projects 
 
If you are participating in other research projects at the same time, please let us know 
before the commencement of acupuncture treatment. 
 
This project has been reviewed and approved by the Human Research Ethics Committee 
of RMIT University. 
 
If you have any discomfort after the acupuncture treatment or electrical stimulation tests, 
please contact me (Sam) on 9925 7176 or E-mail s3069785@student.rmit.edu.au. 
 
Any question or complaints about your participation in this project may be directed to the Secretary, 
RMIT Human Research Ethics Committee, University Secretariat, RMIT, GPO Box 2476, Melbourne, 
3001. Tel: 9925 1745. 
Details of the complaints procedure are available also from the above address. 
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 Appendix 06 Inform consent form-A 
 
HREC Form 2a 
 
RMIT HUMAN RESEARCH ETHICS COMMITTEE 
Prescribed Consent Form For Persons Participating In Research Projects Involving Tests and/or 
Medical Procedures 
 
PORTFOLIO OF Science, Engineering and Technology 
SCHOOL OF Health Sciences 
Name of participant: 
 
Project Title: The effect of acupuncture on experimental pain (temporal summation of pain): a 
randomised, single-blind, controlled-study 
Name(s) of investigators:    (1)  
Jian Qiang (Sam) Feng 
 
Phone: 
 
9925 7167, 0432214011 
(2)  
(3)  
(4) 
Zhen Zheng                                                                   
Charlie Xue                                                       
Chun Guang Li   
Phone: 9925 7176 
9925 7745 
9925 7635 
 
1. I have received a statement explaining the tests/procedures involved in this project. 
 
2. I consent to participate in the above project, the particulars of which - including details of tests or procedures - 
have been explained to me. 
 
3. I authorise the investigator or his or her assistant to use with me the tests or procedures referred to in 1 above. 
 
4. I acknowledge that: 
 
(a) The possible effects of the tests or procedures have been explained to me to my satisfaction. 
(b) I have been informed that I am free to withdraw from the project at any time and to withdraw any 
unprocessed data previously supplied (unless follow-up is needed for safety). 
(c) The project is for the purpose of research and/or teaching.  It may not be of direct benefit to me. 
(d) The privacy of the personal information I provide will be safeguarded and only disclosed where I 
have consented to the disclosure or as required by law.  
(e) The security of the research data is assured during and after completion of the study.  The data 
collected during the study may be published, and a report of the project outcomes will be provided 
to me. Any information which will identify me will not be used. 
 
 
Participant’s Consent 
 
 
Name: 
 
Date: 
 
(Participant) 
 
 
Name: 
 
Date: 
 
(Witness to signature) 
 
 
 Any complaints about your participation in this project may be directed to the Secretary, RMIT Human Research Ethics Committee, 
University Secretariat, RMIT, GPO Box 2476V, Melbourne, 3001.  The telephone number is (03) 9925 1745.   
Details of the complaints procedure are available from the above address. 
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Appendix 07 Inform consent form-B 
 
HREC Form No 2b 
 
RMIT HUMAN RESEARCH ETHICS COMMITTEE 
Prescribed Consent Form For Persons Participating In Research Projects Involving Interviews, 
Questionnaires or Disclosure of Personal Information 
 
 
PORTFOLIO OF Science, Engineering and Technology 
SCHOOL OF Health Sciences 
Name of participant: 
 
Project Title: The effect of acupuncture on experimental pain (temporal summation of pain): a 
randomised, single-blind, controlled-study 
Name(s) of investigators:    (1)  
Jian Qiang (Sam) Feng 
 
Phone: 
 
9925 7167, 0432214011 
(2) 
 (3)  
(4) 
Zhen Zheng                                                                   
Charlie Xue                                                                  
Chun Guang Li   
Phone: 9925 7176 
9925 7745 
9925 7635 
 
1. I have received a statement explaining the interview/questionnaire involved in this project. 
 
2. I consent to participate in the above project, the particulars of which - including details of the interviews or 
questionnaires - have been explained to me. 
 
3. I authorise the investigator or his or her assistant to interview me or administer questionnaires. 
 
4. I acknowledge that: 
 
(a) Having read Plain Language Statement, I agree to the general purpose, methods and demands of the 
study. 
(b) I have been informed that I am free to withdraw from the project at any time and to withdraw any 
unprocessed data previously supplied. 
(c) The project is for the purpose of research and/or teaching. It may not be of direct benefit to me. 
(d) The privacy of the personal information I provide will be safeguarded and only disclosed where I 
have consented to the disclosure or as required by law.   
(e) The security of the research data is assured during and after completion of the study.  The data 
collected during the study may be published, and a report of the project outcomes will be provided 
to me. Any information which will identify me will not be used. 
 
Participant’s Consent 
 
 
Name: 
 
Date: 
 
(Participant) 
 
 
Name: 
 
Date: 
 
(Witness to signature) 
 
 
Participants should be given a photocopy of this consent form after it has been signed. 
 
Any complaints about your participation in this project may be directed to the Secretary, RMIT Human Research Ethics Committee, 
University Secretariat, RMIT, GPO Box 2476V, Melbourne, 3001.  The telephone number is (03) 9925 1745.   
Details of the complaints procedure are available from the above address. 
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 Appendix 08 Computer generated sequence for randomisation 
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Appendix 09 Visual Analogue Scale (0-100) 
 
Pain Intensity Rating (Visual Analogue Scale) 
 
Name:                                                                                 Date/time:    
Dominant hand:    Right         Left                              Dominant leg:      Right        Left 
Electrical resistance btw electrodes:                                  Voltage: 
Measure Type:       Baseline     0.5h     2h     24h      Measure area:    Forearm   R-leg    L-Leg  
 
Acupuncture site:   R-Leg      L-Leg 
 
Pain threshold:  1st                 2nd                    TS Threshold: 1st              2nd 
 
Level of stimulation: 1.2 x P T/H             1st              2nd              1.4 x p T/H           1st             2nd 
 
The following is an example of how to use the scale to rate the intensity of your pain. 
 
For example, if you draw a perpendicular line on the scale, the distance from 0 to the line is 
35mm. The distance represents the intensity of your pain, which is 35 out of 100. 
 
 
           0                                                                                                                              100 
             (No pain)                                                                                                                    (Worst pain imaginable) 
 
Test 1: Please indicate the intensity of your sensation in response to the 1st and 5th electrical stimulus                    
                
 
1st:  
               0                                                                                                                              100 
              (No Pain)                                                                                               (Worst pain imaginable) 
5th: 
 
 
Test 2: Please indicate the intensity of your sensation in response to the 1st and 5th electrical stimulus 
 
1st: 
                           0                                                                                                                              100 
              (No Pain)                                                                                               (Worst pain imaginable) 
5th: 
 
 
 Test 3: Please indicate the intensity of your sensation in response to the 1st and 5th electrical stimulus 
 
1st: 
 
               0                                                                                                                              100 
              (No Pain)                                                                                               (Worst pain imaginable) 
  5th: 
 
 
 Test 4: Please indicate the intensity of your sensation in response to the 1st and 5th electrical stimulus 
 
1st: 
 
                           0                                                                                                                              100 
              (No Pain)                                                                                               (Worst pain imaginable) 
5th: 
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 Appendix 10 Post-treatment questionnaire 
 
Post-treatment questionnaire  
Project title:  
The effect of acupuncture on experimental pain (temporal summation of pain): a randomised, double-blind, 
controlled-study 
 
Name:                                             Number: 
Please circle the answer.  
 
Section A 
How strong was your sensation of the acupuncture stimulation?  
(1) No pain 
(2) Slight / mild pain 
(3) Moderate pain 
(4) Severe pain 
 
Section B  
(modified from Lao et al., 1999) 
 
Please indicate which treatment you believe you had received. 
 
(1) Acupuncture 
(2) Placebo/sham 
(3) Don’t know 
 
If you answer either Acupuncture or Placebo/sham, what led to that belief? 
 
(1) The manner, attitude, or words of the acupuncturist 
(2) The manner, attitude, or words of the assistant 
(3) The sensation of the acupuncture stimulation  
(4) The results of the acupuncture treatment (eg, changes in pain threshold or rating) 
(5) The experience of the acupuncture procedure (eg, what the acupuncturist did and how it felt) 
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Appendix 11 Reasons for exclusion of any experimental RCT 
 
Study Reason for exclusion 
Li C. L. et al., 1975 No non-invasive control group. 
Saletu B. et al.,1975 No non-invasive control group. 
Stacher G. et al., 1975 No non-invasive control group. 
Stern J. A. et al., 1977 No non-invasive control group. 
Knox V. J. et al., 1979 No non-invasive control group. 
Ashton H. et al. 1984 The needled acupoint was not a recognised acupoints (2cm 
above PC7). 
Ernst M. et al.,1987 No non-invasive control group. 
Lundeberg T. et al., 1988 No non-invasive control group. 
Lundeberg T. et al., 1989 No non-invasive control group. 
Brockhaus A. et al., 1990 No non-invasive control group. 
Moret V. et al., 1991 No non-invasive control group. 
Olausson B. et al., 2000 No non-invasive control group. 
Xu W. D. et al., 2003 No non-invasive control group. No acupuncture technique 
description. 
Leung A. et al., 2005 No non-invasive control group. 
 
Note: The above studies are experimental RCTs using healthy pain-free human subjects to 
evaluate the analgesic effects of EA and MA (133; 143; 144; 145; 146; 147; 148; 149; 150; 151; 
152; 153; 154; 155).  
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Appendix 12 Instructions for reading RveMan output figures showing the results of 
data analyses 
 
The results of RevMan are saved as figure documents and exported to the appendices of the 
thesis (Appendices 13 - 20). When the RevMan output is read from the figures, the positive 
SMD value (+) favours the intervention presented on the right side of the output, whereas the 
negative (-) value favours the intervention presented on the left side of the output. In this 
review, the SMD value was used to indicate the standardised mean difference, and the 
interpretations of the results of data analyses depended on the p value of each comparison. 
The p value less than 0.05 indicates statistically significant differences between the two 
interventions. The SMD is calculated using Hedges’ g. Hedges’ g examines the sample sizes 
of the respective standard deviations and also adjusts the overall effect size based on the 
sample sizes (123) (also see section 4.3.6.2). 
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Appendix 13 Estimation of standardised mean differences, study 01 
 
 MA Non-invasive control SMD (random) SMD (random) Sub-category 
N Mean (SD) N Mean (SD) 95% CI 95% CI 
01 The change of pain threshold 
Mayer et al.         40   6.90(16.84)   35  27.10(27.55)    0.89 [0.41, 1.37]        
Test for effect: Z = 3.66 (P = 0.0003) 
 -4  -2  0  2  4 
 Favours Non-invasive control  Favours MA 
Comparison: MA vs. non-invasive control (the effect instantly during intervention) 
Pain model: Single electrical stimulus induced dental pain 
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Appendix 14 Estimation of standardised mean differences, study 02 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparison 01: 2Hz EA vs. non-invasive control (the effect immediately after inteverntion) 
 2Hz EA Non-invasive control  SMD (random) 
 SMD (random) Sub-category 
N Mean (SD) N Mean (SD)  95% CI  95% CI 
01 Pain rating to pain threshold level stimulation 
Chapman et al.      15        0.83(0.78)           15     1.99(0.95)      
    -1.30 [-2.10, -0.50]      
Test for effect: Z = 3.19 (P = 0.001) 
02 Pain rating to supra-threshold level stimulation 
Chapman et al.      15      1.62(0.65)   15    3.02(0.94)     
    -1.69 [-2.54, -0.84]      
Test for effect: Z = 3.89 (P = 0.0001) 
03 Pain rating to pain tolerance level stimulation 
Chapman et al.      15     2.91(0.83)   15     4.09(0.84)     
    -1.37 [-2.18, -0.57]      
Test for effect: Z = 3.34 (P = 0.0008) 
 -4  -2  0  2  4 
 Favours 2Hz EA  Favours Non-invasive control 
  Invasive control  e+ 
 EA 
 SMD (random) SMD (random) 
Sub-category N Mean (SD) N Mean (SD) 
 95% CI 95% CI 
01 Pain rating to pain threshold level stimulation (VAS) 
Chapman et al.                    15     1.43(0.62)                 15       0.83(0.78)      
   0.83 [0.08, 1.58]        
Test for effect: Z = 2.16 (P = 0.03) 
02 Pain rating to supra-threshold level stimulation (VAS) 
Chapman et al.             
       15      2.36(0.73)                15       1.62(0.65)      
   1.04 [0.27, 1.81]        
Test for effect: Z = 2.65 (P = 0.008) 
03 Pain rating to pain tolerance level stimulation (VAS) 
Chapman et al.                   15      3.43(0.82)                15       2.91(0.83)      
   0.61 [-0.12, 1.35]       
Test for effect: Z = 1.64 (P = 0.10) 
 -4  -2  0  2  4 
 Favours Invasive electrical control  Favours EA 
Comparison 02: 2Hz EA vs. invasive control with electrical stimulation (the effect immediately 
after inteverntion) 
Pain model: Single electrical stimulus induced dental pain assessed by pain response rating 
(VAS) 
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Comparison 03: Invasive control with electrical stimulation vs. non-invasive control (the effect 
immediately after inteverntion) 
 Invasive control e+ Non-invasive control 
 SMD (random)  SMD (random) 
Sub-category N Mean (SD) N Mean (SD) 
 95% CI  95% CI 
01 Pain rating to pain threshold level stimulation (VAS) 
Chapman      15       1.43(0.62)            15      1.99(0.95)     
    -0.68 [-1.42, 0.06]       
Test for effect: Z = 1.80 (P = 0.07) 
02 Pain rating to supra-threshold level stimulation (VAS) 
Chapman             15       2.36(0.73)            15      3.02(0.94)     
    -0.76 [-1.51, -0.02]      
Test for effect: Z = 2.01 (P = 0.04) 
03 Pain rating to pain tolerance level stimulation (VAS) 
Chapman             15       3.43(0.82)            15      4.09(0.84)     
    -0.77 [-1.52, -0.03]      
Test for effect: Z = 2.03 (P = 0.04) 
 -4  -2  0  2  4 
 Favours Invasive electrical control  Favours Non-invasive control 
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Appendix 15 Estimation of standardised mean differences, study 03 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparison 01: MA vs. non-invasive control (the effect instantly during intervention) 
 MA Non-invasive control  SMD (random)  SMD (random) Sub-category 
N Mean (SD) N Mean (SD)  95% CI  95% CI 
   01 The intensity to reach pain threshold 
Johnson et al.           6      15.60(18.60)                6      5.30(2.00)   
    -0.72 [-1.90, 0.47]       
   Test for effect: Z = 1.19 (P = 0.23) 
   02 The intensity to reach pain tolerance threshold 
Johnson et al.           6       33.10(39.40)               6      17.40(2.10)    
  -0.52 [-1.68, 0.64]       
   Test for effect: Z = 0.88 (P = 0.38) 
 -4  -2  0  2  4 
 Favours Non-invasive control  Favours MA 
Pain model: Transcutaneous single electrical stimulus induced pain assessed by the 
change of intensity (µA) to achieve PT or PTT pain responses                                      
Comparison 02: MA vs. non-invasive control (the effect immediately after inteverntion) 
 
 MA Non-invasive control  SMD (random)  SMD (random) Sub-category 
N Mean (SD) N Mean (SD)  95% CI  95% CI 
  01 The intensity to reach pain threshold 
Johnson et al.       6     16.60 (20.60)              6    5.70 (1.70)   
    -0.69 [-1.87, 0.49]       
  Test for effect: Z = 1.14 (P = 0.25) 
  02 The intensity to reach pain tolerance threshold 
Johnson et al.          6     43.40 (78.20)              6    10.20 (3.90)           
    -0.55 [-1.72, 0.61]       
  Test for effect: Z = 0.93 (P = 0.35) 
 -4  -2  0  2  4 
 Favours Non-invasive control  Favours MA 
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Appendix 16 Estimation of standardised mean differences, study 04 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparison: MA vs. non-invasive control (the effect immediately after inteverntion) 
 
 MA (m-) Non-invasive control 
 SMD (random)  SMD (random) 
  Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
   01 The intensity to reach cold pain threshold 
Downs               18     10.36 (4.24)            18     11.87 (5.07)          
     0.32 [-0.34, 0.97]       
  Test for effect: Z = 0.94 (P = 0.35) 
   02 The intensity to reach heat pain threshold 
Downs               18     10.19 (3.44)             18     11.87 (3.02)          
     0.51 [-0.16, 1.17]       
   Test for effect: Z = 1.50 (P = 0.13) 
 -4  -2  0  2  4 
 Favours Non-invasive control  Favours MA 
Pain model: Transcutaneous cold-heat prolonged stimuli induced pain assessed by 
temperature (degree Celsius)       
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Appendix 17 Estimation of standardised mean differences, study 05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparison 01: 120Hz EA vs. non-invasive control (the effect immediately after inteverntion)                                                     
 120Hz EA  Non-invasive control  SMD (random) 
 SMD (random) 
Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
 The duration of heat stimuli to reach pain tolerance threshold 
Berlin et al.           10      9.60 (0.10)        10      7.15 (0.15)     
 18.41 [11.98, 24.83]      
Test for effect: Z = 5.61 (P < 0.00001) 
 -100  -50  0  50  100 
 Favours Non-invasive  Favours 120Hz EA 
Pain model: Transcutaneous prolonged heat stimuli induced pain assessed by the 
stimulating duration to reach pain tolerance threshold 
 Invasive control e+  120Hz EA  SMD (random)  SMD (random) 
Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
The duration of heat stimulation to reach pain tolerance threshold 
Berlin et al.       10       8.10 (0.10)          10     9.60 (0.10)          -14.37 [-19.41, -9.32]     
Test for effect: Z = 5.58 (P < 0.00001) 
 -4  -2  0  2  4 
 Favours 120Hz EA  Favours Invasive control e+ 
Comparison 02: 120Hz EA vs. invasive control with electrical stimulation (the effect immediately 
after inteverntion)                                                      
 Invasive control e+  Non-invasive control  SMD (random) 
 SMD (random) Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
The duration of heat stimulation to reach pain tolerance threshold 
Berlin et al.       10      8.10 (0.10)         10      7.15(0.15)     
     7.14 [4.52, 9.76]        
Test for effect: Z = 5.34 (P < 0.00001) 
 -100  -50  0  50  100 
 Favours Non-invasive  Favours Invasive control e+ 
Comparison 03:  Invasive control with electrical stimulation vs. non-invasive control (the effect 
immediately after inteverntion)                                                      
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Appendix 18 Estimation of standardised mean differences, study 06 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2.5Hz EA  Non-invasive control 
 SMD (random) 
 SMD (random) Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
01 The duration of heat stimuli to reach pain threshold 
Stewart et al.          12    3.40(2.77)    12     1.60(1.73)     
     0.75 [-0.08, 1.59]       
Test for effect: Z = 1.77 (P = 0.08) 
 02 The duration of heat stimuli to reach pain tolerance threshold 
Stewart et al.      
 12    4.60(3.12)    12    2.50(2.08)          0.76 [-0.07, 1.60]       
Test for effect: Z = 1.80 (P = 0.07) 
 -100  -50  0  50  100 
 Favours Non-invasive  Favours 2.5Hz EA 
Pain model: Transcutaneous prolonged heat stimuli induced pain assessed by the 
stimulating duration to reach pain threshold and pain tolerance threshold 
Comparison 01: 2.5Hz EA vs. non-invasive control (the effect immediately after inteverntion)                                                     
Invasive control e+  2.5Hz EA  SMD (random)  SMD (random) 
 Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
 01 The duration of heat stimuli to reach pain threshold 
Stewart et al.         12     3.40(2.77)       12      2.30(1.73)              -0.46 [-1.27, 0.35]       
Test for effect: Z = 1.11 (P = 0.27) 
02 The duration of heat stimuli to reach pain tolerance threshold 
Stewart et al.          12     4.60(3.12)        12      3.70(3.12)              -0.28 [-1.08, 0.53]       
Test for effect: Z = 0.68 (P = 0.50) 
 -4  -2  0  2  4 
 Favours 2.5Hz EA  Favours Invasive control e+ 
Comparison 02: 2.5Hz EA vs. Invasive control with electrical stimulation (the effect immediately 
after inteverntion)                                                                                                            
 - 177 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Invasive control e+  Non-invasive control 
 SMD (random)  SMD (random) 
Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
01 The duration of heat stimuli to reach pain threshold 
  Stewart et al.      12    2.30(1.73)             12      1.60(1.73)          0.39 [-0.42, 1.20]       
Test for effect: Z = 0.95 (P = 0.34) 
02 The duration of heat stimuli to reach pain tolerance threshold 
  Stewart et al.      12    3.70(3.12)             12       2.50(2.08)          0.44 [-0.37, 1.25]       
Test for effect: Z = 1.06 (P = 0.29) 
 -100  -50  0  50  100 
 Favours Non-invasive  Favours Invasive control e+ 
Comparison 03: Invasive control with electrical stimulation vs. non-invasive control (the effect 
immediately after inteverntion)                                                  
 - 178 - 
Appendix 19 Estimation of standardised mean differences, study 07 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparison 01: MA vs. non-invasive control (the effect immediately after inteverntion)                                      
 MA Non-invasive control 
 SMD (random)  SMD (random) Sub-category N Mean (SD) N Mean (SD) 
 95% CI  95% CI 
  01 Pain rating to low-level stimulation 
Kong et al. 11     7.80(2.32)      11      8.60(2.32)         -0.33 [-1.17, 0.51]       
  Test for effect: Z = 0.77 (P = 0.44) 
  02 Pain rating to medium-level stimulation 
Kong et al. 11    11.90(1.33)      11     12.40(1.99)     
    -0.28 [-1.13, 0.56]       
  Test for effect: Z = 0.66 (P = 0.51) 
  03 Pain rating to high-level stimulation 
Kong et al. 11    15.70(1.33)       11    15.90(1.66)         -0.13 [-0.96, 0.71]       
  Test for effect: Z = 0.30 (P = 0.76) 
 -4  -2  0  2  4 
 Favours MA     Favours Non-invasive control 
Pain model: Transcutaneous single heat stimulation (12 seconds duration each) induced 
pain assessed by pain response rating (VAS)                                              
Comparison 02: EA vs. non-invasive control (the effect immediately after inteverntion)                                       
 EA Non-invasive control 
 SMD (random)  SMD (random) Sub-category 
N Mean (SD) N Mean (SD)  95% CI  95% CI 
  01 Pain rating to low-level stimulation 
Kong et al.   11       7.90 (1.99)    11      8.60 (2.32)     
    -0.31 [-1.15, 0.53]       
  Test for effect: Z = 0.73 (P = 0.47) 
  02 Pain rating to medium-level stimulation 
Kong et al.   11     11.30 (1.99)    11     12.40 (1.99)         -0.53 [-1.39, 0.32]       
 Test for effect: Z = 1.22 (P = 0.22) 
  03 Pain rating to high-level stimulation 
Kong et al.    11     15.10 (1.99)    11     15.90 (1.66)     
    -0.42 [-1.27, 0.43]       
  Test for effect: Z = 0.97 (P = 0.33) 
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 EA  MA 
 SMD (random)  SMD (random) Sub-category N Mean (SD) N Mean (SD) 
 95% CI  95% CI 
 01 Pain rating to low-level stimulation 
Kong et al.          11    7.90(1.99)     11        7.80(2.32)          0.04 [-0.79, 0.88]       
 Test for effect: Z = 0.10 (P = 0.92) 
 02 Pain rating to medium-level stimulation 
Kong et al.          11    11.30(1.99)     11      11.90(1.33)     
    -0.34 [-1.18, 0.50]       
 Test for effect: Z = 0.79 (P = 0.43) 
 03 Pain rating to high-level stimulation 
Kong et al.          11     15.10(1.99)     11      15.70(1.33)         -0.34 [-1.18, 0.50]       
 Test for effect: Z = 0.79 (P = 0.43) 
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Comparison 03: EA vs. MA (the effect immediately after inteverntion) 
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Appendix 20 Estimation of standardised mean differences, study 08 
 
 
 Pain model: Transcutaneous prolonged mechanical stimulus induced pain (pressure pain) 
Comparison 01: MA vs. Non-invasive control (the effect immediately after inteverntion)                      
 MA 
 Non-invasive 
control 
 SMD (random)  SMD (random) 
Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
01 PT measured at acupoint LI5 (C5 area) 
Zaslawski  et al.    13     26.30(5.61)    13      3.20(4.69)     
     4.33 [2.84, 5.82]        
Test for effect: Z = 5.69 (P < 0.00001) 
02 PT measured at acupoint LI10 (C6 area) 
Zaslawski et al.  13     27.40(5.66)    13      7.10(4.67)          3.79 [2.43, 5.15]        
Test for effect: Z = 5.47 (P < 0.00001) 
03 PT measured at acupoint LI20 (Distal region) 
Zaslawski et al.    13     20.40(5.71)     13     -1.10(4.80)     
     3.95 [2.55, 5.34]        
Test for effect: Z = 5.54 (P < 0.00001) 
04 PT measured at acupoint SI3 (C8 area) 
Zaslawski et al.          13     17.60(5.59)     13      1.90(4.64)     
     2.96 [1.80, 4.12]        
Test for effect: Z = 4.99 (P < 0.00001) 
05 PT measured at acupoint PC6 (C7 area) 
Zaslawski et al.    13     22.00(5.64)       13      0.40(4.74)     
     4.02 [2.60, 5.43]        
Test for effect: Z = 5.57 (P < 0.00001) 
06 PT measured at acupoint CV12 (T8 area) 
Zaslawski et al.    13     25.40(5.71)       13      5.20(4.74)     
     3.73 [2.39, 5.07]        
Test for effect: Z = 5.44 (P < 0.00001) 
07 PT measured at acupoint ST36 (LI5) 
Zaslawski et al.    13     17.60(5.64)        13      4.70(4.67)          2.41 [1.36, 3.46]        
Test for effect: Z = 4.51 (P < 0.00001) 
08 PT measured at non-acupoint 1R (C6 area) 
Zaslawski et al. 13     22.40(5.66)         13      1.10(4.77)     
     3.94 [2.55, 5.34]        
Test for effect: Z = 5.54 (P < 0.00001) 
09 PT measured at non-acupoint 2R (C8 area) 
Zaslawski et al.    13     25.40(5.64)         13      0.50(4.74)     
     4.63 [3.06, 6.20]        
Test for effect: Z = 5.79 (P < 0.00001) 
10 PT measured at non-acupoint 3R (L5 area) 
Zaslawski et al.     13     17.50(5.72)         13     -0.20(4.69)     
     3.28 [2.04, 4.51]        
Test for effect: Z = 5.20 (P < 0.00001) 
 -10  -5  0  5  10 
 Favours Non-invasive  Favours MA m+ 
 - 181 - 
 
 
 Invasive 
control m+  MA 
 SMD (random)  SMD (random) 
Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
01 PT measured at acupoint LI5 (C5 area) 
Zaslawski et al.  13      26.30(5.61)       9       12.60(4.26)              -2.58 [-3.77, -1.38]      
Test for effect: Z = 4.23 (P < 0.0001) 
02 PT measured at acupoint LI10 (C6 area) 
Zaslawski et al.        13     27.40(5.66)       9       10.90(4.36)              -3.06 [-4.38, -1.75]      
Test for effect: Z = 4.58 (P < 0.00001) 
03 PT measured at acupoint LI20 (Distal region) 
Zaslawski et al.        13   20.40(5.71)          9        6.50(4.29)              -2.58 [-3.77, -1.38]      
Test for effect: Z = 4.23 (P < 0.0001) 
04 PT measured at acupoint SI3 (C8 area) 
Zaslawski et al.        13    17.60(5.59)          9      5.80(4.26)              -2.23 [-3.34, -1.11]      
Test for effect: Z = 3.90 (P < 0.0001) 
05 PT measured at acupoint PC6 (C7 area) 
Zaslawski et al.        13    22.00(5.64)          9       9.50(4.21)              -2.35 [-3.49, -1.21]      
Test for effect: Z = 4.03 (P < 0.0001) 
06 PT measured at acupoint CV12 (T8 area) 
Zaslawski et al.     13     25.40(5.71)        9      14.20(4.31)             -2.07 [-3.16, -0.99]      
Test for effect: Z = 3.74 (P = 0.0002) 
07 PT measured at acupoint ST36 (LI5) 
Zaslawski et al.         13     17.60(5.64)         9       8.30(4.29)              -1.74 [-2.76, -0.72]      
Test for effect: Z = 3.34 (P = 0.0008) 
08 PT measured at non-acupoint 1R (C6 area) 
Zaslawski et al.         13     22.40(5.66)          9       15.10(4.23)         
    -1.37 [-2.33, -0.41]      
Test for effect: Z = 2.79 (P = 0.005) 
09 PT measured at non-acupoint 2R (C8 area) 
Zaslawski et al.         13     25.40(5.64)          9      7.40(4.36)          
    -3.35 [-4.74, -1.97]      
Test for effect: Z = 4.74 (P < 0.00001) 
10 PT measured at non-acupoint 3R (L5 area) 
Zaslawski et al.         13     17.50(5.72)           9     14.90(4.34)          
    -0.48 [-1.34, 0.38]       
Test for effect: Z = 1.09 (P = 0.28) 
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Comparison 02: MA vs. invasive control m+ (the effect immediately after inteverntion) 
 - 182 - 
Comparison 03: MA vs. invasive control m- (the effect immediately after inteverntion) 
 Invasive 
control m- 
 MA  
 SMD (random)  SMD (random) Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
01 PT measured at acupoint LI5 (C5 area) 
Zaslawski et al.    13     26.30(5.61)     13      0.40(4.46)          
    -4.95 [-6.60, -3.30]      
Test for effect: Z = 5.88 (P < 0.00001) 
02 PT measured at acupoint LI10 (C6 area) 
Zaslawski et al.    13     27.40(5.66)     13     -1.40(4.54)              -5.44 [-7.21, -3.66]      
Test for effect: Z = 5.99 (P < 0.00001) 
03 PT measured at acupoint LI20 (Distal region) 
Zaslawski et al.    13     20.40(5.71)     13      2.80(4.62)              -3.28 [-4.52, -2.05]      
Test for effect: Z = 5.20 (P < 0.00001) 
04 PT measured at acupoint SI3 (C8 area) 
Zaslawski et al.    13     17.60(5.59)     13     -2.50(4.59)              -3.81 [-5.17, -2.44]      
Test for effect: Z = 5.48 (P < 0.00001) 
05 PT measured at acupoint PC6 (C7 area) 
Zaslawski et al.    13     22.00(5.64)     13      4.20(4.62)              -3.34 [-4.59, -2.09]      
Test for effect: Z = 5.24 (P < 0.00001) 
06 PT measured at acupoint CV12 (T8 area) 
Zaslawski et al.  13     25.40(5.71)     13     -1.60(4.52)              -5.08 [-6.76, -3.39]      
Test for effect: Z = 5.91 (P < 0.00001) 
07 PT measured at acupoint ST36 (LI5) 
Zaslawski et al.    13     17.60(5.64)     13      2.20(4.80)              -2.85 [-3.99, -1.71] 
Test for effect: Z = 4.90 (P < 0.00001) 
08 PT measured at non-acupoint 1R (C6 area) 
Zaslawski et al.   13     22.40(5.66)     13     -2.50(4.54)          
    -4.70 [-6.29, -3.11]      
Test for effect: Z = 5.81 (P < 0.00001) 
09 PT measured at non-acupoint 2R (C8 area) 
Zaslawski et al.   13     25.40(5.64)     13     -3.70(4.62)              -5.47 [-7.25, -3.68]      
Test for effect: Z = 6.00 (P < 0.00001) 
10 PT measured at non-acupoint 3R (L5 area) 
Zaslawski et al.    13     17.50(5.72)     13     -0.70(4.82)              -3.33 [-4.58, -2.08]      
Test for effect: Z = 5.23 (P < 0.00001) 
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 Invasive 
control m+ 
 Non-invasive 
control 
 SMD (random)  SMD (random) 
Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
01 PT measured at acupoint LI5 (C5 area) 
Zaslawski et al.      13      3.20(4.69)         9     12.60(4.26)          
     2.00 [0.93, 3.07]        
Test for effect: Z = 3.66 (P = 0.0003) 
02 PT measured at acupoint LI10 (C6 area) 
Zaslawski et al.       13      7.10(4.67)        9     10.90(4.36)               0.80 [-0.09, 1.69]       
Test for effect: Z = 1.77 (P = 0.08) 
03 PT measured at acupoint LI20 (Distal region) 
Zaslawski et al.  13     -1.10(4.80)        9      6.50(4.29)          
     1.59 [0.59, 2.58]        
Test for effect: Z = 3.13 (P = 0.002) 
04 PT measured at acupoint SI3 (C8 area) 
Zaslawski et al.       13      1.90(4.64)         9      5.80(4.26)               0.84 [-0.06, 1.73]       
Test for effect: Z = 1.83 (P = 0.07) 
05 PT measured at acupoint PC6 (C7 area) 
Zaslawski et al.   13      0.40(4.74)         9      9.50(4.21)          
     1.93 [0.87, 2.99]        
Test for effect: Z = 3.58 (P = 0.0003) 
06 PT measured at acupoint CV12 (T8 area) 
Zaslawski et al.   13      5.20(4.74)         9     14.20(4.31)          
     1.89 [0.84, 2.94]        
Test for effect: Z = 3.53 (P = 0.0004) 
07 PT measured at acupoint ST36 (LI5) 
Zaslawski et al.   13      4.70(4.67)         9      8.30(4.29)               0.77 [-0.12, 1.65]       
Test for effect: Z = 1.69 (P = 0.09) 
08 PT measured at non-acupoint 1R (C6 area) 
Zaslawski et al.       13      1.10(4.77)          9     15.10(4.23)          
     2.95 [1.67, 4.24]        
Test for effect: Z = 4.51 (P < 0.00001) 
09 PT measured at non-acupoint 2R (C8 area) 
Zaslawski et al.       13      1.10(4.77)          9      7.40(4.36)                    1.45 [0.47, 2.42]        
Test for effect: Z = 2.92 (P = 0.004) 
10 PT measured at non-acupoint 3R (L5 area) 
Zaslawski et al.   13     -0.20(4.69)          9     14.90(4.34)               3.19 [1.85, 4.53]        
Test for effect: Z = 4.65 (P < 0.00001) 
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Comparison 04: Invasive control m+ vs. Non-invasive control (the effect immediately after 
inteverntion) 
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 Invasive 
control m- 
 Non-invasive 
control 
 SMD (random)  SMD (random) 
Sub-category N Mean (SD) N Mean (SD)  95% CI  95% CI 
01 PT measured at acupoint LI5 (C5 area) 
 Zaslawski et al.    13      3.20(4.69)     13      0.40(4.46)          
    -0.59 [-1.38, 0.20]       
Test for effect: Z = 1.47 (P = 0.14) 
02 PT measured at acupoint LI10 (C6 area) 
 Zaslawski et al.    13      7.10(4.67)     13     -1.40(4.54)          
    -1.79 [-2.72, -0.86]      
Test for effect: Z = 3.76 (P = 0.0002) 
03 PT measured at acupoint LI20 (Distal region) 
 Zaslawski et al.    13     -1.10(4.80)     13      2.80(4.62)               0.80 [0.00, 1.61]        
Test for effect: Z = 1.95 (P = 0.05) 
04 PT measured at acupoint SI3 (C8 area) 
 Zaslawski et al.    13      1.90(4.64)     13     -2.50(4.59)              -0.92 [-1.74, -0.11]      
Test for effect: Z = 2.22 (P = 0.03) 
05 PT measured at acupoint PC6 (C7 area) 
 Zaslawski et al.    13      0.40(4.74)     13      4.20(4.62)               0.79 [-0.02, 1.59]       
Test for effect: Z = 1.92 (P = 0.05) 
06 PT measured at acupoint CV12 (T8 area) 
  Zaslawski et al.   13      5.20(4.74)     13     -1.60(4.52)          
    -1.42 [-2.30, -0.55]      
Test for effect: Z = 3.18 (P = 0.001) 
07 PT measured at acupoint ST36 (LI5) 
 Zaslawski et al.    13      4.70(4.67)     13      2.20(4.80)              -0.51 [-1.29, 0.27]       
Test for effect: Z = 1.28 (P = 0.20) 
08 PT measured at non-acupoint 1R (C6 area) 
 Zaslawski et al.    13      1.10(4.77)     13     -2.50(4.54)              -0.75 [-1.55, 0.05]       
Test for effect: Z = 1.83 (P = 0.07) 
09 PT measured at non-acupoint 2R (C8 area) 
 Zaslawski et al.    13      0.50(4.74)     13     -3.70(4.62)              -0.87 [-1.68, -0.06]      
Test for effect: Z = 2.10 (P = 0.04) 
10 PT measured at non-acupoint 3R (L5 area) 
 Zaslawski et al.    13     -0.20(4.69)     13     -0.70(4.82)          
    -0.10 [-0.87, 0.67]       
Test for effect: Z = 0.26 (P = 0.80) 
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Comparison 05: Invasive control m- vs. Non-invasive control (the effect immediately after 
inteverntion) 
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Appendix 21 Abbreviation list 
Abbreviation List (in alphabetical order) 
ANOVA = analysis of variance mRNA = messenger ribonucleic acid 
CNS = central nervous system NIH = National Institutes of Health 
cRNA = catalytic ribonucleic acid NMDA = N-methyl-D-aspartic 
D-D = dense-disperse PLS = Plain Language Statement 
DNIC = Diffuse Noxious Inhibitory 
Control PPD = prepro-dynorphin 
e+ = electro-acupuncture type of electrical 
stimulation is presented PPE = prepro-enkephalin 
ECG = electrocardiogram PT = pain threshold 
EA = electro-acupuncture PTT = pain tolerance threshold 
EBM = evidence base medicine RCT = randomised controlled trials 
EMG = electromyogram RevMan = Review Manager  
EOP = endogenous opioid peptide SA = sham-acupuncture 
ES = electrical stimuli SD = standard deviation 
fMRI = functional magnetic resonance 
imaging SEM = stand error of mean 
Hz = hertz SMD = standardised mean difference 
IASP = International Association for the 
Study of Pain 
SPSS = Statistical Package for the Social 
Sciences 
IVS = Internal Validity Scale SPT = single-stimulus pain threshold 
kg/s = kilogram per second SSAI = Spielberg State and Anxiety Inventory 
µA = microampere ST = supra-threshold 
m- = manipulation was absent STRICTA = Standards for Reporting Interventions in Controlled Trials of Acupuncture 
m+ = manipulation was present TEAS = transcutaneous electrical acupoint 
stimulation 
MA = manual acupuncture TS = temporal summation 
mA = milliampere TST = temporal summation pain threshold 
MEAP = Met-enkephalin-Arg-Phe VAS = visual analogue scale 
mg = milligram WDR = wide dynamic range 
mg/kg = milligram per kilogram WHO = World Health Organisation 
 
